<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB04272</drugbank-id>
  <drugbank-id>EXPT00922</drugbank-id>
  <name>Citric acid</name>
  <description>A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.</description>
  <cas-number>77-92-9</cas-number>
  <unii>XF417D3PSL</unii>
  <average-mass>192.1235</average-mass>
  <monoisotopic-mass>192.02700261</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference>Karl E. Wiegand, "Chemical process for producing citric acid." U.S. Patent US3962287, issued 0000.</synthesis-reference>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity>ORAL (LD50): Acute: 5040 mg/kg [Mouse]. 3000 mg/kg [Rat].</toxicity>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as tricarboxylic acids and derivatives. These are carboxylic acids containing exactly three carboxyl groups.</description>
    <direct-parent>Tricarboxylic acids and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Tricarboxylic acids and derivatives</subclass>
    <alternative-parent>Alpha hydroxy acids and derivatives</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Tertiary alcohols</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-hydroxy acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Hydroxy acid</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Tertiary alcohol</substituent>
    <substituent>Tricarboxylic acid or derivatives</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT001502</drugbank-id>
      <name>Citric acid monohydrate</name>
      <unii>2968PHW8QP</unii>
      <cas-number>5949-29-1</cas-number>
      <inchikey>YASYEJJMZJALEJ-UHFFFAOYSA-N</inchikey>
      <average-mass>210.138</average-mass>
      <monoisotopic-mass>210.037567282</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english" coder="">2-hydroxy-1,2,3-propanetricarboxyic acid</synonym>
    <synonym language="english" coder="">2-Hydroxytricarballylic acid</synonym>
    <synonym language="english" coder="">3-carboxy-3-hydroxypentane-1,5-dioic acid</synonym>
    <synonym language="spanish" coder="">ácido cítrico</synonym>
    <synonym language="latin" coder="">Acidum citricum</synonym>
    <synonym language="english" coder="">Anhydrous citric acid</synonym>
    <synonym language="english" coder="">Citric acid monoglyceride</synonym>
    <synonym language="english" coder="">Citric Acid, Anhydrous</synonym>
    <synonym language="english" coder="">Citric acid,anhydrous</synonym>
    <synonym language="german" coder="">Citronensäure</synonym>
  </synonyms>
  <products>
    <product>
      <name>A-C-D Solution</name>
      <labeller>Draximage A Division Of Draxis Specialty Pharmaceuticals Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00108081</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1959-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-08</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Acd A</name>
      <labeller>Terumo BCT Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>14537-967</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-02-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BA010228</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Acd A</name>
      <labeller>Terumo Bct, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>14537-817</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-02-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BA010228</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Acd A</name>
      <labeller>Terumo Bct, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>14537-815</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-02-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BA010228</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ACD Blood-Pack Units (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN160918</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ACD Solution Modified</name>
      <labeller>Anazao Health Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>51808-201</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-05-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>8 mg/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Acd-A</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-0641</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN160918</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Acd-A</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-10-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN160918</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Acd-A</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53157-796</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-11-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA710497</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Additive Formula 3</name>
      <labeller>Terumo Bct, Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>14537-824</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN001214</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Additive Formula 3</name>
      <labeller>Terumo Bct, Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>14537-826</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN001214</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Additive Formula 3</name>
      <labeller>Terumo Bct, Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>14537-828</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN001214</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Additive Solution Formula 3 As-3</name>
      <labeller>Terumo Bct, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02324393</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-05-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6493</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-05-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6466</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6444</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6495</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6439</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6458</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6487</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6461</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6459</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6502</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-01-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6496</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-06-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6482</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6430</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6501</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6485</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6492</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-05-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6462</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6475</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6484</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6477</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6489</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6453</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6494</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6431</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6483</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-02-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6436</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6464</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6470</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6486</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6488</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6457</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6445</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6449</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6499</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-09-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6508</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6506</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6504</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6507</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka Seltzer</name>
      <labeller>Salimex, S.A.</labeller>
      <ndc-id/>
      <ndc-product-code>53666-403</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka Seltzer</name>
      <labeller>Salimex, S.A.</labeller>
      <ndc-id/>
      <ndc-product-code>53666-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka Seltzer Evt</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00623008</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alka Seltzer Flavoured</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00709077</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alka Seltzer Original</name>
      <labeller>Savings Distributors LLC</labeller>
      <ndc-id/>
      <ndc-product-code>73097-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka Seltzer Original</name>
      <labeller>Navajo Manufacturing Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>67751-143</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer</name>
      <labeller>Lil' Drug Store Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>66715-9703</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer</name>
      <labeller>Bayer</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02152746</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alka-Seltzer Extra Strength</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-0211</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-04-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-seltzer Flavoured</name>
      <labeller>Bayer</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245367</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-09-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alka-seltzer Flavoured - Evt</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02152754</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2004-06-28</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alka-Seltzer Gold</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-4100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-11-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer HEARTBURN</name>
      <labeller>Bayer Bitterfeld GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>65662-408</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on>2010-07-27</ended-marketing-on>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part341</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Heartburn</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-0047</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer HEARTBURN</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-4085</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on>2012-07-31</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Lemon Lime</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-4020</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-11-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Original</name>
      <labeller>Your Safety Company</labeller>
      <ndc-id/>
      <ndc-product-code>70262-304</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-03-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Original</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-4000</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Original</name>
      <labeller>Bayer Bitterfeld GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>65662-005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer Original</name>
      <labeller>R J General Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>70264-014</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer XTRA STRENGTH</name>
      <labeller>Bayer Healthcare Llc.</labeller>
      <ndc-id/>
      <ndc-product-code>0280-4035</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on>2011-04-18</ended-marketing-on>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alka-Seltzer XTRA STRENGTH</name>
      <labeller>Bayer Bitterfeld GmbH</labeller>
      <ndc-id/>
      <ndc-product-code>65662-403</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-03-02</started-marketing-on>
      <ended-marketing-on>2011-04-18</ended-marketing-on>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>All-Natural Pen Spray</name>
      <labeller>Hangzhou Karic Commodities Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>50538-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-02-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Aerosol, spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part333</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Cit Phos Dex Adenine Sol USP</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01960865</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextr Sol Formula A USP</name>
      <labeller>Cutter Med &amp; Biol, Division Of Miles Canada Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00743496</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose A</name>
      <labeller>Citra Labs</labeller>
      <ndc-id/>
      <ndc-product-code>23731-6051</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN020037</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose A ACD-A</name>
      <labeller>Arteriocyte Medical Systems, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>43203-852</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-05-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BA110057</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula A</name>
      <labeller>Terumo Bct, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02469731</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula A</name>
      <labeller>Fresenius Kabi Ag</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00788139</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula B</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00788112</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-07-14</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Dextrose Solution-A</name>
      <labeller>Biomet Biologics</labeller>
      <ndc-id/>
      <ndc-product-code>23731-6040</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-01</started-marketing-on>
      <ended-marketing-on>2010-09-06</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9201</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN170401</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9202</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN170401</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anticoagulant Solution Citrate Phosphate Dextrose (cpd)</name>
      <labeller>Maco Pharma</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02444100</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-08-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>As 3</name>
      <labeller>Terumo BCT Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>14537-966</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN001214</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>bdr Re-action natural low base skin refiner exfoliation essence</name>
      <labeller>Hanaim International Llc</labeller>
      <ndc-id/>
      <ndc-product-code>71056-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>1.5 g/30mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Best Choice Effervescent Antacid Pain Relief</name>
      <labeller>Valu Merchandisers Company</labeller>
      <ndc-id/>
      <ndc-product-code>63941-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bicaruvas</name>
      <labeller>Prosana Distribuciones, S.A. De C.V.</labeller>
      <ndc-id/>
      <ndc-product-code>69728-0002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bicaruvas</name>
      <labeller>Prosana Distribuciones, S.A. De C.V.</labeller>
      <ndc-id/>
      <ndc-product-code>69728-0003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bicaruvas</name>
      <labeller>Prosana Distribuciones, S.A. De C.V.</labeller>
      <ndc-id/>
      <ndc-product-code>69728-0001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Blood Pack Unit Cpd</name>
      <labeller>Fenwal Labs, Division of Baxter Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00273953</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-14</ended-marketing-on>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bromo Seltzer</name>
      <labeller>Tower Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>50201-0421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-07-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bromo Seltzer</name>
      <labeller>Tower Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241892</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-08-21</started-marketing-on>
      <ended-marketing-on>2009-08-31</ended-marketing-on>
      <dosage-form>Granule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Care One Original Antacid and Pain Relief</name>
      <labeller>Foodhold U.S.A.</labeller>
      <ndc-id/>
      <ndc-product-code>41520-444</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-02-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Citracleen</name>
      <labeller>Laboratorios Casen Fleet, S.L.U.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02437880</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C0125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366533</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-03-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C10125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02325640</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C1125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366541</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-07-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C1150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366592</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C2125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366568</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-07-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C2150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366606</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C3125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366576</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-07-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C3150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366614</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citrasate C4125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02366584</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Citric Buffered Normal Saline</name>
      <labeller>Nabriva Therapeutics US, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>72000-030</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-09-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>166 mg/270mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA211673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Citrocarbonate Eff Pws</name>
      <labeller>Roberts Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01971948</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1999-03-31</ended-marketing-on>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clenpiq</name>
      <labeller>Ferring Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55566-6700</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-06-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>NDA209589</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpd</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9206</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN170401</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpd Adenine Cpda 1</name>
      <labeller>Fenwal Labs, Division of Baxter Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00516775</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cpd Solution</name>
      <labeller>Laboratorios Grifols s.a.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02421135</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Unknown</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cpd/adsol</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6476</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpd/adsol</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6503</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpd/adsol</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6505</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN811104</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6479</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN900223</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6478</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN900223</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6481</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN900223</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6336</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-06-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6320</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6343</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9394</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6322</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6331</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6321</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9304</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9395</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9393</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6327</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6329</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6312</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6344</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-12-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6316</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-06-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6332</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-06-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6326</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6308</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6301</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-9398</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6319</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6330</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6305</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6317</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6309</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6307</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cpda-1</name>
      <labeller>Fenwal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0942-6328</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN770420</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CPDA-1 Blood Collection System</name>
      <labeller>Haemonetics Manufacturing Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53157-130</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-11-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN800077</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CPDA-1 Blood Collection System</name>
      <labeller>Haemonetics Manufacturing Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53157-730</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-11-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN800077</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CVS Health Antacid and Pain Reliever</name>
      <labeller>CVS Health</labeller>
      <ndc-id/>
      <ndc-product-code>69842-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra 3</name>
      <labeller>Pegasus Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>55246-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-05-05</started-marketing-on>
      <ended-marketing-on>2009-10-17</ended-marketing-on>
      <dosage-form>Syrup</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra 3</name>
      <labeller>Cypress Pharmaceuticals, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>60258-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-07-29</started-marketing-on>
      <ended-marketing-on>2014-10-11</ended-marketing-on>
      <dosage-form>Syrup</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra-2</name>
      <labeller>Cypress Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60258-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-10-01</started-marketing-on>
      <ended-marketing-on>2014-10-11</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra-2</name>
      <labeller>Pegasus Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>55246-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-05-05</started-marketing-on>
      <ended-marketing-on>2010-12-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra-K</name>
      <labeller>Cypress Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60258-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-09-30</started-marketing-on>
      <ended-marketing-on>2014-10-11</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cytra-K Crystals</name>
      <labeller>Cypress Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60258-005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>DG Health Effervescent Antacid and Pain Relief</name>
      <labeller>DOLGENCORP, INC</labeller>
      <ndc-id/>
      <ndc-product-code>55910-422</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Drug Mart Effervescent Pain Relief</name>
      <labeller>Discount Drug Mart, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53943-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-gas II</name>
      <labeller>E-Z-EM, INC.</labeller>
      <ndc-id/>
      <ndc-product-code>10361-793</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Effervescent Antacid and Pain Relief</name>
      <labeller>H. E. Butt Grocery Company</labeller>
      <ndc-id/>
      <ndc-product-code>37808-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Effervescent Antacid and Pain Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>37205-196</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Effervescent Pain Relief</name>
      <labeller>Western Family Foods</labeller>
      <ndc-id/>
      <ndc-product-code>55312-469</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-01-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Effervescent Pain Relief Fast Relief</name>
      <labeller>Deseret Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>62982-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-09-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Effervescent Pain Relief Fast Relief Fast Relief</name>
      <labeller>Major</labeller>
      <ndc-id/>
      <ndc-product-code>0904-7948</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-04-26</started-marketing-on>
      <ended-marketing-on>2018-08-07</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>EnLyte</name>
      <labeller>Jaymac Pharmaceuticals Llc</labeller>
      <ndc-id/>
      <ndc-product-code>64661-711</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, delayed release pellets</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equaline Effervescent Antacid and Pain Relief</name>
      <labeller>SUPERVALU INC.</labeller>
      <ndc-id/>
      <ndc-product-code>41163-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-11-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Equate Effervescent Antacid and Pain Relief</name>
      <labeller>Walmart</labeller>
      <ndc-id/>
      <ndc-product-code>49035-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-09-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Family Care Effervescent Antacid and Pain Relief</name>
      <labeller>United Exchange Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>65923-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-08-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Family Wellness Effervescent Antacid and Pain Relief</name>
      <labeller>Family Wellness Services, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55319-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-06-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Freds Effervescent Antacid Pain Relief</name>
      <labeller>Freds, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55315-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-06-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Good Sense Effervescent Antacid and Pain Relief</name>
      <labeller>Tower Laboratories Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>50201-4216</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-02-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Additive Solution Formula 3 (AS-3)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-460</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Additive Solution Formula 3 (AS-3)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-462</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Anticoagulant Citrate Dextrose Solution</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-426</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BA980728</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)</name>
      <labeller>Haemonetics Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>57826-455</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-01-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Extracorporeal</route>
      <fda-application-number>BN000127</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hand Sanitizer</name>
      <labeller>NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD</labeller>
      <ndc-id/>
      <ndc-product-code>47993-204</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hand Washing</name>
      <labeller>NINGBO JIANGBEI OCEAN STAR TRADING CO.,LTD</labeller>
      <ndc-id/>
      <ndc-product-code>47993-206</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>0.3 g/100g</strength>
      <route>Topical</route>
      <fda-application-number>part356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs0125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422557</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs1125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422573</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs1150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422565</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs2125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422581</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs2150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422409</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs3125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422603</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs3150</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422611</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemasate Ultra Hs4125</name>
      <labeller>Chief Medical Supplies Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02422417</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs0125</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413876</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs1125</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413892</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs1150</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413930</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs2125</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413906</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs2150</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413957</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs3125</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413914</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs3150</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413965</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemosate Ultra Hs4125</name>
      <labeller>Tqm Enterprises Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02413922</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Hemodialysis</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Heparin Sodium 1000units In 0.9% Sodium Chloride Injection USP</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01935933</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-09-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Heparin Sodium In 5% Dextrose Injection, 25000unit/500ml</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01935941</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>HyVee Health Effervescent Antacid and Pain Relief</name>
      <labeller>Hy-Vee Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>42507-873</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-03</started-marketing-on>
      <ended-marketing-on>2019-09-30</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>IDkit HP ONE</name>
      <labeller>Exalenz Bioscience Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>50402-100</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>NDA021314</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-006</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>IMUFLEX WB-SP BLOOD BAG SYSTEM with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-02-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-007</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kroger Effervescent Antacid and Pain Relief</name>
      <labeller>Kroger Company</labeller>
      <ndc-id/>
      <ndc-product-code>30142-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Effervescent Antacid and Pain Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leader Effervescent Antacid and Pain Relief</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>70000-0412</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-07-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leucoflex CGP</name>
      <labeller>Maco Productions</labeller>
      <ndc-id/>
      <ndc-product-code>14498-002</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-05-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN040083</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leukotrap WB System</name>
      <labeller>Haemonetics Manufacturing Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53157-136</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-11-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN800077</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Leukotrap WB System</name>
      <labeller>Haemonetics Manufacturing Inc</labeller>
      <ndc-id/>
      <ndc-product-code>53157-736</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1980-11-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN800077</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Lytren</name>
      <labeller>Mead Johnson Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00654957</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-08</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lytren Rhs Liq</name>
      <labeller>Mead Johnson Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00841803</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2000-09-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Medique Medi Seltzer</name>
      <labeller>Unifirst First Aid Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>47682-135</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2008-12-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Meijer Effervescent Antacid and Pain Relief</name>
      <labeller>Meijer Distribution Inc</labeller>
      <ndc-id/>
      <ndc-product-code>41250-222</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-05-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MTL1 Leucoflex</name>
      <labeller>Maco Productions</labeller>
      <ndc-id/>
      <ndc-product-code>14498-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-11-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN040083</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Neutra-seltzer</name>
      <labeller>TEVA Canada Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02351544</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nutricel Additive System - CP2D</name>
      <labeller>Medsep Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>62646-120</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA820915</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Oracit</name>
      <labeller>Carolina Medical Products Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00722472</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Oracit</name>
      <labeller>Cmp Pharma, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>46287-014</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-05-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Oracit</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-7352</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-06-07</started-marketing-on>
      <ended-marketing-on>2018-05-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Oral Purgative</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02370271</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-11-16</started-marketing-on>
      <ended-marketing-on>2017-06-22</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pain Relief Fast Relief</name>
      <labeller>Select Brand</labeller>
      <ndc-id/>
      <ndc-product-code>15127-968</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-10-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pico-salax</name>
      <labeller>Ferring Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02254794</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-11-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Picodan</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02300583</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-10-17</started-marketing-on>
      <ended-marketing-on>2012-12-31</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Picoflo</name>
      <labeller>Pharmascience Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02358298</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Picot Plus Effervescent</name>
      <labeller>Bristol Myers Squibb De Mexico, S. De R.L. De C. V.</labeller>
      <ndc-id/>
      <ndc-product-code>64613-5600</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-28</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate and Citric Acid</name>
      <labeller>Pharmaceutical Associates, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0121-0676</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-10-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate Citric Acid Crystals</name>
      <labeller>Virtus Pharmaceuticals LLC</labeller>
      <ndc-id/>
      <ndc-product-code>76439-261</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-06-13</started-marketing-on>
      <ended-marketing-on>2019-04-30</ended-marketing-on>
      <dosage-form>Granule, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-312</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-12-21</started-marketing-on>
      <ended-marketing-on>2016-03-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-412</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-10-20</started-marketing-on>
      <ended-marketing-on>2015-12-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate-Sodium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-311</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-12-21</started-marketing-on>
      <ended-marketing-on>2016-03-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Potassium Citrate-Sodium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-411</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-10-20</started-marketing-on>
      <ended-marketing-on>2015-12-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PramLyte</name>
      <labeller>Allegis Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>28595-400</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-09-11</started-marketing-on>
      <ended-marketing-on>2016-01-04</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>ANDA078604</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premier Value Antacid and Pain Relief Medicine</name>
      <labeller>Chain Drug Consortium</labeller>
      <ndc-id/>
      <ndc-product-code>68016-381</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-05-29</started-marketing-on>
      <ended-marketing-on>2018-03-31</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prepopik</name>
      <labeller>Ferring Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55566-9300</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-07-16</started-marketing-on>
      <ended-marketing-on>2020-05-31</ended-marketing-on>
      <dosage-form>Powder, metered</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>NDA202535</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prepopik</name>
      <labeller>Ferring Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>55566-9700</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-09-05</started-marketing-on>
      <ended-marketing-on>2020-05-31</ended-marketing-on>
      <dosage-form>Powder, metered</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>NDA202535</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Publix Fast Relief Effervescent</name>
      <labeller>Publix Super Markets Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>56062-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-11-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Puralor</name>
      <labeller>Centurion Labs</labeller>
      <ndc-id/>
      <ndc-product-code>23359-700</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-01-01</started-marketing-on>
      <ended-marketing-on>2017-09-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Purg-odan</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02317966</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Quality Choice Effervescent Antacid and Pain Relief</name>
      <labeller>Chain Drug Marketing Association</labeller>
      <ndc-id/>
      <ndc-product-code>63868-229</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-03-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Renacidin</name>
      <labeller>Guardian Laboratories, Division Of United Guardian Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00113069</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1960-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-07</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Irrigation; Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Renacidin</name>
      <labeller>United-Guardian, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0327-0011</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1991-01-01</started-marketing-on>
      <ended-marketing-on>2018-06-01</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number>NDA019481</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Renacidin</name>
      <labeller>United-Guardian, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0327-0012</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number>NDA019481</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Riga Purgative Lemon Flav Liq</name>
      <labeller>Glendale Agencies</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00421367</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1996-11-29</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sal de Uvas Picot</name>
      <labeller>Reckitt Benckiser Mexico, s.a. De c.v.</labeller>
      <ndc-id/>
      <ndc-product-code>70565-580</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-03-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sal de Uvas Picot</name>
      <labeller>Bristol Myers Squibb De Mexico, S. De R.L. De C. V.</labeller>
      <ndc-id/>
      <ndc-product-code>64613-0456</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-03</started-marketing-on>
      <ended-marketing-on>2017-06-30</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sal De Uvas Picot</name>
      <labeller>Navajo Manufacturing Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>67751-174</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Signature Care Effervescent Antacid and Pain Relief</name>
      <labeller>Safeway, Inc</labeller>
      <ndc-id/>
      <ndc-product-code>21130-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Smart Sense Effervescent Antacid and Pain Relief</name>
      <labeller>Kmart Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>49738-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-12-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-9419</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Atlantic Biologicals Corps.</labeller>
      <ndc-id/>
      <ndc-product-code>17856-0595</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Pharmaceutical Associates, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0121-0595</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Pharmaceutical Associates, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0121-1190</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-5777</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate and Citric Acid</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-9410</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-01-01</started-marketing-on>
      <ended-marketing-on>2019-10-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-310</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-12-21</started-marketing-on>
      <ended-marketing-on>2016-03-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sodium Citrate-Citric Acid</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-410</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-10-20</started-marketing-on>
      <ended-marketing-on>2015-12-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sterile Cord Blood Collection Unit</name>
      <labeller>Medsep Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>62646-791</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2011-03-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA800222</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sterile Cord Blood Collection Unit (MSC127D)</name>
      <labeller>Maco Productions</labeller>
      <ndc-id/>
      <ndc-product-code>14498-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-12-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN125552</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sterile Cord Blood Collection Unit (MSC128D)</name>
      <labeller>Maco Productions</labeller>
      <ndc-id/>
      <ndc-product-code>14498-004</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-12-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN125552</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stop Hair</name>
      <labeller>Stop Hair Pty Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>50965-123</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray</dosage-form>
      <strength>0.7 mg/100mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stop Hair</name>
      <labeller>Mila Beauty Pty Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>50965-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray</dosage-form>
      <strength>7 mg/1mL</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-005</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-05-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN820528</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TERUFLEX Blood Bag System with Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-009</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <labeller>Terumo Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>53877-008</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-05-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>BN880217</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Top Value Effervescent Pain Relief</name>
      <labeller>Tower Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>50201-4212</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Top Value Effervescent Pain Relief</name>
      <labeller>Tower Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>50201-4213</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TopCare Effervescent Antacid and Pain Relief</name>
      <labeller>Topco Associates LLC</labeller>
      <ndc-id/>
      <ndc-product-code>36800-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-08-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tricitrates</name>
      <labeller>Pharmaceutical Associates, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0121-0677</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-05-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tricitrates</name>
      <labeller>Atlantic Biologicals Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>17856-0677</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-08-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Urologic G for Irrigation</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00039365</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1969-12-31</started-marketing-on>
      <ended-marketing-on>2018-05-24</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Urologic G for Irrigation</name>
      <labeller>Icu Medical Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00039373</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1971-12-31</started-marketing-on>
      <ended-marketing-on>2018-05-24</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Urologic Solution G</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00800015</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>2011-07-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Irrigation</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vida Mia Pain Relief</name>
      <labeller>Navarro Discount Pharmacies, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>59970-205</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-08-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-2</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-367</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-15</started-marketing-on>
      <ended-marketing-on>2017-05-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-2</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>69543-367</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-17</started-marketing-on>
      <ended-marketing-on>2016-09-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-3</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-366</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-15</started-marketing-on>
      <ended-marketing-on>2017-05-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-3</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>69543-366</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-07</started-marketing-on>
      <ended-marketing-on>2016-09-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-K</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-262</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-05-15</started-marketing-on>
      <ended-marketing-on>2017-05-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virtrate-K</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>69543-262</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-08-07</started-marketing-on>
      <ended-marketing-on>2016-09-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Walgreens Effervescent Pain Relief</name>
      <labeller>Walgreens</labeller>
      <ndc-id/>
      <ndc-product-code>0363-0421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-05-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Whitening Lemon Peel</name>
      <labeller>Ami Cosmetic Co.,Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>59535-1401</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-08-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength>0.007 g/1mL</strength>
      <route>Topical</route>
      <fda-application-number>part331</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>WinCo Foods Effervescent Antacid and Pain Relief</name>
      <labeller>WinCo Foods, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>67091-108</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Zee-Seltzer Antacid and Pain Reliever</name>
      <labeller>Zee Medical Inc</labeller>
      <ndc-id/>
      <ndc-product-code>35418-233</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2006-08-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number>part343</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Cytra-2</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Cytra 3</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose Solution-A</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>All-Natural Pen Spray</name>
      <ingredients>Citric acid + Silver citrate</ingredients>
    </mixture>
    <mixture>
      <name>IDkit HP ONE</name>
      <ingredients>Citric acid + Urea C-13</ingredients>
    </mixture>
    <mixture>
      <name>Stop Hair</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>ACD Solution Modified</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Effervescent Pain Relief Fast Relief Fast Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Effervescent Pain Relief Fast Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Oracit</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Whitening Lemon Peel</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>Pain Relief Fast Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Vida Mia Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Zee-Seltzer Antacid and Pain Reliever</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Effervescent Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cytra-K</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Cytra-2</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Acd-A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Bicaruvas</name>
      <ingredients>Calcium carbonate + Citric acid + L-tartaric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate-Sodium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Bicaruvas</name>
      <ingredients>Calcium carbonate + Citric acid + L-tartaric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cytra 3</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Stop Hair</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>PramLyte</name>
      <ingredients>1,2-Docosahexanoyl-sn-glycero-3-phosphoserine + 1,2-icosapentoyl-sn-glycero-3-phosphoserine + Citric acid + Cobamamide + Cocarboxylase + Escitalopram + Ferrous cysteine glycinate + Flavin adenine dinucleotide + Folic acid + Glycine betaine + Leucovorin + Levomefolic acid + Magnesium ascorbate + NADH + Phosphatidyl serine + Pyridoxal phosphate + Sodium citrate + Zinc ascorbate</ingredients>
    </mixture>
    <mixture>
      <name>Picot Plus Effervescent</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate-Sodium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate-Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cytra-K Crystals</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Sal de Uvas Picot</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bicaruvas</name>
      <ingredients>Calcium carbonate + Citric acid + L-tartaric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Sal de Uvas Picot</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>CVS Health Antacid and Pain Reliever</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer HEARTBURN</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Extra Strength</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Gold</name>
      <ingredients>Citric acid + Potassium bicarbonate + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Puralor</name>
      <ingredients>1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphocholine + 1-(c14-c18 esteroyl)-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine + Acetylcysteine amide + Ascorbic acid + Cholecalciferol + Citric acid + Cobamamide + Egg phospholipids + Folic acid + Gastric intrinsic factor + L-threonic acid + Leucovorin + Levomefolic acid + Magnesium glycinate + Niacin + Pantethine + Papain + Riboflavin + Sodium citrate + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Hand Washing</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>Sterile Cord Blood Collection Unit (MSC128D)</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer XTRA STRENGTH</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer XTRA STRENGTH</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Hand Sanitizer</name>
      <ingredients>Citric acid + Cocamidopropyl betaine</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Premier Value Antacid and Pain Relief Medicine</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Oracit</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>HyVee Health Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Sterile Cord Blood Collection Unit (MSC127D)</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Top Value Effervescent Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Renacidin</name>
      <ingredients>Citric acid + Gluconolactone + Magnesium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Sterile Cord Blood Collection Unit</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Tricitrates</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Tricitrates</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1)</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Citrate Citric Acid Crystals</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>As 3</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Acd A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Good Sense Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>TopCare Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Acd A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Acd A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose A ACD-A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>bdr Re-action natural low base skin refiner exfoliation essence</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>Cpd/adsol</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Top Value Effervescent Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>IMUFLEX WB-SP BLOOD BAG SYSTEM with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ACD Blood-Pack Units (PL 146 Plastic)</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Medique Medi Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-gas II</name>
      <ingredients>Citric acid + Dimethicone + Silicon dioxide + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Leader Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpd/adsol</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Additive Formula 3</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Additive Formula 3</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Additive Formula 3</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Nutricel Additive System - CP2D</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer HEARTBURN</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-3</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-K</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-2</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-K</name>
      <ingredients>Citric acid + Potassium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-2</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Virtrate-3</name>
      <ingredients>Citric acid + Potassium citrate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Walgreens Effervescent Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Best Choice Effervescent Antacid Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Family Wellness Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Smart Sense Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Adsol Red Cell Preservation System In Plastic Container (pl 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>EnLyte</name>
      <ingredients>1,2-Docosahexanoyl-sn-glycero-3-phosphoserine + 1,2-icosapentoyl-sn-glycero-3-phosphoserine + Citric acid + Cobamamide + Cocarboxylase + Ferrous cysteine glycinate + Flavin adenine dinucleotide + Folic acid + Glycine betaine + L-threonic acid + Leucovorin + Levomefolic acid + Magnesium ascorbate + NADH + Phosphatidyl serine + Pyridoxal phosphate + Sodium citrate + Zinc ascorbate</ingredients>
    </mixture>
    <mixture>
      <name>Sodium Citrate and Citric Acid</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Leukotrap WB System</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>CPDA-1 Blood Collection System</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>CPDA-1 Blood Collection System</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Drug Mart Effervescent Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Freds Effervescent Antacid Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>DG Health Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Citric Buffered Normal Saline</name>
      <ingredients>Citric acid</ingredients>
    </mixture>
    <mixture>
      <name>Prepopik</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Prepopik</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Additive Solution Formula 3 (AS-3)</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Additive Solution Formula 3 (AS-3)</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Anticoagulant Citrate Phosphate Double Dextrose Solution (CP2D)</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Care One Original Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Family Care Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Equaline Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Bromo Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Clenpiq</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>CPD/ADSOL Red Cell Preservation Solution System (PL 2209)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Lemon Lime</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpd/adsol</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpd</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Acd-A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Acd-A</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>MTL1 Leucoflex</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Sal De Uvas Picot</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer Heartburn</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer Original</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Equate Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Publix Fast Relief Effervescent</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Signature Care Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Quality Choice Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Leucoflex CGP</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Cpda-1</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>IMUFLEX WB-SP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Saving Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) and OPTISOL (AS-5) Red Cell Preservative</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>TERUFLEX Blood Bag System with Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>Haemonetics Anticoagulant Citrate Dextrose Solution</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>Kroger Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Meijer Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>WinCo Foods Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Effervescent Antacid and Pain Relief</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Leukotrap WB System</name>
      <ingredients>Adenine + Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>TERUFLEX Blood Bag System with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>TERUFLEX Blood Bag System Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL Red Cell Preservative</name>
      <ingredients>Adenine + Citric acid + D-glucose + D-glucose + Mannitol + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic, unspecified form</ingredients>
    </mixture>
    <mixture>
      <name>Renacidin</name>
      <ingredients>Citric acid + Gluconolactone + Magnesium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Heparin Sodium In 5% Dextrose Injection, 25000unit/500ml</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Heparin + Sodium phosphate, dibasic</ingredients>
    </mixture>
    <mixture>
      <name>Pico-salax</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Purg-odan</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Additive Solution Formula 3 As-3</name>
      <ingredients>Adenine + Citric acid + Dextrose, unspecified form + Sodium chloride + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C0125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C1125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C2125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C3125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C4125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C1150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C2150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C3150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Lytren Rhs Liq</name>
      <ingredients>Citric acid + Potassium citrate + Sodium chloride + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula B</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Citrocarbonate Eff Pws</name>
      <ingredients>Citric acid + Sodium bicarbonate + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>A-C-D Solution</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Blood Pack Unit Cpd</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Renacidin</name>
      <ingredients>Citric acid + Gluconic Acid</ingredients>
    </mixture>
    <mixture>
      <name>Riga Purgative Lemon Flav Liq</name>
      <ingredients>Citric acid + Sodium bicarbonate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer Flavoured</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-seltzer Flavoured - Evt</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Cpd Adenine Cpda 1</name>
      <ingredients>Adenine + Citric acid + Dextrose, unspecified form + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Bromo Seltzer</name>
      <ingredients>Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Lytren</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Potassium citrate + Sodium chloride + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Picodan</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Oracit</name>
      <ingredients>Citric acid + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextr Sol Formula A USP</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Urologic Solution G</name>
      <ingredients>Citric acid + Magnesium oxide + Sodium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Citrasate C10125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs0125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs1125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs2125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs3125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs4125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs1150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs2150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemosate Ultra Hs3150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium acetate + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Cpd Solution</name>
      <ingredients>Citric acid + D-glucose + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs2150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs4125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs0125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs1150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs1125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs2125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs3125</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Hemasate Ultra Hs3150</name>
      <ingredients>Calcium chloride + Citric acid + Dextrose, unspecified form + Magnesium chloride + Potassium chloride + Sodium chloride</ingredients>
    </mixture>
    <mixture>
      <name>Citracleen</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Solution Citrate Phosphate Dextrose (cpd)</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Oral Purgative</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Heparin Sodium 1000units In 0.9% Sodium Chloride Injection USP</name>
      <ingredients>Citric acid + Heparin + Sodium chloride + Sodium phosphate, dibasic</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Cit Phos Dex Adenine Sol USP</name>
      <ingredients>Adenine + Citric acid + Dextrose, unspecified form + Sodium citrate + Sodium phosphate, monobasic</ingredients>
    </mixture>
    <mixture>
      <name>Alka-Seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka-seltzer Flavoured</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Picoflo</name>
      <ingredients>Citric acid + Magnesium oxide + Picosulfuric acid</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula A</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Urologic G for Irrigation</name>
      <ingredients>Citric acid + Magnesium oxide + Sodium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Anticoagulant Citrate Dextrose Solution USP (acd) Formula A</name>
      <ingredients>Citric acid + Dextrose, unspecified form + Sodium citrate</ingredients>
    </mixture>
    <mixture>
      <name>Urologic G for Irrigation</name>
      <ingredients>Citric acid + Magnesium oxide + Sodium carbonate</ingredients>
    </mixture>
    <mixture>
      <name>Neutra-seltzer</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
    <mixture>
      <name>Alka Seltzer Evt</name>
      <ingredients>Acetylsalicylic acid + Citric acid + Sodium bicarbonate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acid Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Acidifying Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Acids, Acyclic</category>
      <mesh-id>D000144</mesh-id>
    </category>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Calcium Chelating Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Calcium Chelating Agents</category>
      <mesh-id>D065096</mesh-id>
    </category>
    <category>
      <category>Calculi Dissolution Agent</category>
      <mesh-id/>
    </category>
    <category>
      <category>Chelating Agents</category>
      <mesh-id>D002614</mesh-id>
    </category>
    <category>
      <category>Citrates</category>
      <mesh-id>D002951</mesh-id>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Decreased Coagulation Factor Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Digestives, Incl. Enzymes</category>
      <mesh-id/>
    </category>
    <category>
      <category>Hematologic Agents</category>
      <mesh-id>D006401</mesh-id>
    </category>
    <category>
      <category>Sequestering Agents</category>
      <mesh-id>D064449</mesh-id>
    </category>
    <category>
      <category>Tricarboxylic Acids</category>
      <mesh-id>D014233</mesh-id>
    </category>
    <category>
      <category>Urinary Acidifying Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Urinary Alkalinisers</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>8 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Unknown</route>
      <strength/>
    </dosage>
    <dosage>
      <form/>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, effervescent</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Aerosol, spray</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Extracorporeal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Extracorporeal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>1.5 g/30mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Granule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Hemodialysis</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>166 mg/270mL</strength>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Syrup</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Granule, for solution</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule, delayed release pellets</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>0.3 g/100g</strength>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, metered</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Irrigation; Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Irrigation</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Granule, effervescent</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Topical</route>
      <strength>0.7 mg/100mL</strength>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Topical</route>
      <strength>7 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Irrigation</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength>0.007 g/1mL</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A09AB04">
      <level code="A09AB">Acid preparations</level>
      <level code="A09A">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A09">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1a59</pdb-entry>
    <pdb-entry>1afl</pdb-entry>
    <pdb-entry>1agr</pdb-entry>
    <pdb-entry>1aj8</pdb-entry>
    <pdb-entry>1az2</pdb-entry>
    <pdb-entry>1b1e</pdb-entry>
    <pdb-entry>1b1i</pdb-entry>
    <pdb-entry>1cts</pdb-entry>
    <pdb-entry>1cwv</pdb-entry>
    <pdb-entry>1cxu</pdb-entry>
    <pdb-entry>1cz9</pdb-entry>
    <pdb-entry>1d3b</pdb-entry>
    <pdb-entry>1dmg</pdb-entry>
    <pdb-entry>1dvp</pdb-entry>
    <pdb-entry>1dyt</pdb-entry>
    <pdb-entry>1e5k</pdb-entry>
    <pdb-entry>1eaz</pdb-entry>
    <pdb-entry>1ekj</pdb-entry>
    <pdb-entry>1emd</pdb-entry>
    <pdb-entry>1eqd</pdb-entry>
    <pdb-entry>1erx</pdb-entry>
    <pdb-entry>1f8r</pdb-entry>
    <pdb-entry>1fq0</pdb-entry>
    <pdb-entry>1fuo</pdb-entry>
    <pdb-entry>1fuq</pdb-entry>
    <pdb-entry>1fwr</pdb-entry>
    <pdb-entry>1g1l</pdb-entry>
    <pdb-entry>1gcz</pdb-entry>
    <pdb-entry>1gd0</pdb-entry>
    <pdb-entry>1gi7</pdb-entry>
    <pdb-entry>1gi8</pdb-entry>
    <pdb-entry>1gi9</pdb-entry>
    <pdb-entry>1gj7</pdb-entry>
    <pdb-entry>1gj8</pdb-entry>
    <pdb-entry>1gj9</pdb-entry>
    <pdb-entry>1gja</pdb-entry>
    <pdb-entry>1gjb</pdb-entry>
    <pdb-entry>1gjc</pdb-entry>
    <pdb-entry>1gjd</pdb-entry>
    <pdb-entry>1go6</pdb-entry>
    <pdb-entry>1gpj</pdb-entry>
    <pdb-entry>1gpm</pdb-entry>
    <pdb-entry>1gv7</pdb-entry>
    <pdb-entry>1gve</pdb-entry>
    <pdb-entry>1h1l</pdb-entry>
    <pdb-entry>1h4c</pdb-entry>
    <pdb-entry>1h4d</pdb-entry>
    <pdb-entry>1h4e</pdb-entry>
    <pdb-entry>1h53</pdb-entry>
    <pdb-entry>1hhc</pdb-entry>
    <pdb-entry>1hhu</pdb-entry>
    <pdb-entry>1hjj</pdb-entry>
    <pdb-entry>1hjl</pdb-entry>
    <pdb-entry>1hqs</pdb-entry>
    <pdb-entry>1hto</pdb-entry>
    <pdb-entry>1htq</pdb-entry>
    <pdb-entry>1i2s</pdb-entry>
    <pdb-entry>1i4k</pdb-entry>
    <pdb-entry>1ixe</pdb-entry>
    <pdb-entry>1j3n</pdb-entry>
    <pdb-entry>1jch</pdb-entry>
    <pdb-entry>1jeo</pdb-entry>
    <pdb-entry>1k4m</pdb-entry>
    <pdb-entry>1k59</pdb-entry>
    <pdb-entry>1k5b</pdb-entry>
    <pdb-entry>1kmp</pdb-entry>
    <pdb-entry>1kq7</pdb-entry>
    <pdb-entry>1kwm</pdb-entry>
    <pdb-entry>1kxg</pdb-entry>
    <pdb-entry>1l8d</pdb-entry>
    <pdb-entry>1lf7</pdb-entry>
    <pdb-entry>1lt7</pdb-entry>
    <pdb-entry>1lt8</pdb-entry>
    <pdb-entry>1m0s</pdb-entry>
    <pdb-entry>1mau</pdb-entry>
    <pdb-entry>1mk0</pdb-entry>
    <pdb-entry>1mld</pdb-entry>
    <pdb-entry>1mqo</pdb-entry>
    <pdb-entry>1mrz</pdb-entry>
    <pdb-entry>1nml</pdb-entry>
    <pdb-entry>1o3p</pdb-entry>
    <pdb-entry>1o4l</pdb-entry>
    <pdb-entry>1o5a</pdb-entry>
    <pdb-entry>1o5b</pdb-entry>
    <pdb-entry>1o5c</pdb-entry>
    <pdb-entry>1ocy</pdb-entry>
    <pdb-entry>1p2z</pdb-entry>
    <pdb-entry>1pca</pdb-entry>
    <pdb-entry>1pq8</pdb-entry>
    <pdb-entry>1q0h</pdb-entry>
    <pdb-entry>1qb7</pdb-entry>
    <pdb-entry>1qb8</pdb-entry>
    <pdb-entry>1qcc</pdb-entry>
    <pdb-entry>1qmh</pdb-entry>
    <pdb-entry>1r74</pdb-entry>
    <pdb-entry>1re0</pdb-entry>
    <pdb-entry>1re5</pdb-entry>
    <pdb-entry>1reo</pdb-entry>
    <pdb-entry>1rpq</pdb-entry>
    <pdb-entry>1rq2</pdb-entry>
    <pdb-entry>1rz6</pdb-entry>
    <pdb-entry>1smk</pdb-entry>
    <pdb-entry>1ss4</pdb-entry>
    <pdb-entry>1t8t</pdb-entry>
    <pdb-entry>1t9r</pdb-entry>
    <pdb-entry>1t9z</pdb-entry>
    <pdb-entry>1ta0</pdb-entry>
    <pdb-entry>1tet</pdb-entry>
    <pdb-entry>1tf0</pdb-entry>
    <pdb-entry>1tm1</pdb-entry>
    <pdb-entry>1tm3</pdb-entry>
    <pdb-entry>1tm4</pdb-entry>
    <pdb-entry>1tm5</pdb-entry>
    <pdb-entry>1tm7</pdb-entry>
    <pdb-entry>1tmg</pdb-entry>
    <pdb-entry>1to1</pdb-entry>
    <pdb-entry>1to2</pdb-entry>
    <pdb-entry>1tzx</pdb-entry>
    <pdb-entry>1u11</pdb-entry>
    <pdb-entry>1u6t</pdb-entry>
    <pdb-entry>1uej</pdb-entry>
    <pdb-entry>1ujp</pdb-entry>
    <pdb-entry>1ult</pdb-entry>
    <pdb-entry>1un4</pdb-entry>
    <pdb-entry>1un5</pdb-entry>
    <pdb-entry>1us0</pdb-entry>
    <pdb-entry>1uyp</pdb-entry>
    <pdb-entry>1uzr</pdb-entry>
    <pdb-entry>1v7r</pdb-entry>
    <pdb-entry>1vbj</pdb-entry>
    <pdb-entry>1vkf</pdb-entry>
    <pdb-entry>1vl1</pdb-entry>
    <pdb-entry>1vma</pdb-entry>
    <pdb-entry>1w2t</pdb-entry>
    <pdb-entry>1w8o</pdb-entry>
    <pdb-entry>1wdi</pdb-entry>
    <pdb-entry>1x96</pdb-entry>
    <pdb-entry>1x98</pdb-entry>
    <pdb-entry>1x9j</pdb-entry>
    <pdb-entry>1xe8</pdb-entry>
    <pdb-entry>1xf1</pdb-entry>
    <pdb-entry>1xjb</pdb-entry>
    <pdb-entry>1xjt</pdb-entry>
    <pdb-entry>1xt3</pdb-entry>
    <pdb-entry>1xvy</pdb-entry>
    <pdb-entry>1y1k</pdb-entry>
    <pdb-entry>1y33</pdb-entry>
    <pdb-entry>1y34</pdb-entry>
    <pdb-entry>1y3b</pdb-entry>
    <pdb-entry>1y3c</pdb-entry>
    <pdb-entry>1y3d</pdb-entry>
    <pdb-entry>1y3f</pdb-entry>
    <pdb-entry>1y48</pdb-entry>
    <pdb-entry>1y4a</pdb-entry>
    <pdb-entry>1yfk</pdb-entry>
    <pdb-entry>1yjx</pdb-entry>
    <pdb-entry>1yki</pdb-entry>
    <pdb-entry>1yul</pdb-entry>
    <pdb-entry>1yum</pdb-entry>
    <pdb-entry>1yy7</pdb-entry>
    <pdb-entry>1z1e</pdb-entry>
    <pdb-entry>1z1f</pdb-entry>
    <pdb-entry>1z7x</pdb-entry>
    <pdb-entry>1z9t</pdb-entry>
    <pdb-entry>1zc2</pdb-entry>
    <pdb-entry>1zea</pdb-entry>
    <pdb-entry>1zpd</pdb-entry>
    <pdb-entry>1zx4</pdb-entry>
    <pdb-entry>2a6c</pdb-entry>
    <pdb-entry>2acs</pdb-entry>
    <pdb-entry>2acu</pdb-entry>
    <pdb-entry>2aex</pdb-entry>
    <pdb-entry>2agk</pdb-entry>
    <pdb-entry>2agt</pdb-entry>
    <pdb-entry>2al0</pdb-entry>
    <pdb-entry>2ang</pdb-entry>
    <pdb-entry>2asf</pdb-entry>
    <pdb-entry>2azt</pdb-entry>
    <pdb-entry>2b5u</pdb-entry>
    <pdb-entry>2bs3</pdb-entry>
    <pdb-entry>2bs4</pdb-entry>
    <pdb-entry>2c4v</pdb-entry>
    <pdb-entry>2c6x</pdb-entry>
    <pdb-entry>2c6z</pdb-entry>
    <pdb-entry>2c74</pdb-entry>
    <pdb-entry>2c7p</pdb-entry>
    <pdb-entry>2c7q</pdb-entry>
    <pdb-entry>2cad</pdb-entry>
    <pdb-entry>2ci1</pdb-entry>
    <pdb-entry>2ci5</pdb-entry>
    <pdb-entry>2cmd</pdb-entry>
    <pdb-entry>2csg</pdb-entry>
    <pdb-entry>2cts</pdb-entry>
    <pdb-entry>2cz5</pdb-entry>
    <pdb-entry>2cze</pdb-entry>
    <pdb-entry>2czq</pdb-entry>
    <pdb-entry>2d1c</pdb-entry>
    <pdb-entry>2dc1</pdb-entry>
    <pdb-entry>2ddf</pdb-entry>
    <pdb-entry>2dtj</pdb-entry>
    <pdb-entry>2dx7</pdb-entry>
    <pdb-entry>2eaa</pdb-entry>
    <pdb-entry>2f2l</pdb-entry>
    <pdb-entry>2f6u</pdb-entry>
    <pdb-entry>2fqd</pdb-entry>
    <pdb-entry>2fqe</pdb-entry>
    <pdb-entry>2fqf</pdb-entry>
    <pdb-entry>2fqg</pdb-entry>
    <pdb-entry>2fus</pdb-entry>
    <pdb-entry>2fw0</pdb-entry>
    <pdb-entry>2fw6</pdb-entry>
    <pdb-entry>2fwp</pdb-entry>
    <pdb-entry>2g88</pdb-entry>
    <pdb-entry>2gbb</pdb-entry>
    <pdb-entry>2gc9</pdb-entry>
    <pdb-entry>2hau</pdb-entry>
    <pdb-entry>2hav</pdb-entry>
    <pdb-entry>2hd9</pdb-entry>
    <pdb-entry>2hi9</pdb-entry>
    <pdb-entry>2hj0</pdb-entry>
    <pdb-entry>2hjr</pdb-entry>
    <pdb-entry>2i16</pdb-entry>
    <pdb-entry>2i17</pdb-entry>
    <pdb-entry>2i29</pdb-entry>
    <pdb-entry>2i2b</pdb-entry>
    <pdb-entry>2i2d</pdb-entry>
    <pdb-entry>2i54</pdb-entry>
    <pdb-entry>2i7f</pdb-entry>
    <pdb-entry>2il2</pdb-entry>
    <pdb-entry>2is5</pdb-entry>
    <pdb-entry>2o2d</pdb-entry>
    <pdb-entry>2oaf</pdb-entry>
    <pdb-entry>2okl</pdb-entry>
    <pdb-entry>2ot4</pdb-entry>
    <pdb-entry>2owz</pdb-entry>
    <pdb-entry>2p3l</pdb-entry>
    <pdb-entry>2p3o</pdb-entry>
    <pdb-entry>2p41</pdb-entry>
    <pdb-entry>2p6z</pdb-entry>
    <pdb-entry>2p7k</pdb-entry>
    <pdb-entry>2p8i</pdb-entry>
    <pdb-entry>2p9e</pdb-entry>
    <pdb-entry>2pev</pdb-entry>
    <pdb-entry>2pf8</pdb-entry>
    <pdb-entry>2pfh</pdb-entry>
    <pdb-entry>2pg4</pdb-entry>
    <pdb-entry>2pqf</pdb-entry>
    <pdb-entry>2q1x</pdb-entry>
    <pdb-entry>2q2h</pdb-entry>
    <pdb-entry>2q4g</pdb-entry>
    <pdb-entry>2q83</pdb-entry>
    <pdb-entry>2qe9</pdb-entry>
    <pdb-entry>2qeu</pdb-entry>
    <pdb-entry>2qik</pdb-entry>
    <pdb-entry>2ql5</pdb-entry>
    <pdb-entry>2ql7</pdb-entry>
    <pdb-entry>2ql9</pdb-entry>
    <pdb-entry>2qlb</pdb-entry>
    <pdb-entry>2qlj</pdb-entry>
    <pdb-entry>2qpq</pdb-entry>
    <pdb-entry>2qvr</pdb-entry>
    <pdb-entry>2qxw</pdb-entry>
    <pdb-entry>2r2v</pdb-entry>
    <pdb-entry>2r4i</pdb-entry>
    <pdb-entry>2rdg</pdb-entry>
    <pdb-entry>2rij</pdb-entry>
    <pdb-entry>2v03</pdb-entry>
    <pdb-entry>2v9m</pdb-entry>
    <pdb-entry>2v9n</pdb-entry>
    <pdb-entry>2vek</pdb-entry>
    <pdb-entry>2ven</pdb-entry>
    <pdb-entry>2vn8</pdb-entry>
    <pdb-entry>2vns</pdb-entry>
    <pdb-entry>2voh</pdb-entry>
    <pdb-entry>2vq3</pdb-entry>
    <pdb-entry>2vuv</pdb-entry>
    <pdb-entry>2vxy</pdb-entry>
    <pdb-entry>2w03</pdb-entry>
    <pdb-entry>2wc8</pdb-entry>
    <pdb-entry>2wcq</pdb-entry>
    <pdb-entry>2wgv</pdb-entry>
    <pdb-entry>2wk0</pdb-entry>
    <pdb-entry>2wrs</pdb-entry>
    <pdb-entry>2wve</pdb-entry>
    <pdb-entry>2x7i</pdb-entry>
    <pdb-entry>2xb9</pdb-entry>
    <pdb-entry>2xcu</pdb-entry>
    <pdb-entry>2xig</pdb-entry>
    <pdb-entry>2xu2</pdb-entry>
    <pdb-entry>2y1p</pdb-entry>
    <pdb-entry>2y6k</pdb-entry>
    <pdb-entry>2y91</pdb-entry>
    <pdb-entry>2z02</pdb-entry>
    <pdb-entry>2z6w</pdb-entry>
    <pdb-entry>2z92</pdb-entry>
    <pdb-entry>2znh</pdb-entry>
    <pdb-entry>2zqm</pdb-entry>
    <pdb-entry>2zwa</pdb-entry>
    <pdb-entry>2zzj</pdb-entry>
    <pdb-entry>2zzk</pdb-entry>
    <pdb-entry>3a56</pdb-entry>
    <pdb-entry>3alp</pdb-entry>
    <pdb-entry>3b0c</pdb-entry>
    <pdb-entry>3b0d</pdb-entry>
    <pdb-entry>3b2q</pdb-entry>
    <pdb-entry>3bb5</pdb-entry>
    <pdb-entry>3bcj</pdb-entry>
    <pdb-entry>3bdl</pdb-entry>
    <pdb-entry>3bhd</pdb-entry>
    <pdb-entry>3bjk</pdb-entry>
    <pdb-entry>3bm3</pdb-entry>
    <pdb-entry>3bsw</pdb-entry>
    <pdb-entry>3bx9</pdb-entry>
    <pdb-entry>3bxa</pdb-entry>
    <pdb-entry>3bzm</pdb-entry>
    <pdb-entry>3c5a</pdb-entry>
    <pdb-entry>3c8d</pdb-entry>
    <pdb-entry>3c8w</pdb-entry>
    <pdb-entry>3c9h</pdb-entry>
    <pdb-entry>3cbw</pdb-entry>
    <pdb-entry>3cgg</pdb-entry>
    <pdb-entry>3ch0</pdb-entry>
    <pdb-entry>3ckj</pdb-entry>
    <pdb-entry>3csw</pdb-entry>
    <pdb-entry>3cts</pdb-entry>
    <pdb-entry>3cwm</pdb-entry>
    <pdb-entry>3dao</pdb-entry>
    <pdb-entry>3dge</pdb-entry>
    <pdb-entry>3drn</pdb-entry>
    <pdb-entry>3e2r</pdb-entry>
    <pdb-entry>3e4f</pdb-entry>
    <pdb-entry>3e8r</pdb-entry>
    <pdb-entry>3edz</pdb-entry>
    <pdb-entry>3ejk</pdb-entry>
    <pdb-entry>3elg</pdb-entry>
    <pdb-entry>3f2e</pdb-entry>
    <pdb-entry>3f7c</pdb-entry>
    <pdb-entry>3fry</pdb-entry>
    <pdb-entry>3g68</pdb-entry>
    <pdb-entry>3gft</pdb-entry>
    <pdb-entry>3ghf</pdb-entry>
    <pdb-entry>3ghr</pdb-entry>
    <pdb-entry>3ghs</pdb-entry>
    <pdb-entry>3ght</pdb-entry>
    <pdb-entry>3ghu</pdb-entry>
    <pdb-entry>3gm5</pdb-entry>
    <pdb-entry>3gni</pdb-entry>
    <pdb-entry>3gve</pdb-entry>
    <pdb-entry>3gz7</pdb-entry>
    <pdb-entry>3h4y</pdb-entry>
    <pdb-entry>3h55</pdb-entry>
    <pdb-entry>3h97</pdb-entry>
    <pdb-entry>3h99</pdb-entry>
    <pdb-entry>3h9b</pdb-entry>
    <pdb-entry>3h9c</pdb-entry>
    <pdb-entry>3hba</pdb-entry>
    <pdb-entry>3hch</pdb-entry>
    <pdb-entry>3hh2</pdb-entry>
    <pdb-entry>3hvs</pdb-entry>
    <pdb-entry>3i09</pdb-entry>
    <pdb-entry>3i43</pdb-entry>
    <pdb-entry>3itc</pdb-entry>
    <pdb-entry>3itj</pdb-entry>
    <pdb-entry>3jvu</pdb-entry>
    <pdb-entry>3jvv</pdb-entry>
    <pdb-entry>3k1l</pdb-entry>
    <pdb-entry>3k49</pdb-entry>
    <pdb-entry>3k6v</pdb-entry>
    <pdb-entry>3kgq</pdb-entry>
    <pdb-entry>3kn3</pdb-entry>
    <pdb-entry>3kx6</pdb-entry>
    <pdb-entry>3l57</pdb-entry>
    <pdb-entry>3l6t</pdb-entry>
    <pdb-entry>3lb0</pdb-entry>
    <pdb-entry>3lbo</pdb-entry>
    <pdb-entry>3ld5</pdb-entry>
    <pdb-entry>3lep</pdb-entry>
    <pdb-entry>3lfk</pdb-entry>
    <pdb-entry>3lif</pdb-entry>
    <pdb-entry>3lmz</pdb-entry>
    <pdb-entry>3lql</pdb-entry>
    <pdb-entry>3ly1</pdb-entry>
    <pdb-entry>3lz3</pdb-entry>
    <pdb-entry>3lz5</pdb-entry>
    <pdb-entry>3m4h</pdb-entry>
    <pdb-entry>3m9y</pdb-entry>
    <pdb-entry>3ma8</pdb-entry>
    <pdb-entry>3mfd</pdb-entry>
    <pdb-entry>3mlp</pdb-entry>
    <pdb-entry>3mmx</pdb-entry>
    <pdb-entry>3mrg</pdb-entry>
    <pdb-entry>3mwd</pdb-entry>
    <pdb-entry>3mxu</pdb-entry>
    <pdb-entry>3n27</pdb-entry>
    <pdb-entry>3n3h</pdb-entry>
    <pdb-entry>3n7q</pdb-entry>
    <pdb-entry>3nat</pdb-entry>
    <pdb-entry>3nnb</pdb-entry>
    <pdb-entry>3no2</pdb-entry>
    <pdb-entry>3nor</pdb-entry>
    <pdb-entry>3nr3</pdb-entry>
    <pdb-entry>3nua</pdb-entry>
    <pdb-entry>3obh</pdb-entry>
    <pdb-entry>3odv</pdb-entry>
    <pdb-entry>3okw</pdb-entry>
    <pdb-entry>3om2</pdb-entry>
    <pdb-entry>3onb</pdb-entry>
    <pdb-entry>3onc</pdb-entry>
    <pdb-entry>3oq2</pdb-entry>
    <pdb-entry>3p4e</pdb-entry>
    <pdb-entry>3p6c</pdb-entry>
    <pdb-entry>3p6l</pdb-entry>
    <pdb-entry>3p98</pdb-entry>
    <pdb-entry>3pg6</pdb-entry>
    <pdb-entry>3pgy</pdb-entry>
    <pdb-entry>3pko</pdb-entry>
    <pdb-entry>3pl2</pdb-entry>
    <pdb-entry>3pma</pdb-entry>
    <pdb-entry>3pp2</pdb-entry>
    <pdb-entry>3ppa</pdb-entry>
    <pdb-entry>3pzn</pdb-entry>
    <pdb-entry>3q6k</pdb-entry>
    <pdb-entry>3q6p</pdb-entry>
    <pdb-entry>3q6t</pdb-entry>
    <pdb-entry>3qae</pdb-entry>
    <pdb-entry>3qlb</pdb-entry>
    <pdb-entry>3qnq</pdb-entry>
    <pdb-entry>3qsl</pdb-entry>
    <pdb-entry>3qu2</pdb-entry>
    <pdb-entry>3r12</pdb-entry>
    <pdb-entry>3r69</pdb-entry>
    <pdb-entry>3r7t</pdb-entry>
    <pdb-entry>3rcm</pdb-entry>
    <pdb-entry>3rju</pdb-entry>
    <pdb-entry>3rqi</pdb-entry>
    <pdb-entry>3rxw</pdb-entry>
    <pdb-entry>3rza</pdb-entry>
    <pdb-entry>3s64</pdb-entry>
    <pdb-entry>3s6e</pdb-entry>
    <pdb-entry>3s9k</pdb-entry>
    <pdb-entry>3sbl</pdb-entry>
    <pdb-entry>3sfp</pdb-entry>
    <pdb-entry>3sk3</pdb-entry>
    <pdb-entry>3soi</pdb-entry>
    <pdb-entry>3sor</pdb-entry>
    <pdb-entry>3sos</pdb-entry>
    <pdb-entry>3t42</pdb-entry>
    <pdb-entry>3tb5</pdb-entry>
    <pdb-entry>3tzt</pdb-entry>
    <pdb-entry>3u02</pdb-entry>
    <pdb-entry>3u1k</pdb-entry>
    <pdb-entry>3u2c</pdb-entry>
    <pdb-entry>3u2g</pdb-entry>
    <pdb-entry>3u3l</pdb-entry>
    <pdb-entry>3u3n</pdb-entry>
    <pdb-entry>3u3u</pdb-entry>
    <pdb-entry>3uwu</pdb-entry>
    <pdb-entry>3v2i</pdb-entry>
    <pdb-entry>3v7q</pdb-entry>
    <pdb-entry>3v7u</pdb-entry>
    <pdb-entry>3v7w</pdb-entry>
    <pdb-entry>3v7y</pdb-entry>
    <pdb-entry>3v80</pdb-entry>
    <pdb-entry>3v85</pdb-entry>
    <pdb-entry>3v8h</pdb-entry>
    <pdb-entry>3v8m</pdb-entry>
    <pdb-entry>3v8n</pdb-entry>
    <pdb-entry>3v8p</pdb-entry>
    <pdb-entry>3v8q</pdb-entry>
    <pdb-entry>3v8r</pdb-entry>
    <pdb-entry>3vpd</pdb-entry>
    <pdb-entry>3vyr</pdb-entry>
    <pdb-entry>3wam</pdb-entry>
    <pdb-entry>3wcz</pdb-entry>
    <pdb-entry>3wl5</pdb-entry>
    <pdb-entry>3wl6</pdb-entry>
    <pdb-entry>3wl7</pdb-entry>
    <pdb-entry>3wl8</pdb-entry>
    <pdb-entry>3wn0</pdb-entry>
    <pdb-entry>3wn1</pdb-entry>
    <pdb-entry>3wn2</pdb-entry>
    <pdb-entry>3wnd</pdb-entry>
    <pdb-entry>3wsf</pdb-entry>
    <pdb-entry>3wsg</pdb-entry>
    <pdb-entry>3wuz</pdb-entry>
    <pdb-entry>3wwc</pdb-entry>
    <pdb-entry>3wwd</pdb-entry>
    <pdb-entry>3wwp</pdb-entry>
    <pdb-entry>3zn4</pdb-entry>
    <pdb-entry>4a2y</pdb-entry>
    <pdb-entry>4a3r</pdb-entry>
    <pdb-entry>4a5r</pdb-entry>
    <pdb-entry>4aci</pdb-entry>
    <pdb-entry>4af5</pdb-entry>
    <pdb-entry>4aiz</pdb-entry>
    <pdb-entry>4ane</pdb-entry>
    <pdb-entry>4axd</pdb-entry>
    <pdb-entry>4bgv</pdb-entry>
    <pdb-entry>4bm1</pdb-entry>
    <pdb-entry>4bvm</pdb-entry>
    <pdb-entry>4bze</pdb-entry>
    <pdb-entry>4bzf</pdb-entry>
    <pdb-entry>4bzg</pdb-entry>
    <pdb-entry>4bzh</pdb-entry>
    <pdb-entry>4bzq</pdb-entry>
    <pdb-entry>4bzx</pdb-entry>
    <pdb-entry>4c2y</pdb-entry>
    <pdb-entry>4c2z</pdb-entry>
    <pdb-entry>4c8i</pdb-entry>
    <pdb-entry>4cfp</pdb-entry>
    <pdb-entry>4cmv</pdb-entry>
    <pdb-entry>4cmw</pdb-entry>
    <pdb-entry>4cnm</pdb-entry>
    <pdb-entry>4cnn</pdb-entry>
    <pdb-entry>4con</pdb-entry>
    <pdb-entry>4csw</pdb-entry>
    <pdb-entry>4d6a</pdb-entry>
    <pdb-entry>4da4</pdb-entry>
    <pdb-entry>4djh</pdb-entry>
    <pdb-entry>4do4</pdb-entry>
    <pdb-entry>4do5</pdb-entry>
    <pdb-entry>4do6</pdb-entry>
    <pdb-entry>4dy6</pdb-entry>
    <pdb-entry>4e1h</pdb-entry>
    <pdb-entry>4eel</pdb-entry>
    <pdb-entry>4ef3</pdb-entry>
    <pdb-entry>4esw</pdb-entry>
    <pdb-entry>4eu3</pdb-entry>
    <pdb-entry>4eu7</pdb-entry>
    <pdb-entry>4eud</pdb-entry>
    <pdb-entry>4f35</pdb-entry>
    <pdb-entry>4f40</pdb-entry>
    <pdb-entry>4f9o</pdb-entry>
    <pdb-entry>4fdi</pdb-entry>
    <pdb-entry>4fin</pdb-entry>
    <pdb-entry>4foe</pdb-entry>
    <pdb-entry>4foi</pdb-entry>
    <pdb-entry>4fpa</pdb-entry>
    <pdb-entry>4fpb</pdb-entry>
    <pdb-entry>4g5o</pdb-entry>
    <pdb-entry>4g5q</pdb-entry>
    <pdb-entry>4g5r</pdb-entry>
    <pdb-entry>4g5s</pdb-entry>
    <pdb-entry>4gp7</pdb-entry>
    <pdb-entry>4gps</pdb-entry>
    <pdb-entry>4gsj</pdb-entry>
    <pdb-entry>4gyp</pdb-entry>
    <pdb-entry>4h0c</pdb-entry>
    <pdb-entry>4h1x</pdb-entry>
    <pdb-entry>4has</pdb-entry>
    <pdb-entry>4hfv</pdb-entry>
    <pdb-entry>4hg9</pdb-entry>
    <pdb-entry>4hk8</pdb-entry>
    <pdb-entry>4i4k</pdb-entry>
    <pdb-entry>4i6k</pdb-entry>
    <pdb-entry>4il0</pdb-entry>
    <pdb-entry>4iuw</pdb-entry>
    <pdb-entry>4ivf</pdb-entry>
    <pdb-entry>4j6o</pdb-entry>
    <pdb-entry>4jbd</pdb-entry>
    <pdb-entry>4jca</pdb-entry>
    <pdb-entry>4jgx</pdb-entry>
    <pdb-entry>4jp3</pdb-entry>
    <pdb-entry>4jph</pdb-entry>
    <pdb-entry>4jz8</pdb-entry>
    <pdb-entry>4jz9</pdb-entry>
    <pdb-entry>4k0w</pdb-entry>
    <pdb-entry>4k3d</pdb-entry>
    <pdb-entry>4k7g</pdb-entry>
    <pdb-entry>4k8o</pdb-entry>
    <pdb-entry>4kae</pdb-entry>
    <pdb-entry>4kax</pdb-entry>
    <pdb-entry>4kdy</pdb-entry>
    <pdb-entry>4kl5</pdb-entry>
    <pdb-entry>4knn</pdb-entry>
    <pdb-entry>4kys</pdb-entry>
    <pdb-entry>4l9m</pdb-entry>
    <pdb-entry>4lc3</pdb-entry>
    <pdb-entry>4lik</pdb-entry>
    <pdb-entry>4lkt</pdb-entry>
    <pdb-entry>4lqb</pdb-entry>
    <pdb-entry>4mdf</pdb-entry>
    <pdb-entry>4mev</pdb-entry>
    <pdb-entry>4mh2</pdb-entry>
    <pdb-entry>4mh3</pdb-entry>
    <pdb-entry>4mhq</pdb-entry>
    <pdb-entry>4mkz</pdb-entry>
    <pdb-entry>4mm2</pdb-entry>
    <pdb-entry>4mp6</pdb-entry>
    <pdb-entry>4n18</pdb-entry>
    <pdb-entry>4n3v</pdb-entry>
    <pdb-entry>4n7c</pdb-entry>
    <pdb-entry>4n7d</pdb-entry>
    <pdb-entry>4n7w</pdb-entry>
    <pdb-entry>4nx0</pdb-entry>
    <pdb-entry>4nxk</pdb-entry>
    <pdb-entry>4nzf</pdb-entry>
    <pdb-entry>4o61</pdb-entry>
    <pdb-entry>4o87</pdb-entry>
    <pdb-entry>4o89</pdb-entry>
    <pdb-entry>4oe9</pdb-entry>
    <pdb-entry>4oi6</pdb-entry>
    <pdb-entry>4oik</pdb-entry>
    <pdb-entry>4olc</pdb-entry>
    <pdb-entry>4ovy</pdb-entry>
    <pdb-entry>4owz</pdb-entry>
    <pdb-entry>4oxf</pdb-entry>
    <pdb-entry>4puw</pdb-entry>
    <pdb-entry>4pux</pdb-entry>
    <pdb-entry>4pw2</pdb-entry>
    <pdb-entry>4q0t</pdb-entry>
    <pdb-entry>4q14</pdb-entry>
    <pdb-entry>4q17</pdb-entry>
    <pdb-entry>4q1o</pdb-entry>
    <pdb-entry>4qbx</pdb-entry>
    <pdb-entry>4qd4</pdb-entry>
    <pdb-entry>4qjp</pdb-entry>
    <pdb-entry>4qlc</pdb-entry>
    <pdb-entry>4qni</pdb-entry>
    <pdb-entry>4qsj</pdb-entry>
    <pdb-entry>4qtp</pdb-entry>
    <pdb-entry>4r03</pdb-entry>
    <pdb-entry>4r29</pdb-entry>
    <pdb-entry>4rgd</pdb-entry>
    <pdb-entry>4rpf</pdb-entry>
    <pdb-entry>4ru1</pdb-entry>
    <pdb-entry>4rxu</pdb-entry>
    <pdb-entry>4twg</pdb-entry>
    <pdb-entry>4u2a</pdb-entry>
    <pdb-entry>4u31</pdb-entry>
    <pdb-entry>4u36</pdb-entry>
    <pdb-entry>4u3e</pdb-entry>
    <pdb-entry>4uhq</pdb-entry>
    <pdb-entry>4umd</pdb-entry>
    <pdb-entry>4w6u</pdb-entry>
    <pdb-entry>4wbd</pdb-entry>
    <pdb-entry>4wca</pdb-entry>
    <pdb-entry>4wdd</pdb-entry>
    <pdb-entry>4wgk</pdb-entry>
    <pdb-entry>4whn</pdb-entry>
    <pdb-entry>4wle</pdb-entry>
    <pdb-entry>4wpk</pdb-entry>
    <pdb-entry>4wry</pdb-entry>
    <pdb-entry>4wrz</pdb-entry>
    <pdb-entry>4ws2</pdb-entry>
    <pdb-entry>4ws4</pdb-entry>
    <pdb-entry>4ws6</pdb-entry>
    <pdb-entry>4wua</pdb-entry>
    <pdb-entry>4wui</pdb-entry>
    <pdb-entry>4wxb</pdb-entry>
    <pdb-entry>4x3n</pdb-entry>
    <pdb-entry>4x3s</pdb-entry>
    <pdb-entry>4x5v</pdb-entry>
    <pdb-entry>4x6p</pdb-entry>
    <pdb-entry>4xes</pdb-entry>
    <pdb-entry>4xfr</pdb-entry>
    <pdb-entry>4xg0</pdb-entry>
    <pdb-entry>4xtm</pdb-entry>
    <pdb-entry>4xtp</pdb-entry>
    <pdb-entry>4xuz</pdb-entry>
    <pdb-entry>4y03</pdb-entry>
    <pdb-entry>4ygs</pdb-entry>
    <pdb-entry>4yhc</pdb-entry>
    <pdb-entry>4ypm</pdb-entry>
    <pdb-entry>4yyy</pdb-entry>
    <pdb-entry>4z6a</pdb-entry>
    <pdb-entry>4zbe</pdb-entry>
    <pdb-entry>4zbl</pdb-entry>
    <pdb-entry>4zjb</pdb-entry>
    <pdb-entry>4zm1</pdb-entry>
    <pdb-entry>4zve</pdb-entry>
    <pdb-entry>5a1p</pdb-entry>
    <pdb-entry>5a3l</pdb-entry>
    <pdb-entry>5a3m</pdb-entry>
    <pdb-entry>5a56</pdb-entry>
    <pdb-entry>5a57</pdb-entry>
    <pdb-entry>5a58</pdb-entry>
    <pdb-entry>5a59</pdb-entry>
    <pdb-entry>5a5a</pdb-entry>
    <pdb-entry>5a8j</pdb-entry>
    <pdb-entry>5a9i</pdb-entry>
    <pdb-entry>5ae0</pdb-entry>
    <pdb-entry>5afe</pdb-entry>
    <pdb-entry>5awv</pdb-entry>
    <pdb-entry>5b3r</pdb-entry>
    <pdb-entry>5b3w</pdb-entry>
    <pdb-entry>5bo8</pdb-entry>
    <pdb-entry>5bqb</pdb-entry>
    <pdb-entry>5byg</pdb-entry>
    <pdb-entry>5cik</pdb-entry>
    <pdb-entry>5clg</pdb-entry>
    <pdb-entry>5clj</pdb-entry>
    <pdb-entry>5cls</pdb-entry>
    <pdb-entry>5col</pdb-entry>
    <pdb-entry>5cr4</pdb-entry>
    <pdb-entry>5cuy</pdb-entry>
    <pdb-entry>5cvt</pdb-entry>
    <pdb-entry>5d77</pdb-entry>
    <pdb-entry>5db5</pdb-entry>
    <pdb-entry>5dft</pdb-entry>
    <pdb-entry>5dhp</pdb-entry>
    <pdb-entry>5dhq</pdb-entry>
    <pdb-entry>5dhr</pdb-entry>
    <pdb-entry>5dhs</pdb-entry>
    <pdb-entry>5dht</pdb-entry>
    <pdb-entry>5dhu</pdb-entry>
    <pdb-entry>5dqn</pdb-entry>
    <pdb-entry>5dwk</pdb-entry>
    <pdb-entry>5dyh</pdb-entry>
    <pdb-entry>5e2n</pdb-entry>
    <pdb-entry>5e8e</pdb-entry>
    <pdb-entry>5efi</pdb-entry>
    <pdb-entry>5ejh</pdb-entry>
    <pdb-entry>5eji</pdb-entry>
    <pdb-entry>5eoe</pdb-entry>
    <pdb-entry>5eog</pdb-entry>
    <pdb-entry>5eom</pdb-entry>
    <pdb-entry>5eoo</pdb-entry>
    <pdb-entry>5fai</pdb-entry>
    <pdb-entry>5ft4</pdb-entry>
    <pdb-entry>5fyj</pdb-entry>
    <pdb-entry>5g2u</pdb-entry>
    <pdb-entry>5gge</pdb-entry>
    <pdb-entry>5gk6</pdb-entry>
    <pdb-entry>5gn0</pdb-entry>
    <pdb-entry>5go2</pdb-entry>
    <pdb-entry>5gpq</pdb-entry>
    <pdb-entry>5gre</pdb-entry>
    <pdb-entry>5grf</pdb-entry>
    <pdb-entry>5gri</pdb-entry>
    <pdb-entry>5gud</pdb-entry>
    <pdb-entry>5h16</pdb-entry>
    <pdb-entry>5h52</pdb-entry>
    <pdb-entry>5h7x</pdb-entry>
    <pdb-entry>5hdn</pdb-entry>
    <pdb-entry>5ii2</pdb-entry>
    <pdb-entry>5iik</pdb-entry>
    <pdb-entry>5iil</pdb-entry>
    <pdb-entry>5ir0</pdb-entry>
    <pdb-entry>5ixd</pdb-entry>
    <pdb-entry>5j72</pdb-entry>
    <pdb-entry>5joc</pdb-entry>
    <pdb-entry>5joq</pdb-entry>
    <pdb-entry>5jos</pdb-entry>
    <pdb-entry>5k2o</pdb-entry>
    <pdb-entry>5k5d</pdb-entry>
    <pdb-entry>5klp</pdb-entry>
    <pdb-entry>5klq</pdb-entry>
    <pdb-entry>5kv8</pdb-entry>
    <pdb-entry>5l6z</pdb-entry>
    <pdb-entry>5ldh</pdb-entry>
    <pdb-entry>5lgw</pdb-entry>
    <pdb-entry>5lla</pdb-entry>
    <pdb-entry>5lln</pdb-entry>
    <pdb-entry>5lr8</pdb-entry>
    <pdb-entry>5m2h</pdb-entry>
    <pdb-entry>5ma5</pdb-entry>
    <pdb-entry>5mak</pdb-entry>
    <pdb-entry>5mej</pdb-entry>
    <pdb-entry>5mew</pdb-entry>
    <pdb-entry>5mhu</pdb-entry>
    <pdb-entry>5mhv</pdb-entry>
    <pdb-entry>5mhw</pdb-entry>
    <pdb-entry>5mhx</pdb-entry>
    <pdb-entry>5mhy</pdb-entry>
    <pdb-entry>5mhz</pdb-entry>
    <pdb-entry>5mi1</pdb-entry>
    <pdb-entry>5mi2</pdb-entry>
    <pdb-entry>5mia</pdb-entry>
    <pdb-entry>5mib</pdb-entry>
    <pdb-entry>5mic</pdb-entry>
    <pdb-entry>5mid</pdb-entry>
    <pdb-entry>5mie</pdb-entry>
    <pdb-entry>5mig</pdb-entry>
    <pdb-entry>5mlq</pdb-entry>
    <pdb-entry>5msa</pdb-entry>
    <pdb-entry>5my8</pdb-entry>
    <pdb-entry>5nc9</pdb-entry>
    <pdb-entry>5ncd</pdb-entry>
    <pdb-entry>5ne6</pdb-entry>
    <pdb-entry>5ne7</pdb-entry>
    <pdb-entry>5nel</pdb-entry>
    <pdb-entry>5nff</pdb-entry>
    <pdb-entry>5nfr</pdb-entry>
    <pdb-entry>5nhx</pdb-entry>
    <pdb-entry>5nij</pdb-entry>
    <pdb-entry>5nkp</pdb-entry>
    <pdb-entry>5ntg</pdb-entry>
    <pdb-entry>5nvj</pdb-entry>
    <pdb-entry>5nxi</pdb-entry>
    <pdb-entry>5o9a</pdb-entry>
    <pdb-entry>5o9h</pdb-entry>
    <pdb-entry>5oco</pdb-entry>
    <pdb-entry>5ocq</pdb-entry>
    <pdb-entry>5ocs</pdb-entry>
    <pdb-entry>5oey</pdb-entry>
    <pdb-entry>5ogj</pdb-entry>
    <pdb-entry>5ohh</pdb-entry>
    <pdb-entry>5ojy</pdb-entry>
    <pdb-entry>5olg</pdb-entry>
    <pdb-entry>5olt</pdb-entry>
    <pdb-entry>5om6</pdb-entry>
    <pdb-entry>5osw</pdb-entry>
    <pdb-entry>5oxo</pdb-entry>
    <pdb-entry>5t8v</pdb-entry>
    <pdb-entry>5thi</pdb-entry>
    <pdb-entry>5thj</pdb-entry>
    <pdb-entry>5thn</pdb-entry>
    <pdb-entry>5tnx</pdb-entry>
    <pdb-entry>5tpp</pdb-entry>
    <pdb-entry>5u0m</pdb-entry>
    <pdb-entry>5u59</pdb-entry>
    <pdb-entry>5u7s</pdb-entry>
    <pdb-entry>5u9c</pdb-entry>
    <pdb-entry>5ubv</pdb-entry>
    <pdb-entry>5ucc</pdb-entry>
    <pdb-entry>5ujw</pdb-entry>
    <pdb-entry>5ul9</pdb-entry>
    <pdb-entry>5uld</pdb-entry>
    <pdb-entry>5uut</pdb-entry>
    <pdb-entry>5uwc</pdb-entry>
    <pdb-entry>5v0l</pdb-entry>
    <pdb-entry>5v6d</pdb-entry>
    <pdb-entry>5v72</pdb-entry>
    <pdb-entry>5v8e</pdb-entry>
    <pdb-entry>5vct</pdb-entry>
    <pdb-entry>5viu</pdb-entry>
    <pdb-entry>5vmk</pdb-entry>
    <pdb-entry>5vxs</pdb-entry>
    <pdb-entry>5w8i</pdb-entry>
    <pdb-entry>5wbo</pdb-entry>
    <pdb-entry>5wbr</pdb-entry>
    <pdb-entry>5wbz</pdb-entry>
    <pdb-entry>5wer</pdb-entry>
    <pdb-entry>5whx</pdb-entry>
    <pdb-entry>5wjd</pdb-entry>
    <pdb-entry>5wqt</pdb-entry>
    <pdb-entry>5wvx</pdb-entry>
    <pdb-entry>5wxx</pdb-entry>
    <pdb-entry>5x0q</pdb-entry>
    <pdb-entry>5x0v</pdb-entry>
    <pdb-entry>5xns</pdb-entry>
    <pdb-entry>5xtg</pdb-entry>
    <pdb-entry>5xub</pdb-entry>
    <pdb-entry>5yxc</pdb-entry>
    <pdb-entry>5z1m</pdb-entry>
    <pdb-entry>5z3a</pdb-entry>
    <pdb-entry>5z3b</pdb-entry>
    <pdb-entry>5z3d</pdb-entry>
    <pdb-entry>5z3e</pdb-entry>
    <pdb-entry>5z3f</pdb-entry>
    <pdb-entry>5z94</pdb-entry>
    <pdb-entry>5zca</pdb-entry>
    <pdb-entry>5zhp</pdb-entry>
    <pdb-entry>5zrd</pdb-entry>
    <pdb-entry>6a4i</pdb-entry>
    <pdb-entry>6a6e</pdb-entry>
    <pdb-entry>6aa1</pdb-entry>
    <pdb-entry>6aaz</pdb-entry>
    <pdb-entry>6acs</pdb-entry>
    <pdb-entry>6apf</pdb-entry>
    <pdb-entry>6ari</pdb-entry>
    <pdb-entry>6atl</pdb-entry>
    <pdb-entry>6auf</pdb-entry>
    <pdb-entry>6ayy</pdb-entry>
    <pdb-entry>6b0k</pdb-entry>
    <pdb-entry>6b1f</pdb-entry>
    <pdb-entry>6b1j</pdb-entry>
    <pdb-entry>6b1x</pdb-entry>
    <pdb-entry>6bfg</pdb-entry>
    <pdb-entry>6bi8</pdb-entry>
    <pdb-entry>6bia</pdb-entry>
    <pdb-entry>6byf</pdb-entry>
    <pdb-entry>6bzr</pdb-entry>
    <pdb-entry>6c99</pdb-entry>
    <pdb-entry>6cn0</pdb-entry>
    <pdb-entry>6csc</pdb-entry>
    <pdb-entry>6cul</pdb-entry>
    <pdb-entry>6d89</pdb-entry>
    <pdb-entry>6dhj</pdb-entry>
    <pdb-entry>6dio</pdb-entry>
    <pdb-entry>6dtd</pdb-entry>
    <pdb-entry>6eno</pdb-entry>
    <pdb-entry>6eun</pdb-entry>
    <pdb-entry>6f0h</pdb-entry>
    <pdb-entry>6f5v</pdb-entry>
    <pdb-entry>6f7r</pdb-entry>
    <pdb-entry>6f81</pdb-entry>
    <pdb-entry>6f82</pdb-entry>
    <pdb-entry>6f84</pdb-entry>
    <pdb-entry>6f8o</pdb-entry>
    <pdb-entry>6fcx</pdb-entry>
    <pdb-entry>6fig</pdb-entry>
    <pdb-entry>6flw</pdb-entry>
    <pdb-entry>6flz</pdb-entry>
    <pdb-entry>6fpg</pdb-entry>
    <pdb-entry>6fsj</pdb-entry>
    <pdb-entry>6fxi</pdb-entry>
    <pdb-entry>6g1p</pdb-entry>
    <pdb-entry>6g5u</pdb-entry>
    <pdb-entry>6g5w</pdb-entry>
    <pdb-entry>6g5x</pdb-entry>
    <pdb-entry>6gjx</pdb-entry>
    <pdb-entry>6gmz</pdb-entry>
    <pdb-entry>6gog</pdb-entry>
    <pdb-entry>6gom</pdb-entry>
    <pdb-entry>6gpj</pdb-entry>
    <pdb-entry>6gqt</pdb-entry>
    <pdb-entry>6gzm</pdb-entry>
    <pdb-entry>6h9w</pdb-entry>
    <pdb-entry>6hlo</pdb-entry>
    <pdb-entry>6hlp</pdb-entry>
    <pdb-entry>6i1l</pdb-entry>
    <pdb-entry>6i3e</pdb-entry>
    <pdb-entry>6igk</pdb-entry>
    <pdb-entry>6igl</pdb-entry>
    <pdb-entry>6ihc</pdb-entry>
    <pdb-entry>6imu</pdb-entry>
    <pdb-entry>6io0</pdb-entry>
    <pdb-entry>6its</pdb-entry>
    <pdb-entry>6j7z</pdb-entry>
    <pdb-entry>6j80</pdb-entry>
    <pdb-entry>6j9w</pdb-entry>
    <pdb-entry>6j9y</pdb-entry>
    <pdb-entry>6jad</pdb-entry>
    <pdb-entry>6jag</pdb-entry>
    <pdb-entry>6jah</pdb-entry>
    <pdb-entry>6jai</pdb-entry>
    <pdb-entry>6jam</pdb-entry>
    <pdb-entry>6jan</pdb-entry>
    <pdb-entry>6jao</pdb-entry>
    <pdb-entry>6jap</pdb-entry>
    <pdb-entry>6jaq</pdb-entry>
    <pdb-entry>6jar</pdb-entry>
    <pdb-entry>6jaz</pdb-entry>
    <pdb-entry>6jb0</pdb-entry>
    <pdb-entry>6jb4</pdb-entry>
    <pdb-entry>6jba</pdb-entry>
    <pdb-entry>6jbb</pdb-entry>
    <pdb-entry>6jbe</pdb-entry>
    <pdb-entry>6jfk</pdb-entry>
    <pdb-entry>6jle</pdb-entry>
    <pdb-entry>6jtb</pdb-entry>
    <pdb-entry>6jv4</pdb-entry>
    <pdb-entry>6k8c</pdb-entry>
    <pdb-entry>6kka</pdb-entry>
    <pdb-entry>6knh</pdb-entry>
    <pdb-entry>6mel</pdb-entry>
    <pdb-entry>6mft</pdb-entry>
    <pdb-entry>6ncs</pdb-entry>
    <pdb-entry>6nds</pdb-entry>
    <pdb-entry>6nkj</pdb-entry>
    <pdb-entry>6nrf</pdb-entry>
    <pdb-entry>6nri</pdb-entry>
    <pdb-entry>6nup</pdb-entry>
    <pdb-entry>6nx6</pdb-entry>
    <pdb-entry>6nx7</pdb-entry>
    <pdb-entry>6nx8</pdb-entry>
    <pdb-entry>6nxb</pdb-entry>
    <pdb-entry>6nxc</pdb-entry>
    <pdb-entry>6nxd</pdb-entry>
    <pdb-entry>6nz9</pdb-entry>
    <pdb-entry>6nza</pdb-entry>
    <pdb-entry>6nzb</pdb-entry>
    <pdb-entry>6nzc</pdb-entry>
    <pdb-entry>6o47</pdb-entry>
    <pdb-entry>6ocw</pdb-entry>
    <pdb-entry>6ocz</pdb-entry>
    <pdb-entry>6omz</pdb-entry>
    <pdb-entry>6p61</pdb-entry>
    <pdb-entry>6pab</pdb-entry>
    <pdb-entry>6prg</pdb-entry>
    <pdb-entry>6q54</pdb-entry>
    <pdb-entry>6qas</pdb-entry>
    <pdb-entry>6r7w</pdb-entry>
    <pdb-entry>6rfx</pdb-entry>
    <pdb-entry>6s2s</pdb-entry>
    <pdb-entry>6u9c</pdb-entry>
    <pdb-entry>6ucz</pdb-entry>
    <pdb-entry>6ugo</pdb-entry>
    <pdb-entry>8ldh</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB04272.pdf?1380564216</msds>
  <patents>
    <patent>
      <number>8450338</number>
      <country>United States</country>
      <approved>2013-05-28</approved>
      <expires>2028-10-10</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>8481083</number>
      <country>United States</country>
      <approved>2013-07-09</approved>
      <expires>2028-10-10</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>9827231</number>
      <country>United States</country>
      <approved>2017-11-28</approved>
      <expires>2034-06-23</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00672</drugbank-id>
      <name>Chlorpropamide</name>
      <description>Citric acid may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00657</drugbank-id>
      <name>Mecamylamine</name>
      <description>Citric acid may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09139</drugbank-id>
      <name>Technetium Tc-99m oxidronate</name>
      <description>Citric acid may decrease effectiveness of Technetium Tc-99m oxidronate as a diagnostic agent.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00182</drugbank-id>
      <name>Amphetamine</name>
      <description>The excretion of Amphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00191</drugbank-id>
      <name>Phentermine</name>
      <description>The excretion of Phentermine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00852</drugbank-id>
      <name>Pseudoephedrine</name>
      <description>The excretion of Pseudoephedrine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00865</drugbank-id>
      <name>Benzphetamine</name>
      <description>The excretion of Benzphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00937</drugbank-id>
      <name>Diethylpropion</name>
      <description>The excretion of Diethylpropion can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01255</drugbank-id>
      <name>Lisdexamfetamine</name>
      <description>The excretion of Lisdexamfetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01365</drugbank-id>
      <name>Mephentermine</name>
      <description>The excretion of Mephentermine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01442</drugbank-id>
      <name>MMDA</name>
      <description>The excretion of MMDA can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01454</drugbank-id>
      <name>Midomafetamine</name>
      <description>The excretion of Midomafetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01467</drugbank-id>
      <name>2,5-Dimethoxy-4-ethylamphetamine</name>
      <description>The excretion of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01484</drugbank-id>
      <name>4-Bromo-2,5-dimethoxyamphetamine</name>
      <description>The excretion of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01509</drugbank-id>
      <name>Tenamfetamine</name>
      <description>The excretion of Tenamfetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01556</drugbank-id>
      <name>Chlorphentermine</name>
      <description>The excretion of Chlorphentermine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01566</drugbank-id>
      <name>Methylenedioxyethamphetamine</name>
      <description>The excretion of Methylenedioxyethamphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01576</drugbank-id>
      <name>Dextroamphetamine</name>
      <description>The excretion of Dextroamphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01577</drugbank-id>
      <name>Metamfetamine</name>
      <description>The excretion of Metamfetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09480</drugbank-id>
      <name>Iofetamine I-123</name>
      <description>The excretion of Iofetamine I-123 can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12080</drugbank-id>
      <name>Ritobegron</name>
      <description>The excretion of Ritobegron can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13108</drugbank-id>
      <name>Mephedrone</name>
      <description>The excretion of Mephedrone can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13624</drugbank-id>
      <name>Methoxyphenamine</name>
      <description>The excretion of Methoxyphenamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13703</drugbank-id>
      <name>Gepefrine</name>
      <description>The excretion of Gepefrine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13940</drugbank-id>
      <name>2,5-Dimethoxy-4-ethylthioamphetamine</name>
      <description>The excretion of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00254</drugbank-id>
      <name>Doxycycline</name>
      <description>The therapeutic efficacy of Doxycycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00256</drugbank-id>
      <name>Lymecycline</name>
      <description>The therapeutic efficacy of Lymecycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00453</drugbank-id>
      <name>Clomocycline</name>
      <description>The therapeutic efficacy of Clomocycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00560</drugbank-id>
      <name>Tigecycline</name>
      <description>The therapeutic efficacy of Tigecycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00595</drugbank-id>
      <name>Oxytetracycline</name>
      <description>The therapeutic efficacy of Oxytetracycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00618</drugbank-id>
      <name>Demeclocycline</name>
      <description>The therapeutic efficacy of Demeclocycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00759</drugbank-id>
      <name>Tetracycline</name>
      <description>The therapeutic efficacy of Tetracycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00931</drugbank-id>
      <name>Metacycline</name>
      <description>The therapeutic efficacy of Metacycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01017</drugbank-id>
      <name>Minocycline</name>
      <description>The therapeutic efficacy of Minocycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01301</drugbank-id>
      <name>Rolitetracycline</name>
      <description>The therapeutic efficacy of Rolitetracycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12035</drugbank-id>
      <name>Sarecycline</name>
      <description>The therapeutic efficacy of Sarecycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12329</drugbank-id>
      <name>Eravacycline</name>
      <description>The therapeutic efficacy of Eravacycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12455</drugbank-id>
      <name>Omadacycline</name>
      <description>The therapeutic efficacy of Omadacycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13092</drugbank-id>
      <name>Meclocycline</name>
      <description>The therapeutic efficacy of Meclocycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13264</drugbank-id>
      <name>Penimepicycline</name>
      <description>The therapeutic efficacy of Penimepicycline can be decreased when used in combination with Citric acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01043</drugbank-id>
      <name>Memantine</name>
      <description>The excretion of Memantine can be decreased when combined with Citric acid.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1.3</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.26</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.06e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>2-hydroxypropane-1,2,3-tricarboxylic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>citric acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>192.1235</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>192.02700261</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OC(=O)CC(O)(CC(O)=O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C6H8O7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KRKNYBCHXYNGOX-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>132.13</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>35.62</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>15.54</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-4.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>5.92E+005 mg/L (at 20 °C)</value>
      <source>MERCK INDEX (1989)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>153 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.64</value>
      <source>AVDEEF,A (1997)</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>0.51</value>
      <source>ADME Research, USCD</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.79</value>
      <source>SERJEANT,EP &amp; DEMPSEY,B (1979)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>10021</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>17610</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>30769</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>311</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508995</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00158</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00037</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>305</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>14672</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449021</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>CIT</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>2478</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>2478</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Citric_acid</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1261</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP0002295</smpdb-id>
      <name>The Oncogenic Action of Fumarate</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q9GZT9</uniprot-id>
        <uniprot-id>Q96KS0</uniprot-id>
        <uniprot-id>Q9H6Z9</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>Q16665</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>Q9UBX3</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002358</smpdb-id>
      <name>The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxygluaricaciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>Q9H9P8</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000057</smpdb-id>
      <name>Citric Acid Cycle</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000550</smpdb-id>
      <name>Pyruvate Dehydrogenase Deficiency (E3)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000551</smpdb-id>
      <name>Pyruvate Dehydrogenase Deficiency (E2)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002292</smpdb-id>
      <name>The Oncogenic Action of Succinate</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Ascorbic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>Q9UBX3</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>Q16665</uniprot-id>
        <uniprot-id>Q9GZT9</uniprot-id>
        <uniprot-id>Q96KS0</uniprot-id>
        <uniprot-id>Q9H6Z9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002298</smpdb-id>
      <name>Glutaminolysis and Cancer</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>Aspartic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P43007</uniprot-id>
        <uniprot-id>Q8WUX1</uniprot-id>
        <uniprot-id>Q99417</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>P77434</uniprot-id>
        <uniprot-id>P0A959</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P00338</uniprot-id>
        <uniprot-id>P53985</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>P53396</uniprot-id>
        <uniprot-id>Q9UM01</uniprot-id>
        <uniprot-id>P42345</uniprot-id>
        <uniprot-id>Q9NWT6</uniprot-id>
        <uniprot-id>P01106</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002359</smpdb-id>
      <name>The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxygluaricaciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>Q8N465</uniprot-id>
        <uniprot-id>Q9H9P8</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000466</smpdb-id>
      <name>Transfer of Acetyl Groups into Mitochondria</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P53396</uniprot-id>
        <uniprot-id>Q6LAP8</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>Q02978</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000546</smpdb-id>
      <name>Congenital Lactic Acidosis</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000547</smpdb-id>
      <name>Fumarase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000548</smpdb-id>
      <name>Mitochondrial Complex II Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000549</smpdb-id>
      <name>2-Ketoglutarate Dehydrogenase Complex Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0000654</smpdb-id>
      <name>Warburg Effect</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB01709</drugbank-id>
          <name>2-phospho-D-glyceric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02263</drugbank-id>
          <name>Glyceraldehyde-3-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04034</drugbank-id>
          <name>Ribulose-5-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04326</drugbank-id>
          <name>Dihydroxyacetone phosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11168</uniprot-id>
        <uniprot-id>P52789</uniprot-id>
        <uniprot-id>P06744</uniprot-id>
        <uniprot-id>P17858</uniprot-id>
        <uniprot-id>P05062</uniprot-id>
        <uniprot-id>P04406</uniprot-id>
        <uniprot-id>P00558</uniprot-id>
        <uniprot-id>P15259</uniprot-id>
        <uniprot-id>P06733</uniprot-id>
        <uniprot-id>P30613</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P53985</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P37837</uniprot-id>
        <uniprot-id>P29401</uniprot-id>
        <uniprot-id>P49247</uniprot-id>
        <uniprot-id>O95336</uniprot-id>
        <uniprot-id>P11413</uniprot-id>
        <uniprot-id>P52209</uniprot-id>
        <uniprot-id>Q6LAP8</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>P14618</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP0002291</smpdb-id>
      <name>The Oncogenic Action of 2-Hydroxyglutarate</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium cation</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P00370</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002077</id>
      <name>KHG/KDPG aldolase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P0A955" source="Swiss-Prot">
        <name>KHG/KDPG aldolase</name>
        <general-function>Identical protein binding</general-function>
        <specific-function>Involved in the degradation of glucose via the Entner-Doudoroff pathway. Catalyzes the reversible, stereospecific retro-aldol cleavage of 2-Keto-3-deoxy-6-phosphogluconate (KDPG) to pyruvate and D-glyceraldehyde-3-phosphate. In the synthetic direction, it catalyzes the addition of pyruvate to electrophilic aldehydes with si-facial selectivity. It accepts some nucleophiles other than pyruvate, including 2-oxobutanoate, phenylpyruvate, and fluorobutanoate. It has a preference for the S-configuration at C2 of the electrophile.</specific-function>
        <gene-name>eda</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.35</theoretical-pi>
        <molecular-weight>22283.8</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X68871</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P0A955</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ALKH_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>hga</synonym>
          <synonym>kdgA</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011505|KHG/KDPG aldolase
MKNWKTSAESILTTGPVVPVIVVKKLEHAVPMAKALVAGGVRVLEVTLRTECAVDAIRAI
AKEVPEAIVGAGTVLNPQQLAEVTEAGAQFAISPGLTEPLLKAATEGTIPLIPGISTVSE
LMLGMDYGLKEFKFFPAEANGGVKALQAIAGPFSQVRFCPTGGISPANYRDYLALKSVLC
IGGSWLVPADALEAGDYDRITKLAREAVEGAKL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011506|KHG/KDPG aldolase (eda)
ATGAAAAACTGGAAAACAAGTGCAGAATCAATCCTGACCACCGGCCCGGTTGTACCGGTT
ATCGTGGTAAAAAAACTGGAACACGCGGTGCCGATGGCAAAAGCGTTGGTTGCTGGTGGG
GTGCGCGTTCTGGAAGTGACTCTGCGTACCGAGTGTGCAGTTGACGCTATCCGTGCTATC
GCCAAAGAAGTGCCTGAAGCGATTGTGGGTGCCGGTACGGTGCTGAATCCACAGCAGCTG
GCAGAAGTCACTGAAGCGGGTGCACAGTTCGCAATTAGCCCGGGTCTGACCGAGCCGCTG
CTGAAAGCTGCTACCGAAGGGACTATTCCTCTGATTCCGGGGATCAGCACTGTTTCCGAA
CTGATGCTGGGTATGGACTACGGTTTGAAAGAGTTCAAATTCTTCCCGGCTGAAGCTAAC
GGCGGCGTGAAAGCCCTGCAGGCGATCGCGGGTCCGTTCTCCCAGGTCCGTTTCTGCCCG
ACGGGTGGTATTTCTCCGGCTAACTACCGTGACTACCTGGCGCTGAAAAGCGTGCTGTGC
ATCGGTGGTTCCTGGCTGGTTCCGGCAGATGCGCTGGAAGCGGGCGATTACGACCGCATT
ACTAAGCTGGCGCGTGAAGCTGTAGAAGGCGCTAAGCTGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01081</identifier>
            <name>Aldolase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>2-dehydro-3-deoxy-phosphogluconate aldolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>4-hydroxy-2-oxoglutarate aldolase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001693</id>
      <name>Molybdenum cofactor guanylyltransferase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P32173" source="Swiss-Prot">
        <name>Molybdenum cofactor guanylyltransferase</name>
        <general-function>Molybdenum cofactor guanylyltransferase activity</general-function>
        <specific-function>Transfers a GMP moiety from GTP to Mo-molybdopterin (Mo-MPT) cofactor (Moco or molybdenum cofactor) to form Mo-molybdopterin guanine dinucleotide (Mo-MGD) cofactor. Is also involved in the biosynthesis of the bis-MGD form of the Moco cofactor (Mo-bisMGD) in which the metal is symmetrically ligated by the dithiolene groups of two MGD molecules. Is necessary and sufficient for the in vitro activation of the DMSOR molybdoenzyme that uses the Mo-bisMGD form of molybdenum cofactor, which implies formation and efficient insertion of the cofactor into the enzyme without the need of a chaperone. Is specific for GTP since other nucleotides such as ATP and GMP can not be utilized.</specific-function>
        <gene-name>mobA</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.3</theoretical-pi>
        <molecular-weight>21642.735</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L19201</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>304962</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P32173</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>MOBA_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.7.77</synonym>
          <synonym>chlB</synonym>
          <synonym>GTP:molybdopterin guanylyltransferase</synonym>
          <synonym>MGD synthase</synonym>
          <synonym>Mo-MPT guanylyltransferase</synonym>
          <synonym>mob</synonym>
          <synonym>MoCo guanylyltransferase</synonym>
          <synonym>Molybdopterin guanylyltransferase</synonym>
          <synonym>Molybdopterin-guanine dinucleotide biosynthesis protein A</synonym>
          <synonym>Molybdopterin-guanine dinucleotide synthase</synonym>
          <synonym>narB</synonym>
          <synonym>Protein FA</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011207|Molybdenum cofactor guanylyltransferase
MNLMTTITGVVLAGGKARRMGGVDKGLLELNGKPLWQHVADALMTQLSHVVVNANRHQEI
YQASGLKVIEDSLADYPGPLAGMLSVMQQEAGEWFLFCPCDTPYIPPDLAARLNHQRKDA
PVVWVHDGERDHPTIALVNRAIEPLLLEYLQAGERRVMVFMRLAGGHAVDFSDHKDAFVN
VNTPEELARWQEKR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011208|Molybdenum cofactor guanylyltransferase (mobA)
GTGAATCTGATGACGACGATAACAGGCGTTGTGCTGGCAGGCGGTAAAGCCAGACGAATG
GGCGGCGTAGATAAAGGATTGCTTGAATTAAACGGCAAACCATTATGGCAACATGTCGCT
GACGCGCTTATGACGCAGCTCTCTCACGTCGTGGTTAATGCTAATCGTCATCAGGAAATC
TATCAGGCAAGCGGTCTGAAAGTGATTGAAGATTCACTGGCGGATTACCCAGGCCCTCTG
GCAGGAATGCTTTCAGTAATGCAGCAGGAAGCTGGTGAGTGGTTTTTGTTTTGCCCGTGC
GATACGCCTTACATTCCCCCTGATTTAGCAGCCAGGCTTAATCATCAGCGCAAAGATGCG
CCTGTCGTGTGGGTCCATGACGGTGAACGCGATCACCCGACTATTGCTCTGGTAAACCGC
GCTATTGAGCCTTTATTACTGGAATATCTGCAAGCAGGAGAACGCCGGGTAATGGTATTT
ATGCGTCTGGCTGGCGGTCATGCGGTTGATTTCAGCGATCATAAAGATGCATTTGTTAAC
GTGAATACGCCAGAGGAGCTTGCCCGATGGCAGGAAAAACGATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF12804</identifier>
            <name>NTP_transf_3</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>molybdenum cofactor guanylyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bis(molybdopterin guanine dinucleotide)molybdenum biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001914</id>
      <name>Fumarate hydratase class II</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P05042" source="Swiss-Prot">
        <name>Fumarate hydratase class II</name>
        <general-function>Fumarate hydratase activity</general-function>
        <specific-function>Catalyzes the reversible addition of water to fumarate to give L-malate.</specific-function>
        <gene-name>fumC</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.57</theoretical-pi>
        <molecular-weight>50488.44</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X04065</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>41513</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P05042</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FUMC_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>4.2.1.2</synonym>
          <synonym>Fumarase C</synonym>
          <synonym>Iron-independent fumarase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011374|Fumarate hydratase class II
MNTVRSEKDSMGAIDVPADKLWGAQTQRSLEHFRISTEKMPTSLIHALALTKRAAAKVNE
DLGLLSEEKASAIRQAADEVLAGQHDDEFPLAIWQTGSGTQSNMNMNEVLANRASELLGG
VRGMERKVHPNDDVNKSQSSNDVFPTAMHVAALLALRKQLIPQLKTLTQTLNEKSRAFAD
IVKIGRTHLQDATPLTLGQEISGWVAMLEHNLKHIEYSLPHVAELALGGTAVGTGLNTHP
EYARRVADELAVITCAPFVTAPNKFEALATCDALVQAHGALKGLAASLMKIANDVRWLAS
GPRCGIGEISIPENEPGSSIMPGKVNPTQCEALTMLCCQVMGNDVAINMGGASGNFELNV
FRPMVIHNFLQSVRLLADGMESFNKHCAVGIEPNRERINQLLNESLMLVTALNTHIGYDK
AAEIAKKAHKEGLTLKAAALALGYLSEAEFDSWVRPEQMVGSMKAGR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011375|Fumarate hydratase class II (fumC)
ATGAATACAGTACGCAGCGAAAAAGATTCGATGGGGGCGATTGATGTCCCGGCAGATAAG
CTGTGGGGCGCACAAACTCAACGCTCGCTGGAGCATTTCCGCATTTCGACGGAGAAAATG
CCCACCTCACTGATTCATGCGCTGGCGCTAACCAAGCGTGCAGCGGCAAAAGTTAATGAA
GATTTAGGCTTGTTGTCTGAAGAGAAAGCGAGCGCCATTCGTCAGGCGGCGGATGAAGTA
CTGGCAGGACAGCATGACGACGAATTCCCGCTGGCTATCTGGCAGACCGGCTCCGGCACG
CAAAGTAACATGAACATGAACGAAGTGCTGGCTAACCGGGCCAGTGAATTACTCGGCGGT
GTGCGCGGGATGGAACGTAAAGTTCACCCTAACGACGACGTGAACAAAAGCCAAAGTTCC
AACGATGTCTTTCCGACGGCGATGCACGTTGCGGCGCTGCTGGCGCTGCGCAAGCAACTC
ATTCCTCAGCTTAAAACCCTGACACAGACACTGAATGAGAAATCCCGTGCTTTTGCCGAT
ATCGTCAAAATTGGTCGTACTCACTTGCAGGATGCCACGCCGTTAACGCTGGGGCAGGAG
ATTTCCGGCTGGGTAGCGATGCTCGAGCATAATCTCAAACATATCGAATACAGCCTGCCT
CACGTAGCGGAACTGGCTCTTGGCGGTACAGCGGTGGGTACTGGACTAAATACCCATCCG
GAGTATGCGCGTCGCGTAGCAGATGAACTGGCAGTCATTACCTGTGCACCGTTTGTTACC
GCGCCGAACAAATTTGAAGCGCTGGCGACCTGTGATGCCCTGGTTCAGGCGCACGGCGCG
TTGAAAGGGTTGGCTGCGTCACTGATGAAAATCGCCAATGATGTCCGCTGGCTGGCCTCT
GGCCCGCGCTGCGGAATTGGTGAAATCTCAATCCCGGAAAATGAGCCGGGCAGCTCAATC
ATGCCGGGGAAAGTGAACCCAACACAGTGTGAGGCATTAACCATGCTCTGCTGTCAGGTG
ATGGGGAACGACGTGGCGATCAACATGGGGGGCGCTTCCGGTAACTTTGAACTGAACGTC
TTCCGTCCAATGGTGATCCACAATTTCCTGCAATCGGTGCGCTTGCTGGCAGATGGCATG
GAAAGTTTTAACAAACACTGCGCAGTGGGTATTGAACCGAATCGTGAGCGAATCAATCAA
TTACTCAATGAATCGCTGATGCTGGTGACTGCGCTTAACACCCACATTGGTTATGACAAA
GCCGCCGAGATCGCCAAAAAAGCGCATAAAGAAGGGCTGACCTTAAAAGCTGCGGCCCTT
GCGCTGGGGTATCTTAGCGAAGCCGAGTTTGACAGCTGGGTACGGCCAGAACAGATGGTC
GGCAGTATGAAAGCCGGGCGTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00206</identifier>
            <name>Lyase_1</name>
          </pfam>
          <pfam>
            <identifier>PF10415</identifier>
            <name>FumaraseC_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>tricarboxylic acid cycle enzyme complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>fumarate hydratase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fumarate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>malate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein tetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to oxidative stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001966</id>
      <name>6-phosphogluconolactonase</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9X0N8" source="Swiss-Prot">
        <name>6-phosphogluconolactonase</name>
        <general-function>6-phosphogluconolactonase activity</general-function>
        <specific-function>Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate.</specific-function>
        <gene-name>pgl</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.81</theoretical-pi>
        <molecular-weight>25324.955</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>4981702</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9X0N8</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>6PGL_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.1.31</synonym>
          <synonym>6PGL</synonym>
          <synonym>devB</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016627|6-phosphogluconolactonase
MEKTVIYLLEDGYVDFVVEKIRTKMEKLLEEKDKIFVVLAGGRTPLPVYEKLAEQKFPWN
RIHFFLSDERYVPLDSDQSNFRNINEVLFSRAKIPSGNVHYVDTSLPIEKACEKYEREIR
SATDQFDLAILGMGPDGHVASIFDLETGNKDNLVTFTDPSGDPKVPRVTLTFRALNTSLY
VLFLIRGKEKINRLTEILKDTPLPAYFVRGKEKTVWFVGK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016628|6-phosphogluconolactonase (pgl)
ATGGAGAAAACTGTGATATACCTGCTCGAAGATGGGTACGTTGATTTTGTAGTCGAGAAA
ATTCGCACAAAGATGGAAAAACTTCTCGAGGAAAAGGATAAGATCTTCGTCGTTCTCGCC
GGCGGGAGAACCCCACTTCCCGTTTATGAGAAACTGGCAGAACAGAAGTTCCCATGGAAT
CGCATCCACTTCTTTTTGAGCGACGAGCGGTACGTGCCCCTCGACTCAGATCAAAGCAAT
TTCAGGAACATAAACGAGGTTCTTTTCAGCAGAGCAAAGATCCCTTCCGGTAATGTTCAC
TACGTTGACACTTCTCTTCCTATTGAAAAAGCCTGCGAGAAATATGAGAGGGAAATAAGA
TCAGCTACTGACCAGTTCGACCTCGCTATTCTTGGAATGGGTCCCGATGGCCATGTCGCG
TCCATATTCGACTTGGAAACGGGAAATAAAGACAACCTTGTGACTTTCACAGATCCTTCC
GGTGACCCTAAGGTTCCCAGAGTCACCCTGACGTTTCGTGCACTGAACACATCACTGTAC
GTGCTCTTTCTCATCAGGGGAAAAGAAAAGATAAACAGACTAACGGAGATCTTAAAAGAT
ACACCACTTCCCGCTTACTTCGTGAGAGGCAAAGAGAAAACCGTCTGGTTTGTGGGAAAA
TAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01182</identifier>
            <name>Glucosamine_iso</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>6-phosphogluconolactonase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pentose-phosphate shunt</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001616</id>
      <name>Oxygen-insensitive NAD(P)H nitroreductase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P38489" source="Swiss-Prot">
        <name>Oxygen-insensitive NAD(P)H nitroreductase</name>
        <general-function>Nad(p)h nitroreductase activity</general-function>
        <specific-function>Reduction of a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred. Capable of reducing nitrofurazone, quinones and the anti-tumor agent CB1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide). The reduction of CB1954 results in the generation of cytotoxic species.</specific-function>
        <gene-name>nfsB</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.16</theoretical-pi>
        <molecular-weight>23904.99</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D25414</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>538227</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P38489</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NFSB_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.-.-.-</synonym>
          <synonym>Dihydropteridine reductase</synonym>
          <synonym>dprA</synonym>
          <synonym>FMN-dependent nitroreductase</synonym>
          <synonym>nfnB</synonym>
          <synonym>nfsI</synonym>
          <synonym>ntr</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019145|Oxygen-insensitive NAD(P)H nitroreductase
MDIISVALKRHSTKAFDASKKLTPEQAEQIKTLLQYSPSSTNSQPWHFIVASTEEGKARV
AKSAAGNYVFNERKMLDASHVVVFCAKTAMDDVWLKLVVDQEDADGRFATPEAKAANDKG
RKFFADMHRKDLHDDAEWMAKQVYLNVGNFLLGVAALGLDAVPIEGFDAAILDAEFGLKE
KGYTSLVVVPVGHHSVEDFNATLPKSRLPQNITLTEV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019146|Oxygen-insensitive NAD(P)H nitroreductase (nfsB)
ATGGATATCATTTCTGTCGCCTTAAAGCGTCATTCCACTAAGGCATTTGATGCCAGCAAA
AAACTTACCCCGGAACAGGCCGAGCAGATCAAAACGCTACTGCAATACAGCCCATCCAGC
ACCAACTCCCAGCCGTGGCATTTTATTGTTGCCAGCACGGAAGAAGGTAAAGCGCGTGTT
GCCAAATCCGCTGCCGGTAATTACGTGTTCAACGAGCGTAAAATGCTTGATGCCTCGCAC
GTCGTGGTGTTCTGTGCAAAAACCGCGATGGACGATGTCTGGCTGAAGCTGGTTGTTGAC
CAGGAAGATGCCGATGGCCGCTTTGCCACGCCGGAAGCGAAAGCCGCGAACGATAAAGGT
CGCAAGTTCTTCGCTGATATGCACCGTAAAGATCTGCATGATGATGCAGAGTGGATGGCA
AAACAGGTTTATCTCAACGTCGGTAACTTCCTGCTCGGCGTGGCGGCTCTGGGTCTGGAC
GCGGTACCCATCGAAGGTTTTGACGCCGCCATCCTCGATGCAGAATTTGGTCTGAAAGAG
AAAGGCTACACCAGTCTGGTGGTTGTTCCGGTAGGTCATCACAGCGTTGAAGATTTTAAC
GCTACGCTGCCGAAATCTCGTCTGCCGCAAAACATCACCTTAACCGAAGTGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00881</identifier>
            <name>Nitroreductase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>6,7-dihydropteridine reductase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>FMN binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NAD(P)H nitroreductase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>2,4,6-trinitrotoluene catabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001907</id>
      <name>Gag-Pro-Pol polyprotein</name>
      <organism>RSV-SRA</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q04095" source="Swiss-Prot">
        <name>Gag-Pro-Pol polyprotein</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Capsid protein p27 forms the spherical core of the virus that encapsulates the genomic RNA-nucleocapsid complex.The aspartyl protease mediates proteolytic cleavages of Gag and Gag-Pol polyproteins during or shortly after the release of the virion from the plasma membrane. Cleavages take place as an ordered, step-wise cascade to yield mature proteins. This process is called maturation. Displays maximal activity during the budding process just prior to particle release from the cell.</specific-function>
        <gene-name>gag-pro-pol</gene-name>
        <locus/>
        <cellular-location>Virion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.1</theoretical-pi>
        <molecular-weight>173931.55</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="269446">RSV-SRA</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M37980</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>210273</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q04095</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>POL_RSVSA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.4.23.-</synonym>
          <synonym>RT-beta</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037153|Gag-Pro-Pol polyprotein
MEAVIKVISSACKTYCGKISPSKKEIGAMLSLLQKEGLLMSPSDLYSPGSWDPITAALSQ
RAMVLGKSGELKTWGLVLGALKAAREEQVTSEQAKFWLGLGGGRVSPPGPECIEKPATER
RIDKGEEVGETTAQRDAKMAPEKMATPKTVGTSCYQCGTATGCNCATASAPPPPYVGSGL
YPSLAGVGEQQGQGGDTPWGAEQPRAEPGHAGLAPGPALTDWARIREELASTGPPVVAMP
VVIKTEGPAWTPLEPKLITRLADTVRTKGLRSPITMAEVEALMSSPLLPHDVTNLMRVIL
GPAPYALWMDAWGVQLQTVIAAATRDPRHPANGQGRGERTNLDRLKGLADGMVGNPQGQA
ALLRPGELVAITASALQAFREVARLAEPAGPWADITQGPSESFVDFANRLIKAVEGSDLP
PSARAPVIIDCFRQKSQPDIQQLIRAAPSTLTTPGEIIKYVLDRQKIAPLTDQGIAAAMS
SAIQPLVMAVVNRERDGQTGSGGRARGLCYTCGSPGHYQAQCPKKRKSGNSRERCQLCDG
MGHNAKQCRRRDGNQGQRPGKGLSSGSWPVSEQPAVSLAMTMEHKDRPLVRVILTNTGSH
PVKQRSVYITALLDSGADITIISEEDWPTDWPVMEAANPQIHGIGGGIPMRKSRDMIEVG
VINRDGSLERPLLLFPAVAMVRGSILGRDCLQGLGLRLTNLIGRATVLTVALHLAIPLKW
KPDHTPVWIDQWPLPEGKLVALTQLVEKELQLGHIEPSLSCWNTPVFVIRKASGSYRLLH
DLRAVNAKLVPFGAVQQGAPVLSALPRGWPLMVLDLKDCFFSIPLAEQDREAFAFTLPSV
NNQAPARRFQWKVLPQGMTCSPTICQLVVGQVLEPLRLKHPSLRMLHYMDDLLLAASSHD
GLEAAGEEVISTLERAGFTISPDKIQREPGVQYLGYKLGSTYVAPVGLVAEPRIATLWDV
QKLVGSLQWLRPALGIPPRLMGPFYEQLRGSDPNEAREWNLDMKMAWREIVQLSTTAALE
RWDPALPLEGAVARCEQGAIGVLGQGLSTHPRPCLWLFSTQPTKAFTAWLEVLTLLITKL
RASAVRTFGKEVDILLLPACFREDLPLPEGILLALRGFAGKIRSSDTPSIFDIARPLHVS
LKVRVTDHPVPGPTAFTDASSSTHKGVVVWREGPRWEIKEIADLGASVQQLEARAVAMAL
LLWPTTPTNVVTDSAFVAKMLLKMGQEGVPSTAAAFILEDALSQRSAMAAVLHVRSHSEV
PGFFTEGNDVADSQATFQAYPLREAKDLHTALHIGPRALSKACNISMQQAREVVQTCPHC
NSAPALEAGVNPRGLGPLQIWQTDFTLEPRMAPRSWLAVTVDTASSAIVVTQHGRVTSVA
AQHHWATAIAVLGRPKAIKTDNGSCFTSKSTREWLARWGIAHTTGIPGNSQGQAMVERAN
RLLKDKIRVLAEGDGFMKRIPTSKQGELLAKAMYALNHFERGENTKTPIQKHWRPTVLTE
GPPVKIRIETGEWEKGWNVLVWGRGYAAVKNRDTDKVIWVPSRKVKPDVTQKDEVTKKDE
ASPLFAGISDWIPWEDEQEGLQGETASNKQERPGEDTLAANES</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003776|2688 bp
ACTGTTGCGCTACATCTGGCTATTCCGCTCAAATGGAAGCCAGACCACACGCCTGTGTGG
ATTGACCAGTGGCCCCTTCCTGAAGGTAAACTTGTAGCGCTAACGCAATTAGTGGAAAAA
GAATTACAGTTAGGACATATAGAACCTTCACTTAGTTGTTGGAACACACCTGTCTTTGTG
ATCCGGAAGGCTTCCGGGTCTTATCGCTTATTGCATGACTTGCGCGCTGTTAACGCCAAG
CTTGTTCCTTTTGGGGCCGTCCAACAGGGGGCGCCAGTTCTCTCCGCGCTCCCGCGTGGC
TGGCCCCTGATGGTCCTAGACCTCAAGGATTGCTTCTTTTCTATTCCTCTTGCGGAACAA
GATCGCGAAGCTTTTGCATTTACGCTCCCCTCTGTGAATAACCAGGCCCCCGCTCGAAGA
TTCCAATGGAAGGTCTTGCCCCAAGGGATGACCTGTTCTCCCACTATCTGTCAGTTGGTG
GTGGGTCAGGTACTTGAGCCCTTGCGACTCAAGCACCCATCTCTGCGCATGTTGCATTAT
ATGGATGATCTTTTGCTAGCCGCCTCAAGTCATGATGGGTTGGAAGCGGCAGGGGAGGAG
GTTATCAGTACATTGGAAAGAGCCGGGTTCACCATTTCGCCTGATAAGATCCAGAGGGAA
CCCGGAGTACAATATCTTGGGTACAAGTTAGGCAGTACGTATGTAGCACCCGTAGGCCTG
GTAGCAGAACCCAGGATAGCCACCTTGTGGGATGTTCAAAAGCTGGTGGGGTCACTTCAG
TGGCTTCGCCCAGCGTTAGGAATCCCGCCACGACTGATGGGCCCCTTCTATGAGCAGTTA
CGAGGGTCAGATCCTAACGAGGCGAGGGAATGGAATCTAGACATGAAAATGGCCTGGAGA
GAGATCGTACAGCTTAGCACCACTGCTGCCTTGGAACGATGGGACCCTGCCCTGCCTTTG
GAGGGAGCGGTCGCTAGGTGTGAACAGGGGGCAATAGGGGTCCTGGGACAGGGACTGTCC
ACACACCCAAGGCCATGTTTGTGGTTATTCTCCACCCAACCCACCAAGGCGTTTACTGCT
TGGTTAGAAGTGCTCACCCTTTTGATTACTAAGCTACGCGCTTCGGCAGTGCGAACCTTT
GGCAAGGAGGTTGATATCCTCCTGTTGCCTGCATGCTTTCGGGAGGACCTTCCGCTCCCG
GAGGGGATCCTGTTAGCCCTTAGGGGGTTTGCAGGAAAAATCAGGAGTAGTGACACGCCA
TCTATTTTTGACATTGCGCGTCCACTGCATGTTTCTCTGAAAGTGAGGGTCACCGACCAC
CCTGTACCGGGACCCACTGCCTTTACCGACGCCTCCTCAAGCACCCATAAAGGGGTGGTA
GTCTGGAGGGAGGGCCCAAGGTGGGAGATAAAAGAAATAGCTGATTTGGGGGCAAGTGTA
CAACAACTGGAAGCACGCGCTGTGGCCATGGCACTTCTGCTGTGGCCGACAACGCCCACT
AATGTAGTGACTGACTCCGCGTTTGTCGCGAAAATGTTACTCAAGATGGGACAGGAGGGA
GTCCCGTCTACAGCGGCGGCTTTTATTTTAGAGGATGCGTTAAGCCAAAGGTCAGCCATG
GCCGCCGTTCTCCACGTGCGGAGTCATTCTGAAGTGCCAGGGTTTTTCACAGAAGGAAAT
GACGTGGCAGATAGCCAAGCCACCTTTCAAGCGTATCCCTTGAGAGAGGCTAAAGATCTT
CATACTGCTCTCCATATTGGACCCCGCGCGCTATCCAAAGCGTGTAATATATCTATGCAG
CAGGCTAGGGAGGTTGTTCAGACCTGCCCGCATTGTAATTCAGCCCCTGCGTTGGAGGCC
GGGGTAAACCCTAGGGGTTTGGGACCCCTACAGATATGGCAGACAGACTTTACGCTTGAG
CCTAGAATGGCCCCCCGTTCCTGGCTCGCTGTTACTGTGGATACCGCCTCATCGGCGATA
GTCGTAACTCAGCATGGCCGTGTCACATCGGTTGCTGCACAACATCATTGGGCCACGGCT
ATCGCCGTTTTGGGAAGACCAAAGGCCATAAAAACAGATAATGGGTCCTGTTTCACGTCT
AAATCCACGCGAGAGTGGCTCGCGAGATGGGGGATAGCACACACCACCGGGATTCCGGGT
AATTCCCAGGGTCAAGCTATGGTAGAGCGGGCCAACCGGCTCCTGAAAGATAAGATCCGT
GTGCTTGCGGAGGGGGACGGCTTTATGAAAAGAATCCCCACCAGCAAACAGGGGGAACTA
CTAGCCAAGGCAATGTATGCCCTCAATCACTTTGAGCGCGGTGAAAACACAAAAACACCG
ATTCAAAAACACTGGAGACCTACCGTTCTTACAGAAGGACCCCCGGTTAAAATACGAATA
GAGACAGGGGAGTGGGAAAAAGGATGGAATGTGCTGGTCTGGGGACGAGGTTATGCAGCT
GTGAAAAACAGGGACACTGATAAGGTTATTTGGGTACCCTCTCGGAAAGTTAAACCGGAT
GTCACCCAAAAGGATGAGGTGACTAAGAAAGATGAGGCGAGCCCTCTTTTTGCAGGCATT
TCTGACTGGATACCCTGGGAAGACGAGCAAGAAGGACTCCAAGGAGAAACCGCTAGCAAC
AAGCAAGAAAGACCCGGAGAAGACACCCTTGCTGCCAACGAGAGTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00078</identifier>
            <name>RVT_1</name>
          </pfam>
          <pfam>
            <identifier>PF00607</identifier>
            <name>Gag_p24</name>
          </pfam>
          <pfam>
            <identifier>PF00552</identifier>
            <name>IN_DBD_C</name>
          </pfam>
          <pfam>
            <identifier>PF02022</identifier>
            <name>Integrase_Zn</name>
          </pfam>
          <pfam>
            <identifier>PF00665</identifier>
            <name>rve</name>
          </pfam>
          <pfam>
            <identifier>PF00077</identifier>
            <name>RVP</name>
          </pfam>
          <pfam>
            <identifier>PF06817</identifier>
            <name>RVT_thumb</name>
          </pfam>
          <pfam>
            <identifier>PF00098</identifier>
            <name>zf-CCHC</name>
          </pfam>
          <pfam>
            <identifier>PF02813</identifier>
            <name>Retro_M</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>viral capsid</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aspartic-type endopeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA-directed DNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-directed DNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-DNA hybrid ribonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA integration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA recombination</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>establishment of integrated proviral latency</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral entry into host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004566</id>
      <name>L-amino-acid oxidase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q96RQ9" source="Swiss-Prot">
        <name>L-amino-acid oxidase</name>
        <general-function>L-amino-acid oxidase activity</general-function>
        <specific-function>Lysosomal L-amino-acid oxidase with highest specific activity with phenylalanine. May play a role in lysosomal antigen processing and presentation (By similarity).</specific-function>
        <gene-name>IL4I1</gene-name>
        <locus/>
        <cellular-location>Lysosome</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-21</signal-regions>
        <theoretical-pi/>
        <molecular-weight>62880.52</molecular-weight>
        <chromosome-location>19</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:19094</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q96RQ9</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>OXLA_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.4.3.2</synonym>
          <synonym>FIG1</synonym>
          <synonym>hFIG1</synonym>
          <synonym>IL4-induced protein 1</synonym>
          <synonym>Interleukin-4-induced protein 1</synonym>
          <synonym>LAAO</synonym>
          <synonym>Protein Fig-1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009487|L-amino-acid oxidase
MAPLALHLLVLVPILLSLVASQDWKAERSQDPFEKCMQDPDYEQLLKVVTWGLNRTLKPQ
RVIVVGAGVAGLVAAKVLSDAGHKVTILEADNRIGGRIFTYRDQNTGWIGELGAMRMPSS
HRILHKLCQGLGLNLTKFTQYDKNTWTEVHEVKLRNYVVEKVPEKLGYALRPQEKGHSPE
DIYQMALNQALKDLKALGCRKAMKKFERHTLLEYLLGEGNLSRPAVQLLGDVMSEDGFFY
LSFAEALRAHSCLSDRLQYSRIVGGWDLLPRALLSSLSGLVLLNAPVVAMTQGPHDVHVQ
IETSPPARNLKVLKADVVLLTASGPAVKRITFSPPLPRHMQEALRRLHYVPATKVFLSFR
RPFWREEHIEGGHSNTDRPSRMIFYPPPREGALLLASYTWSDAAAAFAGLSREEALRLAL
DDVAALHGPVVRQLWDGTGVVKRWAEDQHSQGGFVVQPPALWQTEKDDWTVPYGRIYFAG
EHTAYPHGWVETAVKSALRAAIKINSRKGPASDTASPEGHASDMEGQGHVHGVASSPSHD
LAKEEGSHPPVQGQLSLQNTTHTRTSH</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017476|L-amino-acid oxidase (IL4I1)
ATGCCCAACGATGACTTCTGTCCTGGGCTAACCATAAAGGCCATGGGTGCTGAGAGAGCC
CCCCAGAGGCAGCCATGCACCCTGCACCTCCTCGTCCTCGTCCCCATCCTCCTCAGCCTG
GTGGCCTCCCAGGACTGGAAGGCTGAACGCAGCCAAGACCCCTTCGAGAAATGCATGCAG
GATCCTGACTATGAGCAGCTGCTCAAGGTGGTGACCTGGGGGCTCAATCGGACCCTGAAG
CCCCAGAGGGTGATTGTGGTTGGCGCTGGTGTGGCCGGGCTGGTGGCCGCCAAGGTGCTC
AGCGATGCTGGACACAAGGTCACCATCCTGGAGGCAGATAACAGGATCGGGGGCCGCATC
TTCACCTACCGGGACCAGAACACGGGCTGGATTGGGGAGCTGGGAGCCATGCGCATGCCC
AGCTCTCACAGGATCCTCCACAAGCTCTGCCAGGGCCTGGGGCTCAACCTGACCAAGTTC
ACCCAGTACGACAAGAACACGTGGACGGAGGTGCACGAAGTGAAGCTGCGCAACTATGTG
GTGGAGAAGGTGCCCGAGAAGCTGGGCTACGCCTTGCGTCCCCAGGAAAAGGGCCACTCG
CCCGAAGACATCTACCAGATGGCTCTCAACCAGGCCCTCAAAGACCTCAAGGCACTGGGC
TGCAGAAAGGCGATGAAGAAGTTTGAAAGGCACACGCTCTTGGAATATCTTCTCGGGGAG
GGGAACCTGAGCCGGCCGGCCGTGCAGCTTCTGGGAGACGTGATGTCCGAGGATGGCTTC
TTCTATCTCAGCTTCGCCGAGGCCCTCCGGGCCCACAGCTGCCTCAGCGACAGACTCCAG
TACAGCCGCATCGTGGGTGGCTGGGACCTGCTGCCGCGCGCGCTGCTGAGCTCGCTGTCC
GGGCTTGTGCTGTTGAACGCGCCCGTGGTGGCGATGACCCAGGGACCGCACGATGTGCAC
GTGCAGATCGAGACCTCTCCCCCGGCGCGGAATCTGAAGGTGCTGAAGGCCGACGTGGTG
CTGCTGACGGCGAGCGGACCGGCGGTGAAGCGCATCACCTTCTCGCCGCCGCTGCCCCGC
CACATGCAGGAGGCGCTGCGGAGGCTGCACTACGTGCCGGCCACCAAGGTGTTCCTAAGC
TTCCGCAGGCCCTTCTGGCGCGAGGAGCACATTGAAGGCGGCCACTCAAACACCGATCGC
CCGTCGCGCATGATTTTCTACCCGCCGCCGCGCGAGGGCGCGCTGCTGCTGGCCTCGTAC
ACGTGGTCGGACGCGGCGGCAGCGTTCGCCGGCTTGAGCCGGGAAGAGGCGTTGCGCTTG
GCGCTCGACGACGTGGCGGCATTGCACGGGCCTGTCGTGCGCCAGCTCTGGGACGGCACC
GGCGTCGTCAAGCGTTGGGCGGAGGACCAGCACAGCCAGGGTGGCTTTGTGGTACAGCCG
CCGGCGCTCTGGCAAACCGAAAAGGATGACTGGACGGTCCCTTATGGCCGCATCTACTTT
GCCGGCGAGCACACCGCCTACCCGCACGGCTGGGTGGAGACGGCGGTCAAGTCGGCGCTG
CGCGCCGCCATCAAGATCAACAGCCGGAAGGGGCCTGCATCGGACACGGCCAGCCCCGAG
GGGCACGCATCTGACATGGAGGGGCAGGGGCATGTGCATGGGGTGGCCAGCAGCCCCTCG
CATGACCTGGCAAAGGAAGAAGGCAGCCACCCTCCAGTCCAAGGCCAGTTATCTCTCCAA
AACACGACCCACACGAGGACCTCGCATTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01593</identifier>
            <name>Amino_oxidase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>lysosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-amino-acid oxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-phenylalanine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001855</id>
      <name>Macrophage migration inhibitory factor</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P14174" source="Swiss-Prot">
        <name>Macrophage migration inhibitory factor</name>
        <general-function>Receptor binding</general-function>
        <specific-function>Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.</specific-function>
        <gene-name>MIF</gene-name>
        <locus>22q11.23</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.05</theoretical-pi>
        <molecular-weight>12476.19</molecular-weight>
        <chromosome-location>22</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:7097</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>MIF</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M25639</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>188556</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P14174</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>MIF_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>5.3.2.1</synonym>
          <synonym>GIF</synonym>
          <synonym>GLIF</synonym>
          <synonym>Glycosylation-inhibiting factor</synonym>
          <synonym>L-dopachrome isomerase</synonym>
          <synonym>L-dopachrome tautomerase</synonym>
          <synonym>MIF</synonym>
          <synonym>MMIF</synonym>
          <synonym>Phenylpyruvate tautomerase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0020563|Macrophage migration inhibitory factor
MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALC
SLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020564|Macrophage migration inhibitory factor (MIF)
ATGCCGATGTTCATCGTAAACACCAACGTGCCCCGCGCCTCCGTGCCGGACGGGTTCCTC
TCCGAGCTCACCCAGCAGCTGGCGCAGGCCACCGGCAAGCCCCCCCAGTACATCGCGGTG
CACGTGGTCCCGGACCAGCTCATGGCCTTCGGCGGCTCCAGCGAGCCGTGCGCGCTCTGC
AGCCTGCACAGCATCGGCAAGATCGGCGGCGCGCAGAACCGCTCCTACAGCAAGCTGCTG
TGCGGCCTGCTGGCCGAGCGCCTGCGCATCAGCCCGGACAGGGTCTACATCAACTATTAC
GACATGAACGCGGCCAATGTGGGCTGGAACAACTCCACCTTCGCCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01187</identifier>
            <name>MIF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell surface</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>myelin sheath</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>chemoattractant activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cytokine activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cytokine receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>dopachrome isomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>phenylpyruvate tautomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carboxylic acid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell surface receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA damage response, signal transduction by p53 class mediator</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>inflammatory response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell aging</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell cycle arrest</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cellular protein metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of DNA damage response, signal transduction by p53 class mediator</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of mature B cell apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of myeloid cell apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive chemotaxis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of arachidonic acid secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of B cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of chemokine (C-X-C motif) ligand 2 production</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cytokine secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of ERK1 and ERK2 cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of fibroblast proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of lipopolysaccharide-mediated signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of MAP kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of myeloid leukocyte cytokine production involved in immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of peptidyl-serine phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of peptidyl-tyrosine phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of prostaglandin secretion involved in immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of protein kinase A signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostaglandin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homotrimerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of macrophage activation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004551</id>
      <name>Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9GZU7" source="Swiss-Prot">
        <name>Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1</name>
        <general-function>Metal ion binding</general-function>
        <specific-function>Preferentially catalyzes the dephosphorylation of 'Ser-5' within the tandem 7 residue repeats in the C-terminal domain (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively regulates RNA polymerase II transcription, possibly by controlling the transition from initiation/capping to processive transcript elongation. Recruited by REST to neuronal genes that contain RE-1 elements, leading to neuronal gene silencing in non-neuronal cells.</specific-function>
        <gene-name>CTDSP1</gene-name>
        <locus/>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>29202.94</molecular-weight>
        <chromosome-location>2</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:21614</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9GZU7</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CTDS1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.3.16</synonym>
          <synonym>NIF3</synonym>
          <synonym>NLI-IF</synonym>
          <synonym>NLI-interacting factor 3</synonym>
          <synonym>NLIIF</synonym>
          <synonym>Nuclear LIM interactor-interacting factor 3</synonym>
          <synonym>SCP1</synonym>
          <synonym>Small C-terminal domain phosphatase 1</synonym>
          <synonym>Small CTD phosphatase 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009472|Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1
MDSSAVITQISKEEARGPLRGKGDQKSAASQKPRSRGILHSLFCCVCRDDGEALPAHSGA
PLLVEENGAIPKQTPVQYLLPEAKAQDSDKICVVIDLDETLVHSSFKPVNNADFIIPVEI
DGVVHQVYVLKRPHVDEFLQRMGELFECVLFTASLAKYADPVADLLDKWGAFRARLFRES
CVFHRGNYVKDLSRLGRDLRRVLILDNSPASYVFHPDNAVPVASWFDNMSDTELHDLLPF
FEQLSRVDDVYSVLRQPRPGS</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017469|Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (CTDSP1)
ATGGTGGCCGCCCCGTGGGCTACCCAGGAGCAGGAGGAGGGCCGAGGGATCCAGCCCGGG
GACCGGGGTGACCAGAAGTCAGCAGCTTCCCAGAAGCCCCGAAGCCGGGGCATCCTCCAC
TCACTCTTCTGCTGTGTCTGCCGGGATGATGGGGAGGCCCTGCCTGCTCACAGCGGGGCG
CCCCTGCTTGTGGAGGAGAATGGCGCCATCCCTAAGACCCCAGTCCAATACCTGCTCCCT
GAGGCCAAGGCCCAGGACTCAGACAAGATCTGCGTGGTCATCGACCTGGACGAGACCCTG
GTGCACAGCTCCTTCAAGCCAGTGAACAACGCGGACTTCATCATCCCTGTGGAGATTGAT
GGGGTGGTCCACCAGGTCTACGTGTTGAAGCGTCCTCACGTGGATGAGTTCCTGCAGCGA
ATGGGCGAGCTCTTTGAATGTGTGCTGTTCACTGCTAGCCTCGCCAAGTACGCAGACCCA
GTAGCTGACCTGCTGGACAAATGGGGGGCCTTCCGGGCCCGGCTGTTTCGAGAGTCCTGC
GTCTTCCACCGGGGGAACTACGTGAAGGACCTGAGCCGGTTGGGTCGAGACCTGCGGCGG
GTGCTCATCCTGGACAATTCACCTGCCTCCTATGTCTTCCATCCAGACAATGCTGTACCG
GTGGCCTCGTGGTTTGACAACATGAGTGACACAGAGCTCCACGACCTCCTCCCCTTCTTC
GAGCAACTCAGCCGTGTGGACGACGTGTACTCAGTGCTCAGGCAGCCACGGCCAGGGAGC
TAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF03031</identifier>
            <name>NIF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>CTD phosphatase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of G1/S transition of mitotic cell cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of neuron differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein dephosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001575</id>
      <name>1-deoxy-D-xylulose 5-phosphate reductoisomerase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P45568" source="Swiss-Prot">
        <name>1-deoxy-D-xylulose 5-phosphate reductoisomerase</name>
        <general-function>Nadph binding</general-function>
        <specific-function>Catalyzes the NADP-dependent rearrangement and reduction of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate (MEP).</specific-function>
        <gene-name>dxr</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.88</theoretical-pi>
        <molecular-weight>43387.575</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB013300</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>3434984</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P45568</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>DXR_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1-deoxyxylulose-5-phosphate reductoisomerase</synonym>
          <synonym>1.1.1.267</synonym>
          <synonym>2-C-methyl-D-erythritol 4-phosphate synthase</synonym>
          <synonym>DXP reductoisomerase</synonym>
          <synonym>ispC</synonym>
          <synonym>yaeM</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011117|1-deoxy-D-xylulose 5-phosphate reductoisomerase
MKQLTILGSTGSIGCSTLDVVRHNPEHFRVVALVAGKNVTRMVEQCLEFSPRYAVMDDEA
SAKLLKTMLQQQGSRTEVLSGQQAACDMAALEDVDQVMAAIVGAAGLLPTLAAIRAGKTI
LLANKESLVTCGRLFMDAVKQSKAQLLPVDSEHNAIFQSLPQPIQHNLGYADLEQNGVVS
ILLTGSGGPFRETPLRDLATMTPDQACRHPNWSMGRKISVDSATMMNKGLEYIEARWLFN
ASASQMEVLIHPQSVIHSMVRYQDGSVLAQLGEPDMRTPIAHTMAWPNRVNSGVKPLDFC
KLSALTFAAPDYDRYPCLKLAMEAFEQGQAATTALNAANEITVAAFLAQQIRFTDIAALN
LSVLEKMDMREPQCVDDVLSVDANAREVARKEVMRLAS</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011118|1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr)
ATGAAGCAACTCACCATTCTGGGCTCGACCGGCTCGATTGGTTGCAGCACGCTGGACGTG
GTGCGCCATAATCCCGAACACTTCCGCGTAGTTGCGCTGGTGGCAGGCAAAAATGTCACT
CGCATGGTAGAACAGTGCCTGGAATTCTCTCCCCGCTATGCCGTAATGGACGATGAAGCG
AGTGCGAAACTTCTTAAAACGATGCTACAGCAACAGGGTAGCCGCACCGAAGTCTTAAGT
GGGCAACAAGCCGCTTGCGATATGGCAGCGCTTGAGGATGTTGATCAGGTGATGGCAGCC
ATTGTTGGCGCTGCTGGGCTGTTACCTACGCTTGCTGCGATCCGCGCGGGTAAAACCATT
TTGCTGGCCAATAAAGAATCACTGGTTACCTGCGGACGTCTGTTTATGGACGCCGTAAAG
CAGAGCAAAGCGCAATTGTTACCGGTCGATAGCGAACATAACGCCATTTTTCAGAGTTTA
CCGCAACCTATCCAGCATAATCTGGGATACGCTGACCTTGAGCAAAATGGCGTGGTGTCC
ATTTTACTTACCGGGTCTGGTGGCCCTTTCCGTGAGACGCCATTGCGCGATTTGGCAACA
ATGACGCCGGATCAAGCCTGCCGTCATCCGAACTGGTCGATGGGGCGTAAAATTTCTGTC
GATTCGGCTACCATGATGAACAAAGGTCTGGAATACATTGAAGCGCGTTGGCTGTTTAAC
GCCAGCGCCAGCCAGATGGAAGTGCTGATTCACCCGCAGTCAGTGATTCACTCAATGGTG
CGCTATCAGGACGGCAGTGTTCTGGCGCAGCTGGGGGAACCGGATATGCGTACGCCAATT
GCCCACACCATGGCATGGCCGAATCGCGTGAACTCTGGCGTGAAGCCGCTCGATTTTTGC
AAACTAAGTGCGTTGACATTTGCCGCACCGGATTATGATCGTTATCCATGCCTGAAACTG
GCGATGGAGGCGTTCGAACAAGGCCAGGCAGCGACGACAGCATTGAATGCCGCAAACGAA
ATCACCGTTGCTGCTTTTCTTGCGCAACAAATCCGCTTTACGGATATCGCTGCGTTGAAT
TTATCCGTACTGGAAAAAATGGATATGCGCGAACCACAATGTGTGGACGATGTGTTATCT
GTTGATGCGAACGCGCGTGAAGTCGCCAGAAAAGAGGTGATGCGTCTCGCAAGCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08436</identifier>
            <name>DXP_redisom_C</name>
          </pfam>
          <pfam>
            <identifier>PF02670</identifier>
            <name>DXP_reductoisom</name>
          </pfam>
          <pfam>
            <identifier>PF13288</identifier>
            <name>DXPR_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>1-deoxy-D-xylulose-5-phosphate reductoisomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>manganese ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NADPH binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001719</id>
      <name>Tryptophan synthase alpha chain</name>
      <organism>Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P16608" source="Swiss-Prot">
        <name>Tryptophan synthase alpha chain</name>
        <general-function>Tryptophan synthase activity</general-function>
        <specific-function>The alpha subunit is responsible for the aldol cleavage of indoleglycerol phosphate to indole and glyceraldehyde 3-phosphate.</specific-function>
        <gene-name>trpA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.09</theoretical-pi>
        <molecular-weight>28936.25</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="262724">Thermus thermophilus (strain HB27 / ATCC BAA-163 / DSM 7039)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M32108</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>155133</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P16608</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TRPA_THET2</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>4.2.1.20</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011224|Tryptophan synthase alpha chain
MTTLEAFAKARSEGRAALIPYLTAGFPSREGFLQAVEEVLPYADLLEIGLPYSDPLGDGP
VIQRASELALRKGMSVQGALELVREVRALTEKPLFLMTYLNPVLAWGPERFFGLFKQAGA
TGVILPDLPPDEDPGLVRLAQEIGLETVFLLAPTSTDARIATVVRHATGFVYAVSVTGVT
GMRERLPEEVKDLVRRIKARTALPVAVGFGVSGKATAAQAAVADGVVVGSALVRALEEGR
SLAPLLQEIRQGLQRLEANPGLKESSKKPLS</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011225|Tryptophan synthase alpha chain (trpA)
GTGACCACCCTCGAGGCCTTCGCCAAGGCCCGGTCCGAGGGCCGGGCCGCCCTCATCCCT
TACCTCACCGCGGGCTTCCCCAGCCGGGAGGGCTTTTTGCAGGCGGTGGAGGAGGTCCTC
CCCTATGCCGACCTTCTGGAGATCGGCCTCCCCTACTCCGACCCCCTGGGGGACGGCCCC
GTGATCCAGCGGGCAAGCGAACTGGCCCTGAGGAAGGGGATGAGCGTCCAAGGCGCTTTG
GAGCTCGTCCGCGAGGTGCGCGCCCTCACGGAGAAACCCCTCTTCCTCATGACCTACCTG
AACCCCGTCCTGGCCTGGGGGCCGGAGCGCTTCTTCGGCCTCTTCAAGCAGGCGGGGGCC
ACGGGGGTGATCCTTCCCGACCTTCCCCCCGACGAGGACCCAGGCCTCGTGCGCCTCGCC
CAGGAGATCGGCCTGGAGACGGTCTTCCTTCTCGCCCCCACCTCCACGGACGCCCGCATC
GCCACCGTGGTCCGCCACGCCACGGGCTTCGTCTACGCCGTCTCCGTCACCGGGGTCACG
GGGATGCGGGAAAGGCTTCCCGAGGAGGTCAAGGACCTGGTGCGGCGCATCAAGGCCAGG
ACCGCCCTCCCCGTGGCCGTGGGCTTCGGGGTTTCCGGCAAGGCCACGGCCGCGCAGGCG
GCGGTGGCGGACGGGGTGGTGGTGGGAAGCGCCTTGGTCCGGGCCTTGGAGGAGGGGAGG
TCCCTTGCGCCCCTTCTCCAGGAGATCCGCCAGGGCCTCCAGCGCCTCGAGGCCAACCCC
GGCCTGAAGGAAAGCTCAAAGAAGCCGTTGTCCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00290</identifier>
            <name>Trp_syntA</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>tryptophan synthase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001946</id>
      <name>Sialidase</name>
      <organism>Micromonospora viridifaciens</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q02834" source="Swiss-Prot">
        <name>Sialidase</name>
        <general-function>Exo-alpha-(2-&gt;8)-sialidase activity</general-function>
        <specific-function>To release sialic acids for use as carbon and energy sources for this non-pathogenic bacterium while in pathogenic microorganisms, sialidases have been suggested to be pathogenic factors.</specific-function>
        <gene-name>nedA</gene-name>
        <locus/>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-37</signal-regions>
        <theoretical-pi>6.52</theoretical-pi>
        <molecular-weight>68829.78</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1881">Micromonospora viridifaciens</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D01045</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>216784</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q02834</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NANH_MICVI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.2.1.18</synonym>
          <synonym>Neuraminidase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016618|Sialidase
MTANPYLRRLPRRRAVSFLLAPALAAATVAGASPAQAIAGAPVPPGGEPLYTEQDLAVNG
REGFPNYRIPALTVTPDGDLLASYDGRPTGIDAPGPNSILQRRSTDGGRTWGEQQVVSAG
QTTAPIKGFSDPSYLVDRETGTIFNFHVYSQRQGFAGSRPGTDPADPNVLHANVATSTDG
GLTWSHRTITADITPDPGWRSRFAASGEGIQLRYGPHAGRLIQQYTIINAAGAFQAVSVY
SDDHGRTWRAGEAVGVGMDENKTVELSDGRVLLNSRDSARSGYRKVAVSTDGGHSYGPVT
IDRDLPDPTNNASIIRAFPDAPAGSARAKVLLFSNAASQTSRSQGTIRMSCDDGQTWPVS
KVFQPGSMSYSTLTALPDGTYGLLYEPGTGIRYANFNLAWLGGICAPFTIPDVALEPGQQ
VTVPVAVTNQSGIAVPKPSLQLDASPDWQVQGSVEPLMPGRQAKGQVTITVPAGTTPGRY
RVGATLRTSAGNASTTFTVTVGLLDQARMSIADVDSEETAREDGRASNVIDGNPSTFWHT
EWSRADAPGYPHRISLDLGGTHTISGLQYTRRQNSANEQVADYEIYTSLNGTTWDGPVAS
GRFTTSLAPQRAVFPARDARYIRLVALSEQTGHKYAAVAELEVEGQR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003854|1944 bp
ATGACTGCGAATCCGTACCTCCGCCGCCTGCCCCGGCGCCGAGCCGTCAGCTTCCTGCTC
GCACCAGCGCTGGCGGCCGCCACGGTCGCCGGCGCGTCCCCCGCACAGGCCATCGCCGGG
GCACCCGTCCCGCCCGGCGGCGAGCCGCTCTACACGGAGCAGGACCTCGCCGTGAACGGC
AGGGAGGGCTTTCCGAACTACCGCATCCCAGCGCTGACCGTCACGCCCGACGGGGACCTG
CTGGCCTCGTACGACGGCCGCCCGACCGGTATCGACGCGCCCGGCCCCAACTCCATCCTC
CAACGCCGCAGCACCGACGGCGGCCGGACGTGGGGCGAGCAACAGGTCGTCAGCGCCGGC
CAGACCACCGCGCCGATCAAGGGGTTCTCCGACCCCAGCTACCTTGTCGACCGGGAAACC
GGGACCATCTTCAACTTCCACGTCTACTCCCAGCGGCAGGGCTTCGCCGGCAGCCGGCCC
GGCACCGACCCGGCAGACCCCAACGTGCTCCACGCCAACGTCGCGACCTCGACCGACGGC
GGTCTGACCTGGTCGCACCGGACCATCACGGCCGACATCACCCCGGATCCGGGCTGGCGC
AGCCGCTTCGCCGCCTCCGGCGAAGGCATCCAGCTCCGCTATGGACCCCACGCCGGTCGA
CTCATCCAGCAGTACACGATCATCAACGCTGCCGGCGCCTTCCAGGCGGTGAGCGTGTAC
AGCGACGACCACGGAAGGACCTGGCGCGCCGGCGAAGCCGTCGGGGTCGGCATGGACGAG
AACAAGACCGTGGAACTCTCCGATGGCCGGGTCCTGCTCAACAGCCGCGACTCGGCCCGC
AGCGGATACCGTAAGGTGGCCGTCTCCACTGACGGCGGCCACAGCTACGGCCCGGTGACC
ATCGACCGCGACCTCCCCGACCCGACGAACAACGCATCGATCATCCGGGCCTTCCCTGAC
GCCCCGGCCGGCTCCGCGCGGGCCAAGGTCCTGCTCTTCTCCAACGCCGCCAGCCAGACC
TCGCGCAGTCAGGGCACCATCCGGATGTCCTGCGACGATGGCCAGACCTGGCCGGTTTCG
AAGGTCTTCCAGCCCGGCTCGATGTCGTACTCCACCCTGACCGCACTGCCCGACGGCACC
TACGGGCTGCTGTACGAGCCGGGCACCGGCATCAGATACGCCAACTTCAACCTCGCCTGG
CTGGGCGGCATCTGCGCGCCCTTCACGATTCCGGATGTGGCGCTCGAGCCGGGCCAGCAG
GTCACTGTTCCGGTGGCCGTCACGAACCAGTCCGGTATCGCGGTACCGAAGCCGAGCCTT
CAGCTCGACGCATCGCCGGACTGGCAGGTTCAGGGTTCCGTCGAGCCCCTCATGCCCGGA
CGGCAGGCCAAGGGCCAGGTGACCATCACGGTTCCCGCCGGCACCACCCCCGGTCGCTAC
CGGGTCGGTGCGACGCTGCGCACCTCCGCGGGTAACGCGTCGACGACCTTCACGGTCACG
GTTGGACTGCTCGACCAGGCCCGGATGAGCATCGCGGACGTCGACAGCGAGGAGACCGCC
CGCGAAGACGGGCGGGCGAGCAACGTGATCGACGGCAACCCCTCGACGTTCTGGCACACC
GAATGGTCGCGTGCCGATGCTCCTGGCTACCCGCACCGCATCAGCCTCGACCTCGGTGGC
ACGCACACGATCAGCGGCCTCCAGTACACCCGACGGCAGAACAGCGCCAACGAGCAGGTC
GCGGACTACGAGATCTACACCAGCCTGAACGGCACGACCTGGGATGGCCCGGTTGCCAGC
GGGCGCTTCACCACGTCCCTCGCGCCGCAGCGCGCGGTCTTCCCGGCGCGGGACGCCAGG
TACATCCGGTTGGTGGCCCTCAGCGAGCAGACCGGGCACAAGTACGCCGCGGTCGCTGAG
CTGGAGGTGGAAGGCCAGCGCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00754</identifier>
            <name>F5_F8_type_C</name>
          </pfam>
          <pfam>
            <identifier>PF13088</identifier>
            <name>BNR_2</name>
          </pfam>
          <pfam>
            <identifier>PF10633</identifier>
            <name>NPCBM_assoc</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>exo-alpha-(2-&gt;3)-sialidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>exo-alpha-(2-&gt;6)-sialidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>exo-alpha-(2-&gt;8)-sialidase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002930</id>
      <name>Cytochrome c peroxidase</name>
      <organism>Marinobacter hydrocarbonoclasticus</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P83787" source="TrEMBL">
        <name>Cytochrome c peroxidase</name>
        <general-function>Oxidoreductase activity</general-function>
        <specific-function/>
        <gene-name/>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.3</theoretical-pi>
        <molecular-weight>35354.415</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="2743">Marinobacter hydrocarbonoclasticus</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P83787</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>P83787_MARHY</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012060|Cytochrome c peroxidase
DNLMERANSMFEPIPKYPPVIDGNELTQAKVELGKMEFFEPRLSSSHLISCNTCHNVGLG
GDDELPTSIGHGWQKGPRNSPTVFNAVFNAAQFWDGRAADLAEQAKGPVQAGVEMSSTPD
RVVATLKSMPEYIERFEDAFPGQENPVTFDNMAVAIEAYEATLITPEAPFDKYLRGDTSA
LNESEKEGLALFMDRGCTACHSGVNLGGQNYYPFGLVAKPGAEILPEGDKGRFSVTETAS
DEYVFRASPLRNIELTAPYFHSGAVWSLEEAVAVMGTAQLGTELNNDEVKSIVAFLKTLT
GNVPEVTYPVLPPSTANTPKPVDMIP</amino-acid-sequence>
        <gene-sequence format="FASTA"/>
        <pfams>
          <pfam>
            <identifier>PF00034</identifier>
            <name>Cytochrom_C</name>
          </pfam>
          <pfam>
            <identifier>PF03150</identifier>
            <name>CCP_MauG</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>electron carrier activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>heme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>oxidoreductase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004625</id>
      <name>Hepatocyte growth factor-regulated tyrosine kinase substrate</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O14964" source="Swiss-Prot">
        <name>Hepatocyte growth factor-regulated tyrosine kinase substrate</name>
        <general-function>Protein domain specific binding</general-function>
        <specific-function>Involved in intracellular signal transduction mediated by cytokines and growth factors. When associated with STAM, it suppresses DNA signaling upon stimulation by IL-2 and GM-CSF. Could be a direct effector of PI3-kinase in vesicular pathway via early endosomes and may regulate trafficking to early and late endosomes by recruiting clathrin. May concentrate ubiquitinated receptors within clathrin-coated regions. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with STAM (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes. May contribute to the efficient recruitment of SMADs to the activin receptor complex. Involved in receptor recycling via its association with the CART complex, a multiprotein complex required for efficient transferrin receptor recycling but not for EGFR degradation.</specific-function>
        <gene-name>HGS</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>86191.46</molecular-weight>
        <chromosome-location>17</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4897</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O14964</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>HGS_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>HRS</synonym>
          <synonym>Protein pp110</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009544|Hepatocyte growth factor-regulated tyrosine kinase substrate
MGRGSGTFERLLDKATSQLLLETDWESILQICDLIRQGDTQAKYAVNSIKKKVNDKNPHV
ALYALEVMESVVKNCGQTVHDEVANKQTMEELKDLLKRQVEVNVRNKILYLIQAWAHAFR
NEPKYKVVQDTYQIMKVEGHVFPEFKESDAMFAAERAPDWVDAEECHRCRVQFGVMTRKH
HCRACGQIFCGKCSSKYSTIPKFGIEKEVRVCEPCYEQLNRKAEGKATSTTELPPEYLTS
PLSQQSQLPPKRDETALQEEEELQLALALSQSEAEEKERLRQKSTYTSYPKAEPMPSASS
APPASSLYSSPVNSSAPLAEDIDPELARYLNRNYWEKKQEEARKSPTPSAPVPLTEPAAQ
PGEGHAAPTNVVENPLPETDSQPIPPSGGPFSEPQFHNGESEESHEQFLKALQNAVTTFV
NRMKSNHMRGRSITNDSAVLSLFQSINGMHPQLLELLNQLDERRLYYEGLQDKLAQIRDA
RGALSALREEHREKLRRAAEEAERQRQIQLAQKLEIMRQKKQEYLEVQRQLAIQRLQEQE
KERQMRLEQQKQTVQMRAQMPAFPLPYAQLQAMPAAGGVLYQPSGPASFPSTFSPAGSVE
GSPMHGVYMSQPAPAAGPYPSMPSTAADPSMVSAYMYPAGATGAQAAPQAQAGPTASPAY
SSYQPTPTAGYQNVASQAPQSLPAISQPPQSSTMGYMGSQSVSMGYQPYNMQNLMTTLPS
QDASLPPQQPYIAGQQPMYQQMAPSGGPPQQQPPVAQQPQAQGPPAQGSEAQLISFD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0013223|Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS)
ATGGGGCGAGGCAGCGGCACCTTCGAGCGTCTCCTAGACAAGGCGACCAGCCAGCTCCTG
TTGGAGACAGATTGGGAGTCCATTTTGCAGATCTGCGACCTGATCCGCCAAGGGGACACA
CAAGCAAAATATGCTGTGAATTCCATCAAGAAGAAAGTCAACGACAAGAACCCACACGTC
GCCTTGTATGCCCTGGAGGTCATGGAATCTGTGGTAAAGAACTGTGGCCAGACAGTTCAT
GATGAGGTGGCCAACAAGCAGACCATGGAGGAGCTGAAGGACCTGCTGAAGAGACAAGTG
GAGGTAAACGTCCGTAACAAGATCCTGTACCTGATCCAGGCCTGGGCGCATGCCTTCCGG
AACGAGCCCAAGTACAAGGTGGTCCAGGACACCTACCAGATCATGAAGGTGGAGGGGCAC
GTCTTTCCAGAATTCAAAGAGAGCGATGCCATGTTTGCTGCCGAGAGAGCCCCAGACTGG
GTGGACGCTGAGGAATGCCACCGCTGCAGGGTGCAGTTCGGGGTGATGACCCGTAAGCAC
CACTGCCGGGCGTGTGGGCAGATATTCTGTGGAAAGTGTTCTTCCAAGTACTCCACCATC
CCCAAGTTTGGCATCGAGAAGGAGGTGCGCGTGTGTGAGCCCTGCTACGAGCAGCTGAAC
AGGAAAGCGGAGGGAAAGGCCACTTCCACCACTGAGCTGCCCCCCGAGTACCTGACCAGC
CCCCTGTCTCAGCAGTCCCAGCTGCCCCCCAAGAGGGACGAGACGGCCCTGCAGGAGGAG
GAGGAGCTGCAGCTGGCCCTGGCGCTGTCACAGTCAGAGGCGGAGGAGAAGGAGAGGCTG
AGACAGAAGTCCACGTACACTTCGTACCCCAAGGCGGAGCCCATGCCCTCGGCCTCCTCA
GCGCCCCCCGCCAGCAGCCTGTACTCTTCACCTGTGAACTCGTCGGCGCCTCTGGCTGAG
GACATCGACCCTGAGCTCGCACGGTATCTCAACCGGAACTACTGGGAGAAGAAGCAGGAG
GAGGCTCGCAAGAGCCCCACGCCATCTGCGCCCGTGCCCCTGACGGAGCCGGCTGCACAG
CCTGGGGAAGGGCACGCAGCCCCCACCAACGTGGTGGAGAACCCCCTCCCGGAGACAGAC
TCTCAGCCCATTCCTCCCTCTGGTGGCCCCTTTAGTGAGCCACAGTTCCACAATGGCGAG
TCTGAGGAGAGCCACGAGCAGTTCCTGAAGGCGCTGCAGAACGCCGTCACCACCTTCGTG
AACCGCATGAAGAGTAACCACATGCGGGGCCGCAGCATCACCAATGACTCGGCCGTGCTC
TCACTCTTCCAGTCCATCAACGGCATGCACCCGCAGCTGCTGGAGCTGCTCAACCAGCTG
GACGAGCGCAGGCTGTACTATGAGGGGCTGCAGGACAAGCTGGCACAGATCCGCGATGCC
CGGGGGGCGCTGAGTGCCCTGCGCGAAGAGCACCGGGAGAAGCTTCGCCGGGCAGCCGAG
GAGGCAGAGCGCCAGCGCCAGATCCAGCTGGCCCAGAAGCTGGAGATAATGCGGCAGAAG
AAGCAGGAGTACCTGGAGGTGCAGAGGCAGCTGGCCATCCAGCGCCTGCAGGAGCAGGAG
AAGGAGCGGCAGATGCGGCTGGAGCAGCAGAAGCAGACGGTCCAGATGCGCGCGCAGATG
CCCGCCTTCCCCCTGCCCTACGCCCAGCTCCAGGCCATGCCCGCAGCCGGAGGTGTGCTC
TACCAGCCCTCGGGACCAGCCAGCTTCCCCAGCACCTTCAGCCCTGCCGGCTCGGTGGAG
GGCTCCCCAATGCACGGCGTGTACATGAGCCAGCCGGCCCCTGCCGCTGGCCCCTACCCC
AGCATGCCCAGCACTGCGGCTGATCCCAGCATGGTGAGTGCCTACATGTACCCAGCAGGG
GCCACTGGGGCGCAGGCGGCCCCCCAGGCCCAGGCCGGACCCACCGCCAGCCCCGCTTAC
TCATCCTACCAGCCTACTCCCACAGCGGGCTACCAGAACGTGGCCTCCCAGGCCCCACAG
AGCCTCCCGGCCATCTCTCAGCCTCCGCAGTCCAGCACCATGGGCTACATGGGGAGCCAG
TCAGTCTCCATGGGCTACCAGCCTTACAACATGCAGAATCTCATGACCACCCTCCCAAGC
CAGGATGCGTCTCTGCCACCCCAGCAGCCCTACATCGCGGGGCAGCAGCCCATGTACCAG
CAGATGGCACCCTCTGGCGGTCCCCCCCAGCAGCAGCCCCCCGTGGCCCAGCAACCGCAG
GCACAGGGGCCGCCGGCACAGGGCAGCGAGGCCCAGCTCATTTCATTCGACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01363</identifier>
            <name>FYVE</name>
          </pfam>
          <pfam>
            <identifier>PF12210</identifier>
            <name>Hrs_helical</name>
          </pfam>
          <pfam>
            <identifier>PF00790</identifier>
            <name>VHS</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>early endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>early endosome membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intracellular membrane-bounded organelle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>multivesicular body membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>secretory granule</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein domain specific binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>endosomal transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>endosome to lysosome transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epidermal growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>membrane invagination</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>membrane organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of epidermal growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of JAK-STAT cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of exosomal secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>post-Golgi vesicle-mediated transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein localization to membrane</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein targeting to lysosome</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of MAP kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of protein catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003253</id>
      <name>Invasin</name>
      <organism>Yersinia pseudotuberculosis serotype I (strain IP32953)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P11922" source="Swiss-Prot">
        <name>Invasin</name>
        <general-function/>
        <specific-function>Invasin is a protein that allows enteric bacteria to penetrate cultured mammalian cells. The entry of invasin in the cell is mediated by binding several beta-1 chain integrins.</specific-function>
        <gene-name/>
        <locus/>
        <cellular-location>Cell surface</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.84</theoretical-pi>
        <molecular-weight>106543.46</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="273123">Yersinia pseudotuberculosis serotype I (strain IP32953)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M17448</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P11922</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>INVA_YERPS</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006343|Invasin
MVFQPISEFLLIRNAGMSMYFNKIISFNIISRIVICIFLICGMFMAGASEKYDANAPQQV
QPYSVSSSAFENLHPNNEMESSINPFSASDTERNAAIIDRANKEQETEAVNKMISTGARL
AASGRASDVAHSMVGDAVNQEIKQWLNRFGTAQVNLNFDKNFSLKESSLDWLAPWYDSAS
FLFFSQLGIRNKDSRNTLNLGVGIRTLENGWLYGLNTFYDNDLTGHNHRIGLGAEAWTDY
LQLAANGYFRLNGWHSSRDFSDYKERPATGGDLRANAYLPALPQLGGKLMYEQYTGERVA
LFGKDNLQRNPYAVTAGINYTPVPLLTVGVDQRMGKSSKHETQWNLQMNYRLGESFQSQL
SPSAVAGTRLLAESRYNLVDRNNNIVLEYQKQQVVKLTLSPATISGLPGQVYQVNAQVQG
ASAVREIVWSDAELIAAGGTLTPLSTTQFNLVLPPYKRTAQVSRVTDDLTANFYSLSALA
VDHQGNRSNSFTLSVTVQQPQLTLTAAVIGDGAPANGKTAITVEFTVADFEGKPLAGQEV
VITTNNGALPNKITEKTDANGVARIALTNTTDGVTVVTAEVEGQRQSVDTHFVKGTIAAD
KSTLAAVPTSIIADGLMASTITLELKDTYGDPQAGANVAFDTTLGNMGVITDHNDGTYSA
PLTSTTLGVATVTVKVDGAAFSVPSVTVNFTADPIPDAGRSSFTVSTPDILADGTMSSTL
SFVPVDKNGHFISGMQGLSFTQNGVPVSISPITEQPDSYTATVVGNTAGDVTITPQVDTL
ILSTLQKKISLFPVPTLTGILVNGQNFATDKGFPKTIFKNATFQLQMDNDVANNTQYEWS
SSFTPNVSVNDQGQVTITYQTYSEVAVTAKSKKFPSYSVSYRFYPNRWIYDGGTSLVSSL
EASRQCQGSDMSAVLESSRATNGTRAPDGTLWGEWGSLTAYSSDWQSGEYWVKKTSTDFE
TMNMDTGALVQGPAYLAFPLCALAI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012266|Invasin
ATGGTTTTCCAGCCAATCAGTGAGTTTCTCTTGATAAGGAATGCGGGAATGTCTATGTAT
TTTAATAAAATAATTTCATTTAATATTATTTCACGAATAGTTATTTGTATCTTTTTGATA
TGTGGAATGTTCATGGCTGGGGCTTCAGAAAAATATGATGCTAACGCACCGCAACAGGTC
CAGCCTTATTCTGTCTCTTCATCTGCATTTGAAAATCTCCATCCTAATAATGAAATGGAG
AGTTCAATCAATCCCTTTTCCGCATCGGATACAGAAAGAAATGCTGCAATAATAGATCGC
GCCAATAAGGAGCAGGAGACTGAAGCGGTGAATAAGATGATAAGCACCGGGGCCAGGTTA
GCTGCATCAGGCAGGGCATCTGATGTTGCTCACTCAATGGTGGGCGATGCGGTTAATCAA
GAAATCAAACAGTGGTTAAATCGATTCGGTACGGCTCAAGTTAATCTGAATTTTGACAAA
AATTTTTCGCTAAAAGAAAGCTCTCTTGATTGGCTGGCTCCTTGGTATGACTCTGCTTCA
TTCCTCTTTTTTAGTCAGTTAGGTATTCGCAATAAAGACAGCCGCAACACACTTAACCTT
GGCGTCGGGATACGTACATTGGAGAACGGTTGGCTGTACGGACTTAATACTTTTTATGAT
AATGATTTGACCGGCCACAACCACCGTATCGGTCTTGGTGCCGAGGCCTGGACCGATTAT
TTACAGTTGGCTGCCAATGGGTATTTTCGCCTCAATGGATGGCACTCGTCGCGTGATTTC
TCCGACTATAAAGAGCGCCCAGCCACTGGGGGGGATTTGCGCGCGAATGCTTATTTACCT
GCACTCCCACAACTGGGGGGGAAGTTGATGTATGAGCAATACACCGGTGAGCGTGTTGCT
TTATTTGGTAAAGATAATCTGCAACGCAACCCTTATGCCGTGACTGCCGGGATCAATTAC
ACCCCCGTGCCTCTACTCACTGTCGGGGTAGATCAGCGTATGGGGAAAAGCAGTAAGCAT
GAAACACAGTGGAACCTCCAAATGAACTATCGCCTGGGCGAGAGTTTTCAGTCGCAACTT
AGCCCTTCAGCGGTGGCGGGAACACGTCTACTGGCTGAGAGCCGCTATAACCTTGTCGAT
CGTAACAATAATATCGTGTTGGAGTATCAGAAACAGCAGGTGGTTAAACTGACATTATCG
CCAGCAACTATCTCCGGCCTGCCGGGTCAGGTTTATCAGGTGAACGCACAAGTACAAGGG
GCATCTGCTGTAAGGGAAATTGTCTGGAGTGATGCCGAACTGATTGCCGCTGGCGGCACA
TTAACACCACTGAGTACCACACAATTCAACTTGGTTTTACCGCCTTATAAACGCACAGCA
CAAGTGAGTCGGGTAACGGACGACCTGACAGCCAACTTTTATTCGCTTAGTGCGCTCGCG
GTTGATCACCAAGGAAACAGATCTAACTCATTCACATTGAGCGTCACCGTTCAGCAGCCT
CAGTTGACATTAACGGCGGCCGTCATTGGTGATGGCGCACCGGCTAATGGGAAAACTGCA
ATCACCGTTGAGTTCACCGTTGCTGATTTTGAGGGGAAACCCTTAGCCGGGCAGGAGGTG
GTGATAACCACCAATAATGGTGCGCTACCGAATAAAATCACGGAAAAGACAGATGCAAAT
GGCGTCGCGCGCATTGCATTAACCAATACGACAGATGGCGTGACGGTAGTCACAGCAGAA
GTGGAGGGGCAACGGCAAAGTGTTGATACCCACTTTGTTAAGGGTACTATCGCGGCGGAT
AAATCCACTCTGGCTGCGGTACCGACATCTATCATCGCTGATGGTCTAATGGCTTCAACC
ATCACGTTGGAGTTGAAGGATACCTATGGGGACCCGCAGGCTGGCGCGAATGTGGCTTTT
GACACAACCTTAGGCAATATGGGCGTTATCACGGATCACAATGACGGCACTTATAGCGCA
CCATTGACCAGTACCACGTTGGGGGTAGCAACAGTAACGGTGAAAGTGGATGGGGCTGCG
TTCAGTGTGCCGAGTGTGACGGTTAATTTCACGGCAGATCCTATTCCAGATGCTGGCCGC
TCCAGTTTCACCGTCTCCACACCGGATATCTTGGCTGATGGCACGATGAGTTCCACATTA
TCCTTTGTCCCTGTCGATAAGAATGGCCATTTTATCAGTGGGATGCAGGGCTTGAGTTTT
ACTCAAAACGGTGTGCCGGTGAGTATTAGCCCCATTACCGAGCAGCCAGATAGCTATACC
GCGACGGTGGTTGGGAATACCGCCGGTGATGTCACAATCACGCCGCAGGTTGATACCCTG
ATACTGAGTACATTGCAGAAAAAAATATCCCTATTCCCGGTACCTACGCTGACCGGTATT
CTGGTTAACGGGCAAAATTTCGCTACGGATAAAGGGTTCCCGAAAACGATCTTTAAAAAC
GCCACATTCCAGTTACAGATGGATAACGATGTTGCTAATAATACTCAGTATGAGTGGTCG
TCGTCATTCACACCCAATGTATCGGTTAACGATCAGGGTCAGGTGACGATTACCTACCAA
ACCTATAGCGAAGTGGCTGTGACGGCGAAAAGTAAAAAATTCCCAAGTTATTCGGTGAGT
TATCGGTTCTACCCAAATCGGTGGATATACGATGGCGGCACTTCGCTGGTATCGAGTCTC
GAGGCCAGCAGACAATGCCAAGGTTCAGATATGTCTGCGGTTCTTGAATCCTCACGTGCA
ACCAACGGAACGCGTGCGCCTGACGGGACATTGTGGGGCGAGTGGGGGAGCTTGACCGCG
TATAGTTCTGATTGGCAATCTGGCGAATATTGGGTCAAAAAGACCAGTACGGATTTTGAA
ACCATGAATATGGACACCGGCGCGCTGGTACAAGGGCCTGCATACTTGGCGTTCCCGCTC
TGTGCGCTGGCAATATAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02369</identifier>
            <name>Big_1</name>
          </pfam>
          <pfam>
            <identifier>PF07979</identifier>
            <name>Intimin_C</name>
          </pfam>
          <pfam>
            <identifier>PF09134</identifier>
            <name>Invasin_D3</name>
          </pfam>
          <pfam>
            <identifier>PF11924</identifier>
            <name>Invasin_beta</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell surface</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell adhesion</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002953</id>
      <name>Intron-associated endonuclease 1</name>
      <organism>Enterobacteria phage T4</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P13299" source="Swiss-Prot">
        <name>Intron-associated endonuclease 1</name>
        <general-function>Endonuclease activity</general-function>
        <specific-function>This endonuclease is specific to the thymidylate synthase (td) gene splice junction and is involved in intron homing.</specific-function>
        <gene-name>ITEVIR</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>10.26</theoretical-pi>
        <molecular-weight>28232.2</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="10665">Enterobacteria phage T4</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M12742</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P13299</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TEV1_BPT4</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.-.-</synonym>
          <synonym>I-TevI</synonym>
          <synonym>IRF protein</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012075|Intron-associated endonuclease 1
MKSGIYQIKNTLNNKVYVGSAKDFEKRWKRHFKDLEKGCHSSIKLQRSFNKHGNVFECSI
LEEIPYEKDLIIERENFWIKELNSKINGYNIADATFGDTCSTHPLKEEIIKKRSETVKAK
MLKLGPDGRKALYSKPGSKNGRWNPETHKFCKCGVRIQTSAYTCSKCRNRSGENNSFFNH
KHSDITKSKISEKMKGKKPSNIKKISCDGVIFDCAADAARHFKISSGLVTYRVKSDKWNW
FYINA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012076|Intron-associated endonuclease 1 (ITEVIR)
ATGAAAAGCGGAATTTATCAGATTAAAAATACTTTAAACAATAAAGTATATGTAGGAAGT
GCTAAAGATTTTGAAAAGAGATGGAAGAGGCATTTTAAAGATTTAGAAAAAGGATGCCAT
TCTTCTATAAAACTTCAGAGGTCTTTTAACAAACATGGTAATGTGTTTGAATGTTCTATT
TTGGAAGAAATTCCATATGAGAAAGATTTGATTATTGAACGAGAAAATTTTTGGATTAAA
GAGCTTAATTCTAAAATTAATGGATACAATATTGCTGATGCAACGTTTGGTGATACATGT
TCTACGCATCCATTAAAAGAAGAAATTATTAAGAAACGTTCTGAAACTGTTAAAGCTAAG
ATGCTTAAACTTGGACCTGATGGTCGGAAAGCTCTTTACAGTAAACCCGGAAGTAAAAAC
GGGCGTTGGAATCCAGAAACCCATAAGTTTTGTAAGTGCGGTGTTCGCATACAAACTTCT
GCTTATACTTGTAGTAAATGCAGAAATCGTTCAGGTGAAAATAATTCATTCTTTAATCAT
AAGCATTCAGACATAACTAAATCTAAAATATCAGAAAAGATGAAAGGTAAAAAGCCTAGT
AATATTAAAAAGATTTCATGTGATGGGGTTATTTTTGATTGTGCAGCAGATGCAGCTAGA
CATTTTAAAATTTCGTCTGGATTAGTTACTTATCGTGTAAAATCTGATAAATGGAATTGG
TTCTACATAAATGCCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01541</identifier>
            <name>GIY-YIG</name>
          </pfam>
          <pfam>
            <identifier>PF07460</identifier>
            <name>NUMOD3</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>endonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intron homing</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003254</id>
      <name>Short tail fiber protein</name>
      <organism>Enterobacteria phage T4</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P10930" source="Swiss-Prot">
        <name>Short tail fiber protein gp12</name>
        <general-function>Metal ion binding</general-function>
        <specific-function>Structural component of the short tail fiber. Adhesion protein that binds irreversibly to the lipopolysaccharides component (LPS) on the cell surface of Escherichia coli B strains during virus attachment. After at least three long tail fibers have bound, short tail fibers extend and bind irreversibly to the core region of the host cell LPS.</specific-function>
        <gene-name>12</gene-name>
        <locus/>
        <cellular-location>Virion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.19</theoretical-pi>
        <molecular-weight>56204.88</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="10665">Enterobacteria phage T4</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X06792</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P10930</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FIB12_BPT4</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Gene product 12</synonym>
          <synonym>gp12</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019395|Short tail fiber protein gp12
MSNNTYQHVSNESRYVKFDPTDTNFPPEITDVQAAIAAISPAGVNGVPDASSTTKGILFI
PTEQEVIDGTNNTKAVTPATLATRLSYPNATETVYGLTRYSTNDEAIAGVNNESSITPAK
FTVALNNAFETRVSTESSNGVIKISSLPQALAGADDTTAMTPLKTQQLAIKLIAQIAPSE
TTATESDQGVVQLATVAQVRQGTLREGYAISPYTFMNSSSTEEYKGVIKLGTQSEVNSNN
ASVAVTGATLNGRGSTTSMRGVVKLTTTAGSQSGGDASSALAWNADVIQQRGGQIIYGTL
RIEDTFTIANGGANITGTVRMTGGYIQGNRIVTQNEIDRTIPVGAIMMWAADSLPSDAWR
FCHGGTVSASDCPLYASRIGTRYGGNPSNPGLPDMRGLFVRGSGRGSHLTNPNVNGNDQF
GKPRLGVGCTGGYVGEVQIQQMSYHKHAGGFGEHDDLGAFGNTRRSNFVGTRKGLDWDNR
SYFTNDGYEIDPESQRNSKYTLNRPELIGNETRPWNISLNYIIKVKE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019396|Short tail fiber protein gp12 (12)
ATGAGTAATAATACATATCAACACGTTTCTAATGAATCTCGTTATGTAAAATTTGATCCT
ACCGATACGAATTTTCCACCGGAGATTACTGATGTTCACGCTGCTATAGCAGCCATTTCT
CCTGCTGGAGTAAATGGAGTTCCTGATGCATCGTCAACAACAAAGGGAATTCTATTTATT
CCCACTGAACAGGAAGTTATAGATGGAACTAATAATACCAAAGCAGTTACACCAGCAACG
TTGGCAACAAGATTATCTTATCCAAATGCAACTGAAACTGTTTACGGATTAACAAGATAT
TCAACCAATGATGAAGCCATTGCCGGAGTTAATAATGAATCTTCTATAACTCCAGCTAAA
TTTACTGTCGCCCTTAATAATGCGTTTGAAACGCGAGTTTCAACTGAATCCTCAAATGGT
GTTATTAAAATTTCATCTCTACCGCAAGCATTAGCTGGTGCAGATGATACTACTGCAATG
ACTCCATTAAAAACACAGCAGTTAGCTATTAAATTAATTGCGCAAATTGCTCCTTCTGAA
ACCACAGCTACCGAATCGGACCAAGGTGTTGTTCAATTAGCAACAGTAGCGCAGGTTCGT
CAGGGAACTTTAAGAGAAGGCTATGCAATTTCTCCTTATACGTTTATGAATTCATCTTCT
ACTGAAGAATATAAAGGCGTAATTAAATTAGGAACACAATCAGAAGTTAACTCGAATAAT
GCTTCTGTTGCGGTTACTGGCGCAACTCTTAATGGTCGTGGTTCTACGACGTCAATGAGA
GGCGTAGTTAAATTAACTACAACCGCCGGTTCACAGAGTGGAGGCGATGCTTCATCAGCC
TTAGCTTGGAATGCTGACGTTATCCAGCAAAGAGGTGGTCAAATTATCTATGGAACACTC
CGCATTGAAGACACATTTACAATAGCTAATGGTGGAGCAAATATTACGGGTACCGTCAGA
ATGACTGGCGGTTATATTCAAGGTAACCGCATCGTAACACAAAATGAAATTGATAGAACT
ATTCCTGTCGGAGCTATTATGATGTGGGCCGCTGATAGTCTTCCTAGTGATGCTTGGCGC
TTCTGCCATGGTGGAACTGTTTCAGCGTCAGATTGTCCATTATATGCTTCTAGAATTGGA
ACAAGATATGGCGGAAACCCATCAAATCCTGGATTGCCTGACATGCGTGGTCTTTTTGTT
CGTGGTTCTGGTCGTGGTTCTCACTTAACAAATCCAAATGTTAATGGTAATGACCAATTT
GGTAAACCTAGATTAGGTGTAGGTTGTACCGGTGGATATGTTGGTGAAGTACAGATACAA
CAGATGTCTTATCATAAACATGCTGGTGGATTTGGTGAGCATGATGATCTGGGGGCATTC
GGTAATACCCGTAGATCAAATTTTGTTGGTACACGTAAAGGACTTGACTGGGATAACCGT
TCATACTTCACCAATGACGGATATGAAATTGACCCAGAATCACAACGAAATTCCAAATAT
ACATTAAATCGTCCTGAATTAATTGGAAATGAAACACGTCCATGGAACATTTCTTTAAAC
TACATAATTAAGGTAAAAGAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF07484</identifier>
            <name>Collar</name>
          </pfam>
          <pfam>
            <identifier>PF09089</identifier>
            <name>gp12-short_mid</name>
          </pfam>
          <pfam>
            <identifier>PF14928</identifier>
            <name>S_tail_recep_bd</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>virion</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral entry into host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>virion attachment to host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000780</id>
      <name>Malate dehydrogenase, mitochondrial</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P40926" source="Swiss-Prot">
        <name>Malate dehydrogenase, mitochondrial</name>
        <general-function>Poly(a) rna binding</general-function>
        <specific-function/>
        <gene-name>MDH2</gene-name>
        <locus>7p12.3-q11.2</locus>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.9</theoretical-pi>
        <molecular-weight>35502.935</molecular-weight>
        <chromosome-location>7</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:6971</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>MDH2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF047470</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>2906146</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P40926</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>MDHM_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.1.1.37</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037074|Malate dehydrogenase, mitochondrial
MLSALARPASAALRRSFSTSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAH
TPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATI
VATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTF
VAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKA
KAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIE
KNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010551|Malate dehydrogenase, mitochondrial (MDH2)
ATGCTCTCCGCCCTCGCCCGGCCTGCCAGCGCTGCTCTCCGCCGCAGCTTCAGCACCTCG
GCCCAGAACAATGCTAAAGTAGCTGTGCTAGGGGCCTCTGGAGGCATCGGGCAGCCACTT
TCACTTCTCCTGAAGAACAGCCCCTTGGTGAGCCGCCTGACCCTCTATGATATCGCGCAC
ACACCCGGAGTGGCCGCAGATCTGAGCCACATCGAGACCAAAGCCGCTGTGAAAGGCTAC
CTCGGACCTGAACAGCTGCCTGACTGCCTGAAAGGTTGTGATGTGGTAGTTATTCCGGCT
GGAGTCCCCAGAAAGCCAGGCATGACCCGGGACGACCTGTTCAACACCAATGCCACGATT
GTGGCCACCCTGACCGCTGCCTGTGCCCAGCACTGCCCGGAAGCCATGATCTGCGTCATT
GCCAATCCGGGTTTGGATCCAGCTCGAGTCAACGTCCCTGTCATTGGTGGCCATGCTGGG
AAGACCATCATCCCCCTGATCTCTCAGTGCACCCCCAAGGTGGACTTTCCCCAGGACCAG
CTGACAGCACTCACTGGGCGGATCCAGGAGGCCGGCACGGAGGTGGTCAAGGCTAAAGCC
GGAGCAGGCTCTGCCACCCTCTCCATGGCGTATGCCGGCGCCCGCTTTGTCTTCTCCCTT
GTGGATGCAATGAATGGAAAGGAAGGTGTTGTGGAATGTTCCTTCGTTAAGTCACAGGAA
ACGGAATGTACCTACTTCTCCACACCGCTGCTGCTTGGGAAAAAGGGCATCGAGAAGAAC
CTGGGCATCGGCAAAGTCTCCTCTTTTGAGGAGAAGATGATCTCGGATGCCATCCCCGAG
CTGAAGGCCTCCATCAAGAAGGGGGAAGATTTCGTGAAGACCCTGAAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02866</identifier>
            <name>Ldh_1_C</name>
          </pfam>
          <pfam>
            <identifier>PF00056</identifier>
            <name>Ldh_1_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial inner membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>myelin sheath</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>L-malate dehydrogenase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>malate dehydrogenase (NADP+) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>poly(A) RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gluconeogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glucose metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>internal protein amino acid acetylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>malate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>NADH metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oxaloacetate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003255</id>
      <name>N5-carboxyaminoimidazole ribonucleotide mutase</name>
      <organism>Acetobacter aceti</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q2QJL3" source="TrEMBL">
        <name>N5-carboxyaminoimidazole ribonucleotide mutase</name>
        <general-function>5-(carboxyamino)imidazole ribonucleotide mutase activity</general-function>
        <specific-function>Catalyzes the conversion of N5-carboxyaminoimidazole ribonucleotide (N5-CAIR) to 4-carboxy-5-aminoimidazole ribonucleotide (CAIR).</specific-function>
        <gene-name>purE</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.6</theoretical-pi>
        <molecular-weight>18734.295</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="435">Acetobacter aceti</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>DQ059549</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q2QJL3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q2QJL3_ACEAC</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>5-(carboxyamino)imidazole ribonucleotide mutase</synonym>
          <synonym>5.4.99.18</synonym>
          <synonym>N5-CAIR mutase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012267|N5-carboxyaminoimidazole ribonucleotide mutase
MSETAPLPSASSALEDKAASAPVVGIIMGSQSDWETMRHADALLTELEIPHETLIVSAHR
TPDRLADYARTAAERGLNVIIAGAGGAAHLPGMCAAWTRLPVLGVPVESRALKGMDSLLS
IVQMPGGVPVGTLAIGASGAKNAALLAASILALYNPALAARLETWRALQTASVPNSPITE
DK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0006346|549 bp
GTGAGCGAAACCGCCCCCCTGCCCTCTGCTTCCAGTGCTTTAGAAGATAAAGCAGCCTCT
GCCCCCGTTGTGGGCATTATCATGGGCAGCCAGTCAGACTGGGAAACCATGCGCCATGCA
GACGCATTGCTGACAGAGCTGGAAATTCCGCATGAAACCCTCATTGTTTCAGCACATCGT
ACGCCAGACCGGTTGGCGGATTATGCGCGTACGGCAGCCGAACGCGGCCTGAATGTGATT
ATTGCTGGGGCCGGTGGAGCTGCACATCTGCCGGGTATGTGTGCGGCATGGACACGCCTG
CCCGTGCTGGGTGTTCCAGTAGAATCTCGCGCTCTTAAAGGCATGGACAGCCTGCTTTCC
ATTGTGCAGATGCCCGGCGGCGTGCCTGTGGGCACTTTGGCTATTGGGGCATCCGGCGCC
AAAAATGCCGCCTTGCTGGCCGCCTCCATTCTTGCACTGTATAACCCGGCCCTTGCCGCA
CGCCTTGAAACATGGCGCGCATTGCAGACGGCCTCTGTCCCCAACTCTCCCATTACCGAA
GATAAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00731</identifier>
            <name>AIRC</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>5-(carboxyamino)imidazole ribonucleotide mutase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>'de novo' IMP biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003256</id>
      <name>50S ribosomal protein L4</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P38516" source="Swiss-Prot">
        <name>50S ribosomal protein L4</name>
        <general-function>Structural constituent of ribosome</general-function>
        <specific-function>One of the primary rRNA binding proteins, this protein initially binds near the 5'-end of the 23S rRNA. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity).This protein only weakly controls expression of the E.coli S10 operon. It is incorporated into E.coli ribosomes, however it is not as firmly associated as the endogenous protein.Forms part of the polypeptide exit tunnel.</specific-function>
        <gene-name>rplD</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>10.62</theoretical-pi>
        <molecular-weight>26630.77</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>Z21677</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P38516</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>RL4_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>TmaL4</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012268|50S ribosomal protein L4
MAQVDLLNVKGEKVGTLEISDFVFNIDPNYDVMWRYVDMQLSNRRAGTASTKTRGEVSGG
GRKPWPQKHTGRARHGSIRSPIWRHGGVVHGPKPRDWSKKLNKKMKKLALRSALSVKYRE
NKLLVLDDLKLERPKTKSLKEILQNLQLSDKKTLIVLPWKEEGYMNVKLSGRNLPDVKVI
IADNPNNSKNGEKAVRIDGLNVFDMLKYDYLVLTRDMVSKIEEVLGNEAGKALTA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012269|50S ribosomal protein L4 (rplD)
ATGGCTCAGGTTGATCTGTTGAATGTGAAGGGAGAAAAAGTAGGGACCCTGGAAATCAGT
GATTTCGTTTTCAACATCGATCCCAACTACGACGTGATGTGGAGATACGTGGATATGCAG
CTCTCCAACAGGAGAGCTGGAACTGCCTCTACGAAAACAAGAGGAGAAGTCTCCGGTGGT
GGCAGAAAACCCTGGCCGCAGAAACACACTGGAAGAGCAAGACACGGATCCATAAGATCT
CCCATCTGGAGACATGGAGGAGTAGTACACGGACCTAAACCGAGAGATTGGAGCAAAAAG
CTCAACAAAAAAATGAAGAAACTCGCTTTGCGATCTGCCCTTTCTGTGAAGTACAGAGAA
AACAAACTCCTTGTACTCGATGATCTGAAACTCGAAAGACCCAAGACAAAGTCTCTGAAG
GAAATTCTCCAGAACCTTCAGCTTTCCGACAAGAAAACACTGATTGTCCTTCCGTGGAAA
GAGGAAGGATATATGAATGTGAAACTCTCTGGAAGAAACCTTCCCGACGTGAAGGTAATA
ATTGCGGACAATCCGAACAACAGCAAAAATGGTGAGAAGGCGGTAAGAATAGATGGACTC
AATGTTTTTGACATGCTCAAGTACGATTACCTTGTTCTCACCAGGGACATGGTTTCCAAG
ATAGAGGAGGTGCTCGGAAATGAAGCAGGAAAAGCTCTCACTGCATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00573</identifier>
            <name>Ribosomal_L4</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>ribosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>rRNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural constituent of ribosome</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>translation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003257</id>
      <name>Carboxypeptidase B</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15086" source="Swiss-Prot">
        <name>Carboxypeptidase B</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function/>
        <gene-name>CPB1</gene-name>
        <locus>3q24</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-15</signal-regions>
        <theoretical-pi>6.59</theoretical-pi>
        <molecular-weight>47367.11</molecular-weight>
        <chromosome-location>3</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:2299</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>CPB1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M81057</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1593</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P15086</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CBPB1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.4.17.2</synonym>
          <synonym>CPB</synonym>
          <synonym>Pancreas-specific protein</synonym>
          <synonym>PASP</synonym>
          <synonym>PCPB</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012270|Carboxypeptidase B
MLALLVLVTVALASAHHGGEHFEGEKVFRVNVEDENHINIIRELASTTQIDFWKPDSVTQ
IKPHSTVDFRVKAEDTVTVENVLKQNELQYKVLISNLRNVVEAQFDSRVRATGHSYEKYN
KWETIEAWTQQVATENPALISRSVIGTTFEGRAIYLLKVGKAGQNKPAIFMDCGFHAREW
ISPAFCQWFVREAVRTYGREIQVTELLDKLDFYVLPVLNIDGYIYTWTKSRFWRKTRSTH
TGSSCIGTDPNRNFDAGWCEIGASRNPCDETYCGPAAESEKETKALADFIRNKLSSIKAY
LTIHSYSQMMIYPYSYAYKLGENNAELNALAKATVKELASLHGTKYTYGPGATTIYPAAG
GSDDWAYDQGIRYSFTFELRDTGRYGFLLPESQIRATCEETFLAIKYVASYVLEHLY</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012271|Carboxypeptidase B (CPB1)
ATGTTGGCACTCTTGGTTCTGGTGACTGTGGCCCTGGCATCTGCTCATCATGGTGGTGAG
CACTTTGAAGGCGAGAAGGTGTTCCGTGTTAACGTTGAAGATGAAAATCACATTAACATA
ATCCGCGAGTTGGCCAGCACGACCCAGATTGACTTCTGGAAGCCAGATTCTGTCACACAA
ATCAAACCTCACAGTACAGTTGACTTCCGTGTTAAAGCAGAAGATACTGTCACTGTGGAG
AATGTTCTAAAGCAGAATGAACTACAATACAAGGTACTGATAAGCAACCTGAGAAATGTG
GTGGAGGCTCAGTTTGATAGCCGGGTTCGTGCAACAGGACACAGTTATGAGAAGTACAAC
AAGTGGGAAACGATAGAGGCTTGGACTCAACAAGTCGCCACTGAGAATCCAGCCCTCATC
TCTCGCAGTGTTATCGGAACCACATTTGAGGGACGCGCTATTTACCTCCTGAAGGTTGGC
AAAGCTGGACAAAATAAGCCTGCCATTTTCATGGACTGTGGTTTCCATGCCAGAGAGTGG
ATTTCTCCTGCATTCTGCCAGTGGTTTGTAAGAGAGGCTGTTCGTACCTATGGACGTGAG
ATCCAAGTGACAGAGCTTCTCGACAAGTTAGACTTTTATGTCCTGCCTGTGCTCAATATT
GATGGCTACATCTACACCTGGACCAAGAGCCGATTTTGGAGAAAGACTCGCTCCACCCAT
ACTGGATCTAGCTGCATTGGCACAGACCCCAACAGAAATTTTGATGCTGGTTGGTGTGAA
ATTGGAGCCTCTCGAAACCCCTGTGATGAAACTTACTGTGGACCTGCCGCAGAGTCTGAA
AAGGAGACCAAGGCCCTGGCTGATTTCATCCGCAACAAACTCTCTTCCATCAAGGCATAT
CTGACAATCCACTCGTACTCCCAAATGATGATCTACCCTTACTCATATGCTTACAAACTC
GGTGAGAACAATGCTGAGTTGAATGCCCTGGCTAAAGCTACTGTGAAAGAACTTGCCTCA
CTGCACGGCACCAAGTACACATATGGCCCGGGAGCTACAACAATCTATCCTGCTGCTGGG
GGCTCTGACGACTGGGCTTATGACCAAGGAATCAGATATTCCTTCACCTTTGAACTTCGA
GATACAGGCAGATATGGCTTTCTCCTTCCAGAATCCCAGATCCGGGCTACCTGCGAGGAG
ACCTTCCTGGCAATCAAGTATGTTGCCAGCTACGTCCTGGAACACCTGTACTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00246</identifier>
            <name>Peptidase_M14</name>
          </pfam>
          <pfam>
            <identifier>PF02244</identifier>
            <name>Propep_M14</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>carboxypeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metallocarboxypeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>proteolysis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003258</id>
      <name>Hexon protein</name>
      <organism>HAdV-2</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P03277" source="Swiss-Prot">
        <name>Hexon protein</name>
        <general-function>Structural molecule activity</general-function>
        <specific-function>Major capsid protein that self-associates to form 240 hexon trimers, each in the shape of a hexagon, building most of the pseudo T=25 capsid. Assembled into trimeric units with the help of the chaperone shutoff protein. Transported by pre-protein VI to the nucleus where it associates with other structural proteins to form an empty capsid. Might be involved, through its interaction with host dyneins, in the intracellular microtubule-dependent transport of incoming viral capsid to the nucleus.</specific-function>
        <gene-name/>
        <locus/>
        <cellular-location>Virion</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.84</theoretical-pi>
        <molecular-weight>109151.995</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="10515">HAdV-2</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>J01917</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P03277</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CAPSH_ADE02</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>CP-H</synonym>
          <synonym>Protein II</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019391|Hexon protein
MATPSMMPQWSYMHISGQDASEYLSPGLVQFARATETYFSLNNKFRNPTVAPTHDVTTDR
SQRLTLRFIPVDREDTAYSYKARFTLAVGDNRVLDMASTYFDIRGVLDRGPTFKPYSGTA
YNALAPKGAPNSCEWEQTEDSGRAVAEDEEEEDEDEEEEEEEQNARDQATKKTHVYAQAP
LSGETITKSGLQIGSDNAETQAKPVYADPSYQPEPQIGESQWNEADANAAGGRVLKKTTP
MKPCYGSYARPTNPFGGQSVLVPDEKGVPLPKVDLQFFSNTTSLNDRQGNATKPKVVLYS
EDVNMETPDTHLSYKPGKGDENSKAMLGQQSMPNRPNYIAFRDNFIGLMYYNSTGNMGVL
AGQASQLNAVVDLQDRNTELSYQLLLDSIGDRTRYFSMWNQAVDSYDPDVRIIENHGTED
ELPNYCFPLGGIGVTDTYQAIKANGNGSGDNGDTTWTKDETFATRNEIGVGNNFAMEINL
NANLWRNFLYSNIALYLPDKLKYNPTNVEISDNPNTYDYMNKRVVAPGLVDCYINLGARW
SLDYMDNVNPFNHHRNAGLRYRSMLLGNGRYVPFHIQVPQKFFAIKNLLLLPGSYTYEWN
FRKDVNMVLQSSLGNDLRVDGASIKFDSICLYATFFPMAHNTASTLEAMLRNDTNDQSFN
DYLSAANMLYPIPANATNVPISIPSRNWAAFRGWAFTRLKTKETPSLGSGYDPYYTYSGS
IPYLDGTFYLNHTFKKVAITFDSSVSWPGNDRLLTPNEFEIKRSVDGEGYNVAQCNMTKD
WFLVQMLANYNIGYQGFYIPESYKDRMYSFFRNFQPMSRQVVDDTKYKEYQQVGILHQHN
NSGFVGYLAPTMREGQAYPANVPYPLIGKTAVDSITQKKFLCDRTLWRIPFSSNFMSMGA
LTDLGQNLLYANSAHALDMTFEVDPMDEPTLLYVLFEVFDVVRVHQPHRGVIETVYLRTP
FSAGNATT</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0006352|2907 bp
ATGGCTACCCCTTCGATGATGCCGCAGTGGTCTTACATGCACATCTCGGGCCAGGACGCC
TCGGAGTACCTGAGCCCCGGGCTGGTGCAGTTTGCCCGCGCCACCGAGACGTACTTCAGC
CTGAATAACAAGTTTAGAAACCCCACGGTGGCACCTACGCACGACGTAACCACAGACCGG
TCCCAGCGTTTGACGCTGCGGTTCATCCCTGTGGACCGCGAGGATACCGCGTACTCGTAC
AAAGCGCGGTTCACCCTGGCTGTGGGTGACAACCGTGTGCTTGATATGGCTTCCACGTAC
TTTGACATCCGCGGCGTGCTGGACAGGGGGCCTACTTTTAAGCCCTACTCCGGCACTGCC
TACAACGCTCTAGCTCCCAAGGGCGCTCCTAACTCCTGTGAGTGGGAACAAACCGAAGAT
AGCGGCCGGGCAGTTGCCGAGGATGAAGAAGAGGAAGATGAAGATGAAGAAGAGGAAGAA
GAAGAGCAAAACGCTCGAGATCAGGCTACTAAGAAAACACATGTCTATGCCCAGGCTCCT
TTGTCTGGAGAAACAATTACAAAAAGCGGGCTACAAATAGGATCAGACAATGCAGAAACA
CAAGCTAAACCTGTATACGCAGATCCTTCCTATCAACCAGAACCTCAAATTGGCGAATCT
CAGTGGAACGAAGCTGATGCTAATGCGGCAGGAGGGAGAGTGCTTAAAAAAACAACTCCC
ATGAAACCATGCTATGGATCTTATGCCAGGCCTACAAATCCTTTTGGTGGTCAATCCGTT
CTGGTTCCGGATGAAAAAGGGGTGCCTCTTCCAAAGGTTGACTTGCAATTCTTCTCAAAT
ACTACCTCTTTGAACGACCGGCAAGGCAATGCTACTAAACCAAAAGTGGTTTTGTACAGT
GAAGATGTAAATATGGAAACCCCAGACACACATCTGTCTTACAAACCTGGAAAAGGTGAT
GAAAATTCTAAAGCTATGTTGGGTCAACAATCTATGCCAAACAGACCCAATTACATTGCT
TTCAGGGACAATTTTATTGGCCTAATGTATTATAACAGCACTGGCAACATGGGTGTTCTT
GCTGGTCAGGCATCGCAGCTAAATGCCGTGGTAGATTTGCAAGACAGAAACACAGAGCTG
TCCTATCAACTCTTGCTTGATTCCATAGGTGATAGAACCAGATATTTTTCTATGTGGAAT
CAGGCTGTAGACAGCTATGATCCAGATGTTAGAATCATTGAAAACCATGGAACTGAGGAT
GAATTGCCAAATTATTGTTTTCCTCTTGGGGGTATTGGGGTAACTGACACCTATCAAGCT
ATTAAGGCTAATGGCAATGGCTCAGGCGATAATGGAGATACTACATGGACAAAAGATGAA
ACTTTTGCAACACGTAATGAAATAGGAGTGGGTAACAACTTTGCCATGGAAATTAACCTA
AATGCCAACCTATGGAGAAATTTCCTTTACTCCAATATTGCGCTGTACCTGCCAGACAAG
CTAAAATACAACCCCACCAATGTGGAAATATCTGACAACCCCAACACCTACGACTACATG
AACAAGCGAGTGGTGGCTCCCGGGCTTGTAGACTGCTACATTAACCTTGGGGCGCGCTGG
TCTCTGGACTACATGGACAACGTTAATCCCTTTAACCACCACCGCAATGCGGGCCTCCGT
TATCGCTCCATGTTGTTGGGAAACGGCCGCTACGTGCCCTTTCACATTCAGGTGCCCCAA
AAGTTTTTTGCCATTAAAAACCTCCTCCTCCTGCCAGGCTCATATACATATGAATGGAAC
TTCAGGAAGGATGTTAACATGGTTCTGCAGAGCTCTCTGGGAAACGATCTTAGAGTTGAC
GGGGCTAGCATTAAGTTTGACAGCATTTGTCTTTACGCCACCTTCTTCCCCATGGCCCAC
AACACGGCCTCCACGCTGGAAGCCATGCTCAGAAATGACACCAACGACCAGTCCTTTAAT
GACTACCTTTCCGCCGCCAACATGCTATACCCCATACCCGCCAACGCCACCAACGTGCCC
ATCTCCATCCCATCGCGCAACTGGGCAGCATTTCGCGGTTGGGCCTTCACACGCTTGAAG
ACAAAGGAAACCCCTTCCCTGGGATCAGGCTACGACCCTTACTACACCTACTCTGGCTCC
ATACCATACCTTGACGGAACCTTCTATCTTAATCACACCTTTAAGAAGGTGGCCATTACC
TTTGACTCTTCTGTTAGCTGGCCGGGCAACGACCGCCTGCTTACTCCCAATGAGTTTGAG
ATTAAACGCTCAGTTGACGGGGAGGGCTACAACGTAGCTCAGTGCAACATGACCAAGGAC
TGGTTCCTGGTGCAGATGTTGGCCAACTACAATATTGGCTACCAGGGCTTCTACATTCCA
GAAAGCTACAAGGACCGCATGTACTCGTTCTTCAGAAACTTCCAGCCCATGAGCCGGCAA
GTGGTTGACGATACTAAATACAAGGAGTATCAGCAGGTTGGAATTCTTCACCAGCATAAC
AACTCAGGATTCGTAGGCTACCTCGCTCCCACCATGCGCGAGGGACAGGCTTACCCCGCC
AACGTGCCCTACCCACTAATAGGCAAAACCGCGGTTGACAGTATTACCCAGAAAAAGTTT
CTTTGCGATCGCACCCTTTGGCGCATCCCATTCTCCAGTAACTTTATGTCCATGGGCGCA
CTCACAGACCTGGGCCAAAACCTTCTCTACGCCAACTCCGCCCACGCGCTAGACATGACT
TTTGAGGTGGATCCCATGGACGAGCCCACCCTTCTTTATGTTTTGTTTGAAGTCTTTGAC
GTGGTCCGTGTGCACCAGCCGCACCGCGGCGTCATCGAGACCGTGTACCTGCGCACGCCC
TTCTCGGCCGGCAACGCCACAACATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01065</identifier>
            <name>Adeno_hexon</name>
          </pfam>
          <pfam>
            <identifier>PF03678</identifier>
            <name>Adeno_hexon_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>host cell nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>T=25 icosahedral viral capsid</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>microtubule-dependent intracellular transport of viral material towards nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral entry into host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002551</id>
      <name>Riboflavin biosynthesis protein RibF</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9WZW1" source="TrEMBL">
        <name>Riboflavin biosynthesis protein</name>
        <general-function>Riboflavin kinase activity</general-function>
        <specific-function/>
        <gene-name/>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>9.26</theoretical-pi>
        <molecular-weight>33613.56</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9WZW1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q9WZW1_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.1.26</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016821|Riboflavin biosynthesis protein
MVVSIGVFDGVHIGHQKVLRTMKEIAFFRKDDSLIYTISYPPEYFLPDFPGLLMTVESRV
EMLSRYARTVVLDFFRIKDLTPEGFVERYLSGVSAVVVGRDFRFGKNASGNASFLRKKGV
EVYEIEDVVVQGKRVSSSLIRNLVQEGRVEEIPAYLGRYFEIEGIVHKDREFGRKLGFPT
ANIDRGNEKLVDLKRGVYLVRVHLPDGKKKFGVMNVGFRPTVGDARNVKYEVYILDFEGD
LYGQRLKLEVLKFMRDEKKFDSIEELKAAIDQDVKSARNMIDDIINSKFEKEG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016822|Riboflavin biosynthesis protein
ATGGTTGTCAGCATCGGAGTTTTCGATGGAGTTCACATCGGGCATCAGAAGGTCTTGAGG
ACCATGAAGGAAATAGCATTTTTCAGGAAGGACGATAGCCTTATCTACACCATATCTTAT
CCCCCCGAATATTTCTTACCGGATTTTCCCGGTCTTCTCATGACGGTAGAAAGCAGGGTG
GAGATGCTTTCTCGTTACGCCAGAACCGTTGTTCTGGATTTTTTCAGAATAAAAGATCTC
ACCCCAGAAGGGTTCGTCGAGAGGTATCTATCTGGAGTATCGGCTGTTGTTGTTGGAAGG
GATTTCAGATTTGGCAAGAACGCGAGCGGAAACGCGTCTTTTCTCAGAAAGAAAGGTGTG
GAAGTCTATGAAATTGAAGATGTCGTTGTTCAGGGAAAAAGAGTGAGCAGTTCTCTGATC
AGAAACCTCGTTCAGGAGGGAAGAGTGGAGGAAATTCCTGCATATCTCGGCAGATATTTC
GAAATCGAAGGAATCGTCCACAAAGATAGGGAATTTGGAAGAAAACTGGGATTTCCAACT
GCCAACATCGATAGAGGAAATGAAAAACTCGTAGATCTGAAAAGAGGAGTTTATCTGGTG
AGAGTTCATCTGCCGGATGGAAAGAAAAAATTCGGTGTTATGAACGTGGGTTTCAGGCCC
ACCGTGGGTGATGCGAGAAACGTGAAGTACGAGGTGTACATCCTGGATTTCGAAGGGGAT
CTTTACGGGCAGAGACTGAAACTGGAAGTATTGAAATTCATGAGGGATGAGAAGAAATTT
GATTCAATCGAGGAGCTGAAGGCTGCTATTGACCAGGATGTAAAGAGCGCCAGAAACATG
ATAGATGATATAATCAATTCGAAGTTCGAAAAAGAGGGGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01687</identifier>
            <name>Flavokinase</name>
          </pfam>
          <pfam>
            <identifier>PF06574</identifier>
            <name>FAD_syn</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>FMN adenylyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>riboflavin kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>FAD biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>FMN biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>riboflavin biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003259</id>
      <name>Beta-fructosidase</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O33833" source="Swiss-Prot">
        <name>Beta-fructosidase</name>
        <general-function>Sucrose alpha-glucosidase activity</general-function>
        <specific-function>Hydrolysis of sucrose, raffinose, inulin and levan. Specific for the fructose moiety and the beta-anomeric configuration of the glycosidic linkages of its substrates. The enzyme released fructose from sucrose and raffinose, and the fructose polymer inulin is hydrolyzed quantitatively in an exo-type fashion.</specific-function>
        <gene-name>bfrA</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.1</theoretical-pi>
        <molecular-weight>49841.065</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AJ001073</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O33833</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>BFRA_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.2.1.26</synonym>
          <synonym>Invertase</synonym>
          <synonym>Sucrase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017039|Beta-fructosidase
MFKPNYHFFPITGWMNDPNGLIFWKGKYHMFYQYNPRKPEWGNICWGHAVSDDLVHWRHL
PVALYPDDETHGVFSGSAVEKDGKMFLVYTYYRDPTHNKGEKETQCVAMSENGLDFVKYD
GNPVISKPPEEGTHAFRDPKVNRSNGEWRMVLGSGKDEKIGRVLLYTSDDLFHWKYEGVI
FEDETTKEIECPDLVRIGEKDILIYSITSTNSVLFSMGELKEGKLNVEKRGLLDHGTDFY
AAQTFFGTDRVVVIGWLQSWLRTGLYPTKREGWNGVMSLPRELYVENNELKVKPVDELLA
LRKRKVFETAKSGTFLLDVKENSYEIVCEFSGEIELRMGNESEEVVITKSRDELIVDTTR
SGVSGGEVRKSTVEDEATNRIRAFLDSCSVEFFFNDSIAFSFRIHPENVYNILSVKSNQV
KLEVFELENIWL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017040|Beta-fructosidase (bfrA)
ATGTTCAAGCCGAATTATCACTTTTTCCCGATAACAGGCTGGATGAACGATCCGAACGGT
TTGATCTTCTGGAAGGGAAAATATCATATGTTCTATCAGTATAATCCCAGAAAACCTGAG
TGGGGAAACATCTGCTGGGGCCACGCGGTGAGCGACGATCTCGTTCACTGGAGACACCTT
CCCGTTGCTCTATATCCCGACGATGAAACACACGGAGTGTTCTCTGGAAGCGCTGTCGAG
AAAGATGGGAAAATGTTTCTCGTGTACACCTACTACCGCGATCCGACACACAACAAAGGA
GAAAAAGAAACCCAGTGTGTGGCTATGAGTGAAAACGGATTGGATTTCGTAAAGTACGAT
GGAAACCCGGTCATATCTAAACCCCCAGAGGAAGGGACGCACGCCTTCAGAGACCCGAAG
GTGAACAGAAGCAACGGTGAGTGGCGAATGGTACTGGGATCTGGTAAAGATGAGAAGATT
GGAAGAGTGCTTCTCTATACCTCAGATGACCTTTTTCACTGGAAGTACGAGGGTGTGATC
TTCGAAGATGAAACCACAAAAGAAATAGAGTGTCCCGATCTTGTGAGAATTGGAGAGAAA
GATATCCTCATATACTCGATAACGAGTACAAACAGCGTTCTGTTTTCCATGGGAGAGTTA
AAGGAAGGAAAACTGAATGTCGAAAAGCGGGGGCTTCTCGATCACGGAACGGATTTCTAC
GCTGCTCAAACTTTCTTTGGAACAGACAGAGTTGTAGTTATCGGATGGCTTCAAAGCTGG
TTGAGAACAGGGCTTTACCCGACAAAACGAGAAGGATGGAACGGTGTCATGAGTCTTCCT
AGGGAGCTGTATGTAGAAAACAACGAGTTGAAGGTGAAACCGGTGGATGAACTCTTGGCT
CTCAGAAAGAGAAAGGTTTTCGAAACTGCAAAGTCCGGAACATTTCTGCTGGATGTCAAG
GAAAACAGTTATGAAATTGTGTGTGAATTCAGCGGAGAAATCGAACTTCGAATGGGAAAT
GAATCTGAAGAAGTGGTGATAACGAAGAGTCGAGACGAATTAATCGTGGATACAACGAGA
TCTGGTGTTTCAGGTGGAGAAGTTAGAAAGTCGACAGTCGAAGATGAAGCTACAAATAGA
ATACGAGCTTTCTTGGATTCGTGTTCTGTAGAATTTTTCTTCAACGACTCCATAGCTTTT
TCCTTTAGGATCCATCCAGAGAACGTTTACAACATTCTTTCTGTCAAATCGAACCAAGTG
AAACTCGAAGTCTTTGAACTCGAGAACATATGGTTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08244</identifier>
            <name>Glyco_hydro_32C</name>
          </pfam>
          <pfam>
            <identifier>PF00251</identifier>
            <name>Glyco_hydro_32N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>sucrose alpha-glucosidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003260</id>
      <name>Putative stringent starvation protein A</name>
      <organism>Yersinia pestis</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q7CL96" source="TrEMBL">
        <name>Putative stringent starvation protein A</name>
        <general-function/>
        <specific-function/>
        <gene-name>sspA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.89</theoretical-pi>
        <molecular-weight>24524.98</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="632">Yersinia pestis</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE009952</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q7CL96</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q7CL96_YERPE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>pog</synonym>
          <synonym>Regulator of transcription stringent starvation protein A</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012272|Putative stringent starvation protein A
MAVAANKRSVMTLFSGPTDIFSHQVRIVLAEKGVSVEIEQVEADNLPQDLIDLNPYRTVP
TLVDRELTLYESRIIMEYLDERFPHPPLMPVYPVARGSSRLMMHRIEHDWYSLLYKIEQG
NAQEAEAARKQLREELLSIAPVFNETPFFMSEEFSLVDCYLAPLLWRLPVLGIEFTGAGS
KELKGYMTRVFERDAFLASLTEAEREMHLKTRS</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012273|Putative stringent starvation protein A (sspA)
ATGGCTGTCGCTGCCAACAAACGTTCGGTAATGACGCTGTTTTCCGGCCCGACCGACATT
TTTAGCCATCAAGTACGTATCGTACTGGCAGAGAAAGGTGTCAGTGTTGAGATTGAGCAG
GTTGAAGCTGATAACCTGCCACAGGACCTGATTGACCTCAACCCCTACCGTACTGTCCCT
ACTTTGGTTGATCGCGAGCTGACGCTGTATGAATCCCGCATTATCATGGAATATTTGGAT
GAGCGTTTCCCTCACCCACCATTGATGCCAGTCTATCCTGTTGCTCGTGGTAGCAGCCGC
TTGATGATGCACCGTATTGAGCACGACTGGTATTCCCTGCTGTATAAAATTGAGCAAGGT
AATGCACAGGAAGCTGAAGCGGCACGTAAACAGTTACGTGAAGAGTTACTGTCCATCGCG
CCAGTCTTTAACGAAACACCTTTCTTTATGAGTGAAGAGTTCAGTCTGGTCGATTGTTAC
TTAGCTCCGTTGCTATGGCGTTTACCGGTGTTAGGGATTGAGTTCACAGGGGCGGGCTCT
AAAGAGCTGAAAGGCTATATGACTCGCGTCTTTGAGCGTGATGCGTTCTTGGCTTCACTG
ACTGAAGCTGAACGTGAAATGCATCTGAAAACTCGGAGCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00043</identifier>
            <name>GST_C</name>
          </pfam>
          <pfam>
            <identifier>PF13417</identifier>
            <name>GST_N_3</name>
          </pfam>
        </pfams>
        <go-classifiers/>
      </polypeptide>
    </target>
    <target>
      <id>BE0002685</id>
      <name>Citrate synthase</name>
      <organism>Thermus thermophilus</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9LCX9" source="TrEMBL">
        <name>Citrate synthase</name>
        <general-function>Transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer</general-function>
        <specific-function/>
        <gene-name>cit</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.6</theoretical-pi>
        <molecular-weight>42322.13</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="274">Thermus thermophilus</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB040146</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9LCX9</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q9LCX9_THETH</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011898|Citrate synthase
MEVARGLEGVLFTESRMCYIDGQQGKLYYYGIPIQELAEKSSFEETTFLLLHGRLPRRQE
LEEFSAALARRRAMPAHLLESFKRYPVSAHPMSFLRTAVSEFGMLDPTEGDISREALYEK
GLDLIAKFATIVAANKRLKEGKEPIPPREDLSHAANFLYMANGVEPSPEQARLMDAALIL
HAEHGFNASTFTAIAAFSTETDLYSAITAAVASLKGPRHGGANEAVMRMIQEIGTPERAR
EWVREKLAKKERIMGMGHRVYKAFDPRAGVLEKLARLVAEKHGHSKEYQILKIVEEEAGK
VLNPRGIYPNVDFYSGVVYSDLGFSLEFFTPIFAVARISGWVGHILEYQELDNRLLRPGA
KYVGELDVPYVPLEARE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0005265|1134 bp
ATGGAAGTGGCACGCGGTCTGGAAGGCGTTCTCTTCACGGAAAGCCGGATGTGCTACATT
GACGGCCAGCAGGGGAAGCTCTACTACTACGGCATTCCCATCCAGGAGCTGGCGGAGAAG
AGCAGCTTTGAGGAAACCACCTTCCTCCTCCTCCACGGGAGACTGCCGCGAAGGCAGGAG
CTGGAGGAGTTCTCGGCCGCCCTCGCCCGGCGCCGCGCCATGCCCGCCCACCTTCTGGAG
TCCTTCAAGCGCTACCCCGTCTCCGCCCACCCCATGAGCTTCCTGCGCACGGCGGTCTCC
GAGTTCGGGATGCTGGACCCCACCGAGGGGGACATCTCCCGGGAGGCCCTCTACGAGAAG
GGGCTTGACCTCATCGCCAAGTTCGCCACCATCGTGGCCGCCAACAAGCGCCTCAAGGAG
GGCAAGGAGCCCATCCCTCCCCGGGAGGACCTCTCCCACGCCGCCAACTTCCTCTACATG
GCGAACGGGGTGGAGCCCTCCCCCGAGCAGGCCCGCCTCATGGACGCGGCCCTCATCCTC
CACGCCGAGCACGGCTTCAACGCCAGCACCTTCACCGCCATCGCCGCCTTCTCCACGGAG
ACCGACCTCTACTCGGCCATCACCGCCGCCGTGGCCTCCCTGAAGGGGCCGCGCCACGGC
GGGGCCAACGAGGCCGTGATGCGCATGATCCAGGAGATCGGCACCCCCGAGCGGGCCCGG
GAGTGGGTGCGGGAGAAGCTGGCCAAGAAGGAGCGCATCATGGGCATGGGCCACCGGGTC
TACAAGGCCTTTGACCCCAGGGCCGGGGTCCTGGAAAAGCTCGCCCGGTTGGTGGCGGAG
AAGCACGGCCACTCCAAGGAGTACCAGATCCTGAAGATCGTGGAGGAGGAGGCGGGGAAG
GTCCTGAACCCCAGGGGCATCTACCCCAACGTGGACTTCTACTCCGGGGTGGTCTACTCC
GACCTGGGCTTCAGCCTGGAGTTCTTCACCCCCATCTTCGCCGTGGCCCGGATCTCGGGC
TGGGTGGGGCACATCCTGGAGTACCAGGAGCTGGACAACCGCCTCCTCCGCCCCGGGGCC
AAGTACGTGGGGGAGCTGGACGTGCCCTACGTCCCCCTCGAGGCCCGGGAGTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00285</identifier>
            <name>Citrate_synt</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003261</id>
      <name>RNA 3'-terminal phosphate cyclase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P46849" source="Swiss-Prot">
        <name>RNA 3'-terminal phosphate cyclase</name>
        <general-function>Rna-3'-phosphate cyclase activity</general-function>
        <specific-function>Catalyzes the conversion of 3'-phosphate to a 2',3'-cyclic phosphodiester at the end of RNA. The mechanism of action of the enzyme occurs in 3 steps: (A) adenylation of the enzyme by ATP; (B) transfer of adenylate to an RNA-N3'P to produce RNA-N3'PP5'A; (C) and attack of the adjacent 2'-hydroxyl on the 3'-phosphorus in the diester linkage to produce the cyclic end product. The biological role of this enzyme is unknown but it is likely to function in some aspects of cellular RNA processing.</specific-function>
        <gene-name>rtcA</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.26</theoretical-pi>
        <molecular-weight>35902.925</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U00096</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P46849</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>RTCA_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.5.1.4</synonym>
          <synonym>RNA cyclase</synonym>
          <synonym>yhgJ</synonym>
          <synonym>yhgK</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006359|RNA 3'-terminal phosphate cyclase
MKRMIALDGAQGEGGGQILRSALSLSMITGQPFTITSIRAGRAKPGLLRQHLTAVKAATE
ICGATVEGAELGSQRLLFRPGTVRGGDYRFAIGSAGSCTLVLQTVLPALWFADGPSRVEV
SGGTDNPSAPPADFIRRVLEPLLAKIGIHQQTTLLRHGFYPAGGGVVATEVSPVASFNTL
QLGERGNIVQMRGEVLLAGVPRHVAEREIATLAGSFSLHEQNIHNLPRDQGPGNTVSLEV
ESENITERFFVVGEKRVSAEVVAAQLVKEVKRYLASTAAVGEYLADQLVLPMALAGAGEF
TVAHPSCHLLTNIAVVERFLPVRFSLIETDGVTRVSIE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012274|RNA 3'-terminal phosphate cyclase (rtcA)
ATGAAAAGGATGATTGCGCTGGATGGCGCACAGGGCGAAGGTGGCGGGCAGATCCTGCGC
TCGGCGCTGAGCCTGTCGATGATAACCGGCCAGCCATTTACCATCACCAGCATTCGTGCC
GGGCGGGCGAAACCGGGGCTGTTGCGCCAGCATCTGACCGCGGTAAAGGCGGCGACGGAA
ATTTGCGGAGCAACCGTGGAAGGCGCGGAGCTGGGGTCGCAGCGTCTGCTCTTCCGGCCC
GGCACCGTGCGCGGCGGCGATTACCGCTTTGCTATCGGTAGCGCCGGAAGTTGTACGCTG
GTGCTGCAAACGGTGCTGCCCGCGCTGTGGTTTGCCGATGGACCTTCGCGTGTTGAAGTG
AGCGGCGGCACCGATAACCCGTCGGCGCCGCCTGCGGATTTTATCCGCCGGGTGCTGGAG
CCGCTGCTGGCGAAAATAGGAATTCATCAGCAAACCACGCTGTTACGCCACGGTTTTTAC
CCTGCCGGAGGCGGTGTGGTGGCAACGGAAGTCTCGCCCGTGGCATCGTTTAACACCTTG
CAACTTGGCGAGCGCGGGAACATTGTGCAGATGCGTGGAGAAGTTCTATTAGCTGGTGTG
CCGCGCCATGTTGCTGAGCGTGAAATCGCTACACTGGCGGGGAGTTTTTCCCTGCATGAA
CAGAATATTCATAACCTGCCGCGCGACCAGGGGCCGGGTAATACCGTCTCGCTTGAAGTC
GAAAGTGAAAATATCACCGAACGCTTTTTTGTCGTCGGTGAAAAGCGCGTCAGTGCCGAG
GTGGTTGCGGCACAGTTGGTGAAAGAGGTGAAACGCTACCTGGCAAGCACGGCGGCGGTG
GGGGAATATCTTGCTGACCAACTGGTGCTACCGATGGCGCTGGCGGGCGCGGGGGAATTT
ACGGTCGCCCATCCCTCATGCCATCTGCTGACCAATATCGCGGTGGTGGAGCGTTTCTTG
CCGGTGCGGTTTAGTTTGATAGAAACAGATGGCGTAACGCGGGTGAGCATTGAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01137</identifier>
            <name>RTC</name>
          </pfam>
          <pfam>
            <identifier>PF05189</identifier>
            <name>RTC_insert</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-3'-phosphate cyclase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA processing</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004434</id>
      <name>U6 snRNA-associated Sm-like protein LSm6</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P62312" source="Swiss-Prot">
        <name>U6 snRNA-associated Sm-like protein LSm6</name>
        <general-function>Poly(a) rna binding</general-function>
        <specific-function>Component of LSm protein complexes, which are involved in RNA processing and may function in a chaperone-like manner, facilitating the efficient association of RNA processing factors with their substrates. Component of the cytoplasmic LSM1-LSM7 complex, which is thought to be involved in mRNA degradation by activating the decapping step in the 5'-to-3' mRNA decay pathway. Component of the nuclear LSM2-LSM8 complex, which is involved in splicing of nuclear mRNAs. LSM2-LSM8 associates with multiple snRNP complexes containing the U6 snRNA (U4/U6 di-snRNP, spliceosomal U4/U6.U5 tri-snRNP, and free U6 snRNP). It binds directly to the 3'-terminal U-tract of U6 snRNA and plays a role in the biogenesis and stability of the U6 snRNP and U4/U6 snRNP complexes. LSM2-LSM8 probably also is involved degradation of nuclear pre-mRNA by targeting them for decapping, and in processing of pre-tRNAs, pre-rRNAs and U3 snoRNA (By similarity).</specific-function>
        <gene-name>LSM6</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>9127.525</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:17017</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P62312</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>LSM6_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019566|U6 snRNA-associated Sm-like protein LSm6
MSLRKQTPSDFLKQIIGRPVVVKLNSGVDYRGVLACLDGYMNIALEQTEEYVNGQLKNKY
GDAFIRGNNVLYISTQKRRM</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019567|U6 snRNA-associated Sm-like protein LSm6 (LSM6)
ATGAGTCTTCGGAAGCAAACCCCTAGTGACTTCTTAAAGCAAATCATCGGACGACCAGTT
GTGGTAAAATTAAATTCTGGAGTGGATTATCGAGGGGTCCTGGCTTGCCTGGATGGCTAC
ATGAATATAGCCCTGGAGCAGACAGAAGAATATGTAAATGGACAACTGAAGAATAAGTAT
GGGGATGCATTTATCCGAGGAAACAATGTGTTGTACATCAGTACACAGAAGAGACGGATG
TGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01423</identifier>
            <name>LSM</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasmic mRNA processing body</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleolus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>small nuclear ribonucleoprotein complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>small nucleolar ribonucleoprotein complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>spliceosomal complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>U4/U6 x U5 tri-snRNP complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>U6 snRNP</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>poly(A) RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>maturation of SSU-rRNA</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mRNA splicing, via spliceosome</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA splicing</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tRNA processing</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003262</id>
      <name>Pleckstrin homology domain-containing family A member 1</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9HB21" source="Swiss-Prot">
        <name>Pleckstrin homology domain-containing family A member 1</name>
        <general-function>Phosphatidylinositol-3,4-bisphosphate binding</general-function>
        <specific-function>Binds specifically to phosphatidylinositol 3,4-diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane.</specific-function>
        <gene-name>PLEKHA1</gene-name>
        <locus>10q26.13</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.78</theoretical-pi>
        <molecular-weight>45553.165</molecular-weight>
        <chromosome-location>10</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:14335</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PLEKHA1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF286160</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9HB21</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PKHA1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>PH domain-containing family A member 1</synonym>
          <synonym>Tandem PH domain-containing protein 1</synonym>
          <synonym>TAPP-1</synonym>
          <synonym>TAPP1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006361|Pleckstrin homology domain-containing family A member 1
MPYVDRQNRICGFLDIEENENSGKFLRRYFILDTREDSFVWYMDNPQNLPSGSSRVGAIK
LTYISKVSDATKLRPKAEFCFVMNAGMRKYFLQANDQQDLVEWVNVLNKAIKITVPKQSD
SQPNSDNLSRHGECGKKQVSYRTDIVGGVPIITPTQKEEVNECGESIDRNNLKRSQSHLP
YFTPKPPQDSAVIKAGYCVKQGAVMKNWKRRYFQLDENTIGYFKSELEKEPLRVIPLKEV
HKVQECKQSDIMMRDNLFEIVTTSRTFYVQADSPEEMHSWIKAVSGAIVAQRGPGRSASS
EHPPGPSESKHAFRPTNAATATSHSTASRSNSLVSTFTMEKRGFYESLAKVKPGNFKVQT
VSPREPASKVTEQALLRPQSKNGPQEKDCDLVDLDDASLPVSDV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019400|Pleckstrin homology domain-containing family A member 1 (PLEKHA1)
ATGCCTTATGTGGATCGTCAGAATCGCATTTGTGGTTTTCTAGACATTGAAGAAAATGAA
AACAGTGGGAAATTTCTTCGAAGGTACTTCATACTGGATACCAGAGAAGATAGTTTCGTG
TGGTACATGGATAATCCACAGAACCTACCTTCTGGATCATCACGTGTTGGAGCCATTAAG
CTTACCTACATTTCAAAGGTTAGCGATGCTACTAAGCTAAGGCCAAAGGCGGAGTTCTGT
TTTGTTATGAATGCAGGAATGAGGAAGTACTTCCTACAAGCCAATGATCAGCAGGACCTA
GTGGAATGGGTAAATGTGTTAAACAAAGCTATAAAAATTACAGTACCAAAGCAGTCAGAC
TCACAGCCTAATTCTGATAACCTAAGTCGCCATGGTGAATGTGGGAAAAAGCAAGTGTCT
TACAGAACTGATATTGTTGGTGGCGTACCCATCATTACTCCCACTCAGAAAGAAGAAGTA
AATGAATGTGGTGAAAGTATTGACAGAAATAATCTGAAACGGTCACAAAGCCATCTTCCT
TACTTTACTCCTAAACCACCTCAAGATAGTGCGGTTATCAAAGCTGGATATTGTGTAAAA
CAAGGAGCAGTGATGAAAAACTGGAAGAGAAGATATTTTCAATTGGATGAAAACACAATA
GGCTACTTCAAATCTGAACTGGAAAAGGAACCTCTTCGTGTAATACCACTTAAAGAGGTT
CATAAAGTCCAGGAATGTAAGCAAAGCGACATAATGATGAGGGACAACCTCTTTGAAATT
GTAACAACGTCTCGAACTTTCTATGTGCAGGCTGATAGCCCTGAAGAGATGCACAGTTGG
ATTAAAGCAGTCTCTGGCGCCATTGTAGCACAGCGGGGTCCCGGCAGATCTGCGTCTTCT
GAGCATCCCCCCGGTCCTTCAGAATCCAAACACGCTTTCCGTCCTACCAACGCAGCCACC
GCCACCTCACATTCCACAGCCTCTCGCAGCAACTCTTTGGTCTCAACCTTTACCATGGAG
AAGCGAGGATTTTACGAGTCTCTTGCCAAGGTCAAGCCAGGGAACTTCAAGGTCCAGACT
GTCTCTCCAAGAGAACCAGCTTCCAAAGTGACTGAACAAGCTCTGTTAAGACCTCAAAGT
AAAAATGGCCCTCAGGAAAAAGATTGTGACCTAGTAGACTTGGACGATGCGAGCCTTCCG
GTCAGTGACGTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00169</identifier>
            <name>PH</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>ruffle membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>PDZ domain binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>phosphatidylinositol-3,4-bisphosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>androgen metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>B cell receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to hydrogen peroxide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>establishment of protein localization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>estrogen metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>face morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Leydig cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>luteinization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>multicellular organism growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein kinase B signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>palate development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>phosphatidylinositol 3-kinase signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet-derived growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>post-embryonic development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ruffle organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>skeletal system morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>spermatogenesis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003263</id>
      <name>Fe(3+)-binding periplasmic protein</name>
      <organism>Serratia marcescens</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21408" source="Swiss-Prot">
        <name>Fe(3+)-binding periplasmic protein</name>
        <general-function>Transporter activity</general-function>
        <specific-function>Part of the ABC transporter complex FbpABC (TC 3.A.1.10.1) involved in Fe(3+) ions import. This protein specifically binds Fe(3+) and is involved in its transmembrane transport (By similarity).</specific-function>
        <gene-name>fbpA</gene-name>
        <locus/>
        <cellular-location>Periplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-26</signal-regions>
        <theoretical-pi>9.48</theoretical-pi>
        <molecular-weight>36157.015</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="615">Serratia marcescens</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M33815</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P21408</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FBPA_SERMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Iron(III)-binding periplasmic protein</synonym>
          <synonym>sfuA</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012275|Fe(3+)-binding periplasmic protein
MKLRISSLGPVALLASSMMLAFGAQAASADQGIVIYNAQHENLVKSWVDGFTKDTGIKVT
LRNGGDSELGNQLVQEGSASPADVFLTENSPAMVLVDNAKLFAPLDAATLAQVEPQYRPS
HGRWIGIAARSTVFVYNPAKLSDAQLPKSLLDLAKPEWKGRWAASPSGADFQAIVSALLE
LKGEKATLAWLKAMKTNFTAYKGNSTVMKAVNAGQVDSGVIYHYYPFVDGAKTGENSNNI
KLYYFKHQDPGAFVSISGGGVLASSKHQQQAQAFIKWITGKQGQEILRTNNAFEYAVGVG
AASNPKLVPLKDLDAPKVDAAQLNSKKVVELMTEAGLL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0006362|1017 bp
ATGAAGCTGCGTATTTCATCTCTCGGCCCCGTCGCCCTGCTTGCCTCCTCGATGATGCTG
GCCTTTGGCGCTCAGGCGGCCTCCGCCGACCAGGGCATCGTTATTTACAACGCCCAGCAT
GAAAATCTGGTGAAATCCTGGGTCGACGGGTTTACCAAAGACACCGGCATCAAAGTCACG
CTGCGCAACGGCGGCGACAGCGAGCTGGGCAATCAGCTGGTGCAGGAAGGCAGCGCCTCG
CCTGCCGACGTGTTCCTGACGGAAAACTCCCCGGCGATGGTGTTGGTGGATAACGCCAAG
CTGTTCGCCCCGCTGGACGCCGCCACGCTGGCCCAGGTGGAACCACAATATCGCCCAAGC
CACGGCCGCTGGATCGGCATCGCCGCCCGTTCTACCGTGTTTGTTTATAACCCGGCCAAA
CTGAGCGACGCGCAGTTGCCGAAGTCACTGCTGGATCTGGCCAAACCGGAATGGAAAGGC
CGTTGGGCCGCTTCGCCATCGGGCGCCGATTTCCAGGCGATCGTCAGCGCGCTGCTGGAG
CTGAAAGGCGAGAAAGCCACGCTGGCGTGGCTGAAAGCGATGAAAACCAACTTCACCGCC
TATAAGGGCAACAGCACGGTAATGAAAGCGGTCAATGCCGGCCAGGTCGACAGCGGTGTG
ATCTATCACTACTACCCGTTCGTGGATGGCGCAAAAACCGGCGAAAACAGCAACAACATC
AAGCTGTATTACTTCAAACATCAGGATCCTGGCGCGTTCGTCAGCATCTCCGGCGGCGGC
GTGCTGGCTTCCAGCAAGCATCAGCAGCAGGCGCAGGCGTTCATCAAGTGGATCACCGGC
AAACAGGGCCAGGAAATCCTGCGCACCAACAACGCCTTCGAATACGCCGTCGGCGTCGGC
GCGGCCTCCAACCCGAAACTGGTGCCGCTGAAAGATCTGGACGCACCGAAAGTAGACGCC
GCACAGCTGAACAGTAAAAAAGTTGTCGAACTGATGACCGAGGCCGGCCTGCTGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01547</identifier>
            <name>SBP_bac_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>periplasmic space</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>iron ion homeostasis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003264</id>
      <name>Signal recognition particle receptor FtsY</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9WZ40" source="TrEMBL">
        <name>Signal recognition particle receptor FtsY</name>
        <general-function>Gtpase activity</general-function>
        <specific-function>Involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane. Acts as a receptor for the complex formed by the signal recognition particle (SRP) and the ribosome-nascent chain (RNC).</specific-function>
        <gene-name>ftsY</gene-name>
        <locus/>
        <cellular-location>Cell inner membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.32</theoretical-pi>
        <molecular-weight>32045.975</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9WZ40</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q9WZ40_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>SRP receptor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012276|Signal recognition particle receptor FtsY
MGLFDFLKKGLQKTKETFFGRVVKLLKGKKLDDETREELEELLIQADVGVETTEYILERL
EEKDGDALESLKEIILEILNFDTKLNVPPEPPFVIMVVGVNGTGKTTSCGKLAKMFVDEG
KSVVLAAADTFRAAAIEQLKIWGERVGATVISHSEGADPAAVAFDAVAHALARNKDVVII
DTAGRLHTKKNLMEELRKVHRVVKKKIPDAPHETLLVIDATTGQNGLVQAKIFKEAVNVT
GIILTKLDGTAKGGITLAIARELGIPIKFIGVGEKAEDLRPFDPEAFVEVLLSE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012277|Signal recognition particle receptor FtsY (ftsY)
ATGGGACTCTTCGATTTTTTGAAAAAGGGACTCCAGAAGACGAAAGAAACGTTTTTTGGA
CGAGTGGTGAAGCTCCTCAAAGGAAAAAAGCTGGACGATGAAACCCGCGAGGAGCTGGAA
GAACTTCTCATTCAAGCGGACGTGGGAGTCGAGACAACGGAATACATTCTGGAGAGATTG
GAAGAGAAGGACGGAGACGCTCTCGAGTCTCTCAAGGAAATCATTCTGGAAATTCTGAAC
TTCGATACGAAGCTGAACGTTCCTCCTGAACCCCCGTTCGTGATCATGGTTGTTGGTGTC
AACGGAACGGGAAAGACCACCTCCTGTGGAAAGCTCGCAAAGATGTTCGTGGATGAAGGA
AAGAGTGTGGTGCTCGCTGCGGCGGATACTTTCAGAGCAGCCGCCATAGAACAGCTGAAG
ATATGGGGAGAACGTGTCGGTGCCACGGTGATATCCCACTCGGAAGGAGCAGATCCGGCC
GCCGTTGCCTTTGACGCGGTGGCTCACGCTCTCGCCAGAAACAAAGATGTGGTCATAATA
GACACCGCCGGAAGACTTCACACGAAGAAGAATCTCATGGAGGAATTGCGGAAGGTTCAC
AGAGTTGTCAAGAAGAAGATCCCCGACGCTCCGCACGAAACGCTCCTCGTGATAGACGCC
ACCACCGGCCAAAACGGACTTGTTCAGGCAAAAATATTCAAAGAAGCAGTGAATGTCACC
GGTATAATTCTCACAAAGCTCGACGGAACCGCGAAAGGCGGAATAACTCTGGCCATTGCC
CGGGAACTGGGAATTCCCATAAAGTTCATCGGTGTCGGAGAAAAGGCAGAAGACCTGAGG
CCTTTCGATCCTGAGGCCTTTGTGGAGGTATTGCTTTCAGAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00448</identifier>
            <name>SRP54</name>
          </pfam>
          <pfam>
            <identifier>PF02881</identifier>
            <name>SRP54_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intrinsic component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTPase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell division</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>SRP-dependent cotranslational protein targeting to membrane</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002611</id>
      <name>Nicotinate-nucleotide adenylyltransferase</name>
      <organism>Shigella flexneri</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P0A753" source="Swiss-Prot">
        <name>Nicotinate-nucleotide adenylyltransferase</name>
        <general-function>Nicotinate-nucleotide adenylyltransferase activity</general-function>
        <specific-function>Catalyzes the reversible adenylation of nicotinate mononucleotide (NaMN) to nicotinic acid adenine dinucleotide (NaAD).</specific-function>
        <gene-name>nadD</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.54</theoretical-pi>
        <molecular-weight>24527.75</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="623">Shigella flexneri</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE005674</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P0A753</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NADD_SHIFL</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.7.18</synonym>
          <synonym>Deamido-NAD(+) diphosphorylase</synonym>
          <synonym>Deamido-NAD(+) pyrophosphorylase</synonym>
          <synonym>NaMN adenylyltransferase</synonym>
          <synonym>Nicotinate mononucleotide adenylyltransferase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011856|Nicotinate-nucleotide adenylyltransferase
MKSLQALFGGTFDPVHYGHLKPVETLANLIGLTRVTIIPNNVPPHRPQPEANSVQRKHML
ELAIADKPLFTLDERELKRNAPSYTAQTLKEWRQEQGPDVPLAFIIGQDSLLTFPTWYEY
ETILDNAHLIVCRRPGYPLEMAQPQYQQWLEDHLTHNPEDLHLQPAGKIYLAETPWFNIS
ATIIRERLQNGESCEDLLPEPVLTYINQQGLYR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011857|Nicotinate-nucleotide adenylyltransferase (nadD)
ATGAAATCTTTACAGGCTCTGTTTGGCGGCACCTTTGATCCGGTGCACTATGGTCATCTA
AAACCCGTGGAAACGCTGGCGAATTTGATTGGTCTGACGCGGGTCACAATCATCCCTAAT
AATGTTCCTCCGCATCGTCCCCAGCCGGAAGCGAACAGCGTGCAGCGTAAACACATGCTT
GAACTGGCGATTGCCGACAAGCCATTATTTACTCTTGATGAACGCGAGCTAAAGCGCAAT
GCCCCCTCTTACACTGCGCAAACACTGAAAGAGTGGCGGCAGGAACAAGGACCGGACGTG
CCGCTGGCGTTTATTATTGGTCAGGATTCATTGCTGACCTTTCCGACCTGGTACGAATAC
GAAACGATACTCGACAATGCACATTTGATCGTCTGTCGGCGTCCAGGTTACCCACTTGAA
ATGGCGCAACCGCAATACCAGCAATGGCTGGAAGATCATTTGACACATAACCCGGAAGAT
CTTCACCTTCAGCCTGCCGGTAAAATTTATCTGGCTGAAACGCCGTGGTTTAACATCTCG
GCGACCATCATCCGCGAACGTTTGCAAAACGGTGAATCGTGTGAGGATTTATTGCCGGAA
CCGGTATTGACTTACATTAACCAACAAGGCTTGTATCGCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01467</identifier>
            <name>CTP_transf_like</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nicotinate-nucleotide adenylyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>NAD biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003265</id>
      <name>N utilization substance protein B homolog</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9X286" source="Swiss-Prot">
        <name>N utilization substance protein B homolog</name>
        <general-function>Rna binding</general-function>
        <specific-function>Involved in the transcription termination process.</specific-function>
        <gene-name>nusB</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.56</theoretical-pi>
        <molecular-weight>16973.325</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9X286</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>NUSB_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Protein NusB</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017041|N utilization substance protein B homolog
MKTPRRRMRLAVFKALFQHEFRRDEDLEQILEEILDETYDKKAKEDARRYIRGIKENLSM
IDDLISRYLEKWSLNRLSVVDRNVLRLATYELLFEKDIPIEVTIDEAIEIAKRYGTENSG
KFVNGILDRIAKEHAPKEKFEL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017042|N utilization substance protein B homolog (nusB)
ATGAAAACACCGAGGCGAAGAATGAGGCTTGCTGTCTTCAAAGCCCTGTTTCAGCATGAA
TTCAGAAGAGACGAAGATCTTGAACAAATTCTCGAGGAAATTCTGGACGAAACCTACGAT
AAAAAGGCAAAGGAAGACGCCCGGCGCTACATAAGAGGTATAAAAGAGAACCTTTCCATG
ATAGACGATCTCATTTCCCGATACCTAGAAAAGTGGTCTCTGAACCGATTATCCGTTGTG
GACAGAAACGTTCTGAGACTCGCCACTTATGAACTTCTCTTCGAAAAGGACATCCCCATA
GAAGTGACCATCGATGAAGCCATAGAAATAGCCAAGAGATACGGCACGGAAAACAGTGGA
AAATTCGTCAACGGAATACTGGACAGAATCGCCAAAGAACACGCTCCAAAAGAAAAATTC
GAACTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01029</identifier>
            <name>NusB</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA-templated transcription, termination</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription, DNA-templated</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003266</id>
      <name>Complement component C8 gamma chain</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07360" source="Swiss-Prot">
        <name>Complement component C8 gamma chain</name>
        <general-function>Retinol binding</general-function>
        <specific-function>C8 is a constituent of the membrane attack complex. C8 binds to the C5B-7 complex, forming the C5B-8 complex. C5-B8 binds C9 and acts as a catalyst in the polymerization of C9. The gamma subunit seems to be able to bind retinol.</specific-function>
        <gene-name>C8G</gene-name>
        <locus>9q34.3</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-20</signal-regions>
        <theoretical-pi>8.48</theoretical-pi>
        <molecular-weight>22277.285</molecular-weight>
        <chromosome-location>9</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:1354</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>C8G</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M17263</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P07360</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CO8G_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Complement component C8 gamma chain precursor</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019397|Complement component C8 gamma chain
MLPPGTATLLTLLLAAGSLGQKPQRPRRPASPISTIQPKANFDAQQFAGTWLLVAVGSAC
RFLQEQGHRAEATTLHVAPQGTAMAVSTFRKLDGICWQVRQLYGDTGVLGRFLLQARDAR
GAVHVVVAETDYQSFAVLYLERAGQLSVKLYARSLPVSDSVLSGFEQRVQEAHLTEDQIF
YFPKYGFCEAADQFHVLDEVRR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019398|Complement component C8 gamma chain (C8G)
ATGCTGCCCCCTGGGACTGCGACCCTCTTGACTCTGCTCCTGGCAGCTGGCTCGCTGGGC
CAGAAGCCTCAGAGGCCACGCCGGCCCGCATCCCCCATCAGCACCATCCAGCCCAAGGCC
AATTTTGATGCTCAGCAGTTTGCAGGGACCTGGCTCCTTGTGGCTGTGGGCTCCGCTTGC
CGTTTCCTGCAGGAGCAGGGCCACCGGGCCGAGGCCACCACACTGCATGTGGCTCCCCAG
GGCACAGCCATGGCTGTCAGTACCTTCCGAAAGCTGGATGGGATCTGCTGGCAGGTGCGC
CAGCTCTATGGAGACACAGGGGTCCTCGGCCGCTTCCTGCTTCAAGCCCGAGACGCCCGA
GGGGCTGTGCACGTGGTTGTCGCTGAGACCGACTACCAGAGTTTCGCTGTCCTGTACCTG
GAGCGGGCGGGGCAGCTGTCAGTGAAGCTCTACGCCCGCTCGCTCCCTGTGAGCGACTCG
GTCCTGAGTGGGTTTGAGCAGCGGGTCCAGGAGGCCCACCTGACTGAGGACCAGATCTTC
TACTTCCCCAAGTACGGCTTCTGCGAGGCTGCAGACCAGTTCCACGTCCTGGACGAAGTG
AGGAGGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00061</identifier>
            <name>Lipocalin</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>blood microparticle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane attack complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>retinol binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>complement activation, alternative pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>complement activation, classical pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cytolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of complement activation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003267</id>
      <name>Ribonucleoside-diphosphate reductase subunit beta</name>
      <organism>Mycobacterium leprae (strain TN)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9CBQ2" source="Swiss-Prot">
        <name>Ribonucleoside-diphosphate reductase subunit beta</name>
        <general-function>Ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor</general-function>
        <specific-function>Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides (By similarity).</specific-function>
        <gene-name>nrdF</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.43</theoretical-pi>
        <molecular-weight>37315.67</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="272631">Mycobacterium leprae (strain TN)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AL583923</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9CBQ2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>RIR2_MYCLE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.17.4.1</synonym>
          <synonym>Ribonucleotide reductase small subunit</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012278|Ribonucleoside-diphosphate reductase subunit beta
MLTGKMKLIDRVSAINWNWLQDDKDAEVWDRLTGNFWLPEKVPVSNDLPSWGTLTASEKQ
LTMRVFTGLTLLDTIQGTVGAVSLIPDALTPHEEAVYTNIAFMESVHAKSYSSIFSTLCS
TAEIDEAFRWSEENNNLQRKAKIVMEYYRGDEPLKRKVASTLLESFLFYSGFYLPMYWSS
RAKLTNTADMIRLIIRDEAVHGYYIGYKFQRGLVLVDDARRAELKEYTYELLFELYDNEV
EYTQDLYDRVGLTEDVKKFLRYNANKALMNLGYEALFPRDETDVNPAILSALSPNADENH
DFFSGSGSSYVIGKAVVTEDEDWDF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012279|Ribonucleoside-diphosphate reductase subunit beta (nrdF)
TTGTTGACTGGGAAGATGAAGCTAATTGACCGCGTTTCGGCGATTAATTGGAACTGGCTG
CAAGACGACAAGGACGCCGAGGTCTGGGACCGGCTGACTGGAAACTTCTGGCTGCCCGAG
AAGGTGCCGGTGTCCAACGATCTCCCGTCGTGGGGCACGCTGACTGCTAGTGAAAAGCAG
CTGACAATGCGGGTGTTCACCGGTTTGACGCTGCTCGACACGATCCAAGGCACGGTCGGA
GCGGTCAGCCTTATTCCTGATGCGCTAACGCCGCATGAGGAAGCCGTCTACACCAACATT
GCATTCATGGAGTCGGTGCACGCCAAGAGCTACAGTTCGATCTTTTCCACGCTGTGCTCG
ACAGCGGAGATCGACGAAGCGTTTCGCTGGTCGGAGGAGAACAACAACCTGCAGCGCAAA
GCTAAGATTGTGATGGAGTACTATCGAGGCGACGAACCGCTCAAGCGCAAGGTGGCCTCC
ACCTTGCTCGAAAGCTTCCTGTTTTACTCTGGGTTCTACCTGCCGATGTACTGGTCAAGT
CGGGCCAAGCTGACCAACACCGCTGATATGATTCGGCTGATCATCCGCGACGAAGCAGTC
CACGGTTACTATATCGGCTACAAATTTCAGCGTGGCTTGGTGTTGGTCGACGACGCCAGG
CGGGCAGAACTCAAGGAATACACCTACGAATTGCTCTTTGAGCTCTACGACAACGAGGTG
GAATACACCCAAGATCTCTACGACAGAGTCGGGTTGACCGAAGACGTCAAGAAGTTCTTG
CGCTACAACGCAAATAAGGCGTTGATGAACCTTGGCTACGAGGCGCTGTTCCCGCGGGAC
GAGACCGACGTGAACCCGGCGATCCTGTCGGCCTTGTCTCCCAACGCCGATGAGAATCAT
GACTTTTTCTCCGGCTCGGGGTCGTCGTATGTGATCGGGAAAGCCGTCGTCACTGAGGAC
GAGGACTGGGACTTCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00268</identifier>
            <name>Ribonuc_red_sm</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>ribonucleoside-diphosphate reductase complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>deoxyribonucleoside diphosphate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>deoxyribonucleotide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>DNA replication</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002555</id>
      <name>Glutamine synthetase 1</name>
      <organism>Mycobacterium tuberculosis</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P9WN39" source="Swiss-Prot">
        <name>Glutamine synthetase</name>
        <general-function>Involved in nitrogen metabolism via ammonium assimilation. Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia (PubMed:7937767, PubMed:12819079). Also able to use GTP (PubMed:7937767). D-glutamate is a poor substrate, and DL-glutamate shows about 50% of the standard specific activity (PubMed:7937767). Also plays a key role in controlling the ammonia levels within infected host cells and so contributes to the pathogens capacity to inhibit phagosome acidification and phagosome-lysosome fusion (PubMed:7937767, PubMed:12819079). Involved in cell wall biosynthesis via the production of the major component poly-L-glutamine (PLG) (PubMed:7937767, PubMed:10618433). PLG synthesis in the cell wall occurs only in nitrogen limiting conditions and on the contrary high nitrogen conditions inhibit PLG synthesis (Probable).</general-function>
        <specific-function>Atp binding</specific-function>
        <gene-name>glnA1</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>53569.475</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83332">Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P9WN39</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLN1B_MYCTU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.3.1.2</synonym>
          <synonym>glnA</synonym>
          <synonym>Glutamate--ammonia ligase</synonym>
          <synonym>Glutamine synthetase I beta</synonym>
          <synonym>GS</synonym>
          <synonym>GSI beta</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0051140|Glutamine synthetase
MTEKTPDDVFKLAKDEKVEYVDVRFCDLPGIMQHFTIPASAFDKSVFDDGLAFDGSSIRG
FQSIHESDMLLLPDPETARIDPFRAAKTLNINFFVHDPFTLEPYSRDPRNIARKAENYLI
STGIADTAYFGAEAEFYIFDSVSFDSRANGSFYEVDAISGWWNTGAATEADGSPNRGYKV
RHKGGYFPVAPNDQYVDLRDKMLTNLINSGFILEKGHHEVGSGGQAEINYQFNSLLHAAD
DMQLYKYIIKNTAWQNGKTVTFMPKPLFGDNGSGMHCHQSLWKDGAPLMYDETGYAGLSD
TARHYIGGLLHHAPSLLAFTNPTVNSYKRLVPGYEAPINLVYSQRNRSACVRIPITGSNP
KAKRLEFRSPDSSGNPYLAFSAMLMAGLDGIKNKIEPQAPVDKDLYELPPEEAASIPQTP
TQLSDVIDRLEADHEYLTEGGVFTNDLIETWISFKRENEIEPVNIRPHPYEFALYYDV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0051141|Glutamine synthetase (glnA1)
GTGACGGAAAAGACGCCCGACGACGTCTTCAAACTTGCCAAGGACGAGAAGGTCGAATAT
GTCGACGTCCGGTTCTGTGACCTGCCTGGCATCATGCAGCACTTCACGATTCCGGCTTCG
GCCTTTGACAAGAGCGTGTTTGACGACGGCTTGGCCTTTGACGGCTCGTCGATTCGCGGG
TTCCAGTCGATCCACGAATCCGACATGTTGCTTCTTCCCGATCCCGAGACGGCGCGCATC
GACCCGTTCCGCGCGGCCAAGACGCTGAATATCAACTTCTTTGTGCACGACCCGTTCACC
CTGGAGCCGTACTCCCGCGACCCGCGCAACATCGCCCGCAAGGCCGAGAACTACCTGATC
AGCACTGGCATCGCCGACACCGCATACTTCGGCGCCGAGGCCGAGTTCTACATTTTCGAT
TCGGTGAGCTTCGACTCGCGCGCCAACGGCTCCTTCTACGAGGTGGACGCCATCTCGGGG
TGGTGGAACACCGGCGCGGCGACCGAGGCCGACGGCAGTCCCAACCGGGGCTACAAGGTC
CGCCACAAGGGCGGGTATTTCCCAGTGGCCCCCAACGACCAATACGTCGACCTGCGCGAC
AAGATGCTGACCAACCTGATCAACTCCGGCTTCATCCTGGAGAAGGGCCACCACGAGGTG
GGCAGCGGCGGACAGGCCGAGATCAACTACCAGTTCAATTCGCTGCTGCACGCCGCCGAC
GACATGCAGTTGTACAAGTACATCATCAAGAACACCGCCTGGCAGAACGGCAAAACGGTC
ACGTTCATGCCCAAGCCGCTGTTCGGCGACAACGGGTCCGGCATGCACTGTCATCAGTCG
CTGTGGAAGGACGGGGCCCCGCTGATGTACGACGAGACGGGTTATGCCGGTCTGTCGGAC
ACGGCCCGTCATTACATCGGCGGCCTGTTACACCACGCGCCGTCGCTGCTGGCCTTCACC
AACCCGACGGTGAACTCCTACAAGCGGCTGGTTCCCGGTTACGAGGCCCCGATCAACCTG
GTCTATAGCCAGCGCAACCGGTCGGCATGCGTGCGCATCCCGATCACCGGCAGCAACCCG
AAGGCCAAGCGGCTGGAGTTCCGAAGCCCCGACTCGTCGGGCAACCCGTATCTGGCGTTC
TCGGCCATGCTGATGGCAGGCCTGGACGGTATCAAGAACAAGATCGAGCCGCAGGCGCCC
GTCGACAAGGATCTCTACGAGCTGCCGCCGGAAGAGGCCGCGAGTATCCCGCAGACTCCG
ACCCAGCTGTCAGATGTGATCGACCGTCTCGAGGCCGACCACGAATACCTCACCGAAGGA
GGGGTGTTCACAAACGACCTGATCGAGACGTGGATCAGTTTCAAGCGCGAAAACGAGATC
GAGCCGGTCAACATCCGGCCGCATCCCTACGAATTCGCGCTGTACTACGACGTTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00120</identifier>
            <name>Gln-synt_C</name>
          </pfam>
          <pfam>
            <identifier>PF03951</identifier>
            <name>Gln-synt_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell wall</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>fibronectin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate-ammonia ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zymogen binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>evasion or tolerance of host immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>interaction with host via substance in symbiont surface</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nitrogen fixation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pathogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of plasminogen activation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
      <polypeptide id="P9WN38" source="Swiss-Prot">
        <name>Glutamine synthetase</name>
        <general-function>Involved in nitrogen metabolism via ammonium assimilation. Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia. Also plays a key role in controlling the ammonia levels within infected host cells and so contributes to the pathogens capacity to inhibit phagosome acidification and phagosome-lysosome fusion. Involved in cell wall biosynthesis via the production of the major component poly-L-glutamine (PLG). PLG synthesis in the cell wall occurs only in nitrogen limiting conditions and on the contrary high nitrogen conditions inhibit PLG synthesis.</general-function>
        <specific-function>Atp binding</specific-function>
        <gene-name>glnA1</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>53569.475</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83331">Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P9WN38</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLN1B_MYCTO</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.3.1.2</synonym>
          <synonym>glnA</synonym>
          <synonym>Glutamate--ammonia ligase</synonym>
          <synonym>Glutamine synthetase I beta</synonym>
          <synonym>GS</synonym>
          <synonym>GSI beta</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0051142|Glutamine synthetase
MTEKTPDDVFKLAKDEKVEYVDVRFCDLPGIMQHFTIPASAFDKSVFDDGLAFDGSSIRG
FQSIHESDMLLLPDPETARIDPFRAAKTLNINFFVHDPFTLEPYSRDPRNIARKAENYLI
STGIADTAYFGAEAEFYIFDSVSFDSRANGSFYEVDAISGWWNTGAATEADGSPNRGYKV
RHKGGYFPVAPNDQYVDLRDKMLTNLINSGFILEKGHHEVGSGGQAEINYQFNSLLHAAD
DMQLYKYIIKNTAWQNGKTVTFMPKPLFGDNGSGMHCHQSLWKDGAPLMYDETGYAGLSD
TARHYIGGLLHHAPSLLAFTNPTVNSYKRLVPGYEAPINLVYSQRNRSACVRIPITGSNP
KAKRLEFRSPDSSGNPYLAFSAMLMAGLDGIKNKIEPQAPVDKDLYELPPEEAASIPQTP
TQLSDVIDRLEADHEYLTEGGVFTNDLIETWISFKRENEIEPVNIRPHPYEFALYYDV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0051143|Glutamine synthetase (glnA1)
GTGACGGAAAAGACGCCCGACGACGTCTTCAAACTTGCCAAGGACGAGAAGGTCGAATAT
GTCGACGTCCGGTTCTGTGACCTGCCTGGCATCATGCAGCACTTCACGATTCCGGCTTCG
GCCTTTGACAAGAGCGTGTTTGACGACGGCTTGGCCTTTGACGGCTCGTCGATTCGCGGG
TTCCAGTCGATCCACGAATCCGACATGTTGCTTCTTCCCGATCCCGAGACGGCGCGCATC
GACCCGTTCCGCGCGGCCAAGACGCTGAATATCAACTTCTTTGTGCACGACCCGTTCACC
CTGGAGCCGTACTCCCGCGACCCGCGCAACATCGCCCGCAAGGCCGAGAACTACCTGATC
AGCACTGGCATCGCCGACACCGCATACTTCGGCGCCGAGGCCGAGTTCTACATTTTCGAT
TCGGTGAGCTTCGACTCGCGCGCCAACGGCTCCTTCTACGAGGTGGACGCCATCTCGGGG
TGGTGGAACACCGGCGCGGCGACCGAGGCCGACGGCAGTCCCAACCGGGGCTACAAGGTC
CGCCACAAGGGCGGGTATTTCCCAGTGGCCCCCAACGACCAATACGTCGACCTGCGCGAC
AAGATGCTGACCAACCTGATCAACTCCGGCTTCATCCTGGAGAAGGGCCACCACGAGGTG
GGCAGCGGCGGACAGGCCGAGATCAACTACCAGTTCAATTCGCTGCTGCACGCCGCCGAC
GACATGCAGTTGTACAAGTACATCATCAAGAACACCGCCTGGCAGAACGGCAAAACGGTC
ACGTTCATGCCCAAGCCGCTGTTCGGCGACAACGGGTCCGGCATGCACTGTCATCAGTCG
CTGTGGAAGGACGGGGCCCCGCTGATGTACGACGAGACGGGTTATGCCGGTCTGTCGGAC
ACGGCCCGTCATTACATCGGCGGCCTGTTACACCACGCGCCGTCGCTGCTGGCCTTCACC
AACCCGACGGTGAACTCCTACAAGCGGCTGGTTCCCGGTTACGAGGCCCCGATCAACCTG
GTCTATAGCCAGCGCAACCGGTCGGCATGCGTGCGCATCCCGATCACCGGCAGCAACCCG
AAGGCCAAGCGGCTGGAGTTCCGAAGCCCCGACTCGTCGGGCAACCCGTATCTGGCGTTC
TCGGCCATGCTGATGGCAGGCCTGGACGGTATCAAGAACAAGATCGAGCCGCAGGCGCCC
GTCGACAAGGATCTCTACGAGCTGCCGCCGGAAGAGGCCGCGAGTATCCCGCAGACTCCG
ACCCAGCTGTCAGATGTGATCGACCGTCTCGAGGCCGACCACGAATACCTCACCGAAGGA
GGGGTGTTCACAAACGACCTGATCGAGACGTGGATCAGTTTCAAGCGCGAAAACGAGATC
GAGCCGGTCAACATCCGGCCGCATCCCTACGAATTCGCGCTGTACTACGACGTTTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00120</identifier>
            <name>Gln-synt_C</name>
          </pfam>
          <pfam>
            <identifier>PF03951</identifier>
            <name>Gln-synt_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate-ammonia ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamine biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nitrogen fixation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pathogenesis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002690</id>
      <name>Citrate synthase</name>
      <organism>Antarctic bacterium DS2-3R</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O34002" source="Swiss-Prot">
        <name>2-methylcitrate synthase</name>
        <general-function>Citrate synthase activity</general-function>
        <specific-function>Involved in the catabolism of short chain fatty acids (SCFA) via the tricarboxylic acid (TCA)(acetyl degradation route) and via the 2-methylcitrate cycle I (propionate degradation route). Catalyzes the Claisen condensation of propionyl-CoA and oxaloacetate (OAA) to yield (2S,3S)-2-methylcitrate (2-MC) and CoA. Also catalyzes the condensation of oxaloacetate with acetyl-CoA but with a lower specificity.</specific-function>
        <gene-name>gltA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.17</theoretical-pi>
        <molecular-weight>41832.0</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="56673">Antarctic bacterium DS2-3R</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U85944</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O34002</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PRPC_ABDS2</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>(2S,3S)-2-methylcitrate synthase</synonym>
          <synonym>2-MCS</synonym>
          <synonym>2.3.3.5</synonym>
          <synonym>cisY</synonym>
          <synonym>Citrate synthase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016866|2-methylcitrate synthase
MTEPTIHKGLAGVTADVTAISKVNSDTNSLLYRGYPVQELAAKCSFEQVAYLLWNSELPN
DSELKAFVNFERSHRKLDENVKGAIDLLSTACHPMDVARTAVSVLGANHARAQDSSPEAN
LEKAMSLLATFPSVVAYDQRRRRGEELIEPREDLDYSANFLWMTFGEEAAPEVVEAFNVS
MILYAEHSFNASTFTARVITSTLADLHSAVTGAIGALKGPLHGGANEAVMHTFEEIGIRK
DESLDEAATRSKAWMVDALAQKKKVMGFGHRVYKNGDSRVPTMKSALDAMIKHYDRPEML
GLYNGLEAAMEEAKQIKPNLDYPAGPTYNLMGFDTEMFTPLFIAARITGWTAHIMEQVAD
NALIRPLSEYNGPEQRQVP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0005275|1140 bp
ATGACCGAACCAACAATTCATAAGGGCCTTGCCGGCGTCACGGCGGATGTCACCGCCATT
TCGAAGGTCAATTCTGATACCAACTCGCTGCTGTACCGTGGATACCCCGTTCAGGAACTG
GCTGCTAAGTGCAGCTTTGAACAGGTGGCCTACTTGCTGTGGAACAGCGAACTGCCCAAC
GATTCCGAGCTGAAAGCTTTCGTAAATTTCGAACGCTCCCACCGGAAACTGGATGAGAAC
GTCAAAGGGGCAATAGACCTCCTCTCCACTGCCTGTCACCCTATGGACGTTGCGCGGACC
GCCGTCTCAGTTCTGGGAGCCAACCACGCCAGGGCGCAGGATTCCTCCCCGGAAGCAAAT
CTAGAAAAGGCGATGTCGCTGCTGGCAACCTTCCCGTCCGTCGTCGCCTACGACCAAAGG
CGACGACGCGGTGAGGAACTTATCGAACCACGAGAGGATCTCGATTACTCCGCGAACTTC
CTGTGGATGACTTTTGGCGAAGAGGCAGCGCCGGAGGTTGTGGAAGCCTTCAACGTCTCC
ATGATTCTCTACGCGGAGCATTCCTTCAACGCCTCGACGTTCACGGCCCGGGTCATCACC
TCCACCCTGGCGGATCTGCATTCGGCGGTGACCGGAGCCATAGGTGCCCTCAAGGGGCCG
CTGCACGGGGGTGCCAACGAGGCCGTGATGCATACCTTTGAGGAGATTGGGATCCGCAAG
GACGAATCCCTCGATGAGGCAGCCACGCGTTCGAAAGCTTGGATGGTCGATGCCCTTGCG
CAGAAGAAAAAGGTCATGGGTTTTGGGCACCGCGTGTACAAGAATGGTGACTCCCGGGTC
CCCACCATGAAGAGCGCTCTGGACGCCATGATCAAACATTATGATCGTCCGGAAATGCTC
GGCCTGTACAACGGACTCGAAGCCGCTATGGAAGAGGCCAAGCAGATCAAGCCGAATCTC
GACTACCCGGCAGGACCCACCTATAACCTGATGGGCTTTGACACGGAGATGTTCACTCCG
CTCTTCATCGCCGCGCGCATCACCGGTTGGACCGCCCATATCATGGAACAAGTGGCGGAC
AACGCTCTGATCCGCCCACTCAGCGAATATAACGGTCCTGAGCAGCGCCAGGTCCCCTGA
</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00285</identifier>
            <name>Citrate_synt</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>2-methylcitrate synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>citrate synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>propionate metabolic process, methylcitrate cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003121</id>
      <name>Prostaglandin F synthase</name>
      <organism>Trypanosoma brucei brucei</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9GV41" source="Swiss-Prot">
        <name>Prostaglandin F synthase</name>
        <general-function>Prostaglandin-f synthase activity</general-function>
        <specific-function>Catalyzes the NADP-dependent formation of prostaglandin F2-alpha from prostaglandin H2. Has also aldo/ketoreductase activity towards the synthetic substrates 9,10-phenanthrenequinone and p-nitrobenzaldehyde.</specific-function>
        <gene-name/>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.79</theoretical-pi>
        <molecular-weight>30992.385</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="5702">Trypanosoma brucei brucei</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB034727</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9GV41</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PGFS_TRYBB</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.1.1.188</synonym>
          <synonym>Prostaglandin F2-alpha synthase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012186|Prostaglandin F synthase
MALTQSLKLSNGVMMPVLGFGMWKLQDGNEAETATMWAIKSGYRHIDTAAIYKNEESAGR
AIASCGVPREELFVTTKLWNSDQGYESTLSAFEKSIKKLGLEYVDLYLIHWPGKDKFIDT
WKAFEKLYADKKVRAIGVSNFHEHHIEELLKHCKVAPMVNQIELHPLLNQKALCEYCKSK
NIAVTAWSPLGQGHLVEDARLKAIGGKYGKTAAQVMLRWEIQAGVITIPKSGNEARIKEN
GNIFDFELTAEDIQVIDGMNAGHRYGPDPEVFMNDF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0006091|831 bp
ATGGCTCTCACTCAATCCCTAAAACTCTCGAATGGAGTGATGATGCCAGTTCTTGGTTTC
GGTATGTGGAAGTTACAGGATGGCAATGAAGCCGAGACGGCGACGATGTGGGCCATAAAA
AGCGGCTATCGTCACATCGATACTGCAGCCATCTATAAAAATGAAGAAAGCGCTGGCAGA
GCCATTGCCTCATGTGGTGTACCGCGGGAAGAGCTATTCGTCACGACGAAGCTTTGGAAC
TCCGACCAGGGATATGAGAGCACGCTGAGCGCATTTGAGAAGAGCATTAAGAAGCTCGGC
CTGGAATATGTTGACCTATACCTCATCCACTGGCCGGGGAAGGACAAGTTTATCGACACA
TGGAAGGCGTTTGAGAAACTGTACGCCGATAAGAAGGTGCGCGCCATTGGCGTTTCCAAC
TTTCACGAGCACCACATCGAGGAACTGCTAAAGCACTGTAAGGTTGCACCGATGGTTAAC
CAGATCGAGCTCCATCCGCTGCTCAATCAGAAGGCACTCTGCGAGTACTGCAAGTCGAAG
AACATCGCCGTCACTGCCTGGTCGCCGCTTGGTCAAGGACATCTCGTCGAAGACGCCCGT
CTGAAAGCTATCGGAGGAAAGTATGGTAAGACAGCTGCGCAGGTGATGCTCCGCTGGGAA
ATACAAGCAGGGGTCATCACGATTCCCAAATCGGGCAACGAGGCCCGCATCAAGGAAAAT
GGCAATATATTTGACTTCGAACTAACTGCGGAGGACATTCAAGTCATCGATGGTATGAAT
GCCGGCCACCGCTACGGCCCCGATCCGGAGGTCTTCATGAACGACTTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00248</identifier>
            <name>Aldo_ket_red</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleotide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>prostaglandin D2 11-ketoreductase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>prostaglandin-F synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostaglandin biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001380</id>
      <name>Cell division protein FtsZ</name>
      <organism>Mycobacterium tuberculosis</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P9WN95" source="Swiss-Prot">
        <name>Cell division protein FtsZ</name>
        <general-function>Essential cell division protein that forms a contractile ring structure (Z ring) at the future cell division site. The regulation of the ring assembly controls the timing and the location of cell division. One of the functions of the FtsZ ring is to recruit other cell division proteins to the septum to produce a new cell wall between the dividing cells. Binds GTP and shows GTPase activity.</general-function>
        <specific-function>Gtp binding</specific-function>
        <gene-name>ftsZ</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>38755.52</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83332">Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P9WN95</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FTSZ_MYCTU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0051239|Cell division protein FtsZ
MTPPHNYLAVIKVVGIGGGGVNAVNRMIEQGLKGVEFIAINTDAQALLMSDADVKLDVGR
DSTRGLGAGADPEVGRKAAEDAKDEIEELLRGADMVFVTAGEGGGTGTGGAPVVASIARK
LGALTVGVVTRPFSFEGKRRSNQAENGIAALRESCDTLIVIPNDRLLQMGDAAVSLMDAF
RSADEVLLNGVQGITDLITTPGLINVDFADVKGIMSGAGTALMGIGSARGEGRSLKAAEI
AINSPLLEASMEGAQGVLMSIAGGSDLGLFEINEAASLVQDAAHPDANIIFGTVIDDSLG
DEVRVTVIAAGFDVSGPGRKPVMGETGGAHRIESAKAGKLTSTLFEPVDAVSVPLHTNGA
TLSIGGDDDDVDVPPFMRR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0051240|Cell division protein FtsZ (ftsZ)
ATGACCCCCCCGCACAACTACCTGGCCGTCATCAAGGTCGTGGGTATCGGTGGTGGCGGT
GTCAACGCCGTCAACCGAATGATCGAGCAGGGCCTCAAAGGCGTGGAATTCATCGCGATC
AACACCGACGCCCAGGCGTTGTTGATGAGCGATGCCGACGTCAAACTCGACGTCGGCCGC
GACTCCACCCGCGGGCTGGGCGCCGGCGCCGATCCGGAGGTCGGCCGTAAGGCCGCCGAG
GACGCCAAGGACGAGATCGAAGAGCTGCTGCGCGGTGCCGACATGGTGTTTGTCACCGCC
GGCGAGGGGGGCGGAACCGGCACCGGGGGGGCACCCGTCGTCGCCAGCATCGCCCGCAAG
CTGGGCGCGTTGACCGTCGGTGTGGTCACCCGGCCGTTCTCGTTCGAGGGCAAGCGACGC
AGCAATCAGGCCGAAAATGGCATCGCGGCGCTGCGGGAGAGTTGCGACACCCTCATCGTG
ATTCCCAACGACCGGTTGCTGCAGATGGGAGATGCCGCGGTATCGCTGATGGATGCTTTC
CGTAGCGCCGACGAGGTGCTGCTCAACGGCGTGCAGGGCATCACCGACCTGATTACCACC
CCGGGTCTAATCAACGTCGACTTCGCCGACGTCAAGGGCATCATGTCCGGTGCCGGCACC
GCACTGATGGGCATCGGCTCGGCCCGGGGCGAAGGCCGGTCGCTCAAAGCGGCCGAGATC
GCCATCAACTCGCCGTTGCTGGAAGCCTCGATGGAGGGCGCGCAAGGCGTGCTGATGTCG
ATCGCCGGCGGCAGCGACTTGGGCTTGTTCGAGATCAACGAGGCGGCCTCGTTGGTACAA
GACGCCGCTCACCCCGATGCCAACATCATCTTCGGCACCGTCATCGACGATTCGCTCGGT
GACGAGGTGCGGGTGACCGTGATCGCGGCCGGCTTCGACGTCAGCGGTCCCGGCCGCAAG
CCGGTGATGGGCGAGACCGGCGGCGCCCACCGGATCGAGTCAGCCAAGGCAGGCAAGCTC
ACCTCGACCTTGTTCGAGCCGGTCGACGCCGTCAGCGTGCCGTTGCACACCAACGGCGCA
ACCCTGAGCATCGGCGGTGATGACGACGATGTCGACGTGCCGCCCTTCATGCGCCGCTGA
</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00091</identifier>
            <name>Tubulin</name>
          </pfam>
          <pfam>
            <identifier>PF12327</identifier>
            <name>FtsZ_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell division site</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GTPase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>barrier septum assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein polymerization</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000115</id>
      <name>Adenine phosphoribosyltransferase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07741" source="Swiss-Prot">
        <name>Adenine phosphoribosyltransferase</name>
        <general-function>Amp binding</general-function>
        <specific-function>Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis.</specific-function>
        <gene-name>APRT</gene-name>
        <locus>16q24</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.82</theoretical-pi>
        <molecular-weight>19607.535</molecular-weight>
        <chromosome-location>16</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:626</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>APRT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>Y00486</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>28819</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P07741</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>APT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.4.2.7</synonym>
          <synonym>APRT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036953|Adenine phosphoribosyltransferase
MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDY
IAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPG
QRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE
</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0009945|Adenine phosphoribosyltransferase (APRT)
ATGGCCGACTCCGAGCTGCAGCTGGTTGAGCAGCGGATCCGCAGCTTCCCCGACTTCCCC
ACCCCAGGCGTGGTATTCAGGGACATCTCGCCCGTCCTGAAGGACCCCGCCTCCTTCCGC
GCCGCCATCGGCCTCCTGGCGCGACACCTGAAGGCGACCCACGGGGGCCGCATCGACTAC
ATCGCAGGCCTAGACTCCCGAGGCTTCCTCTTTGGCCCCTCCCTGGCCCAGGAGCTTGGA
CTGGGCTGCGTGCTCATCCGAAAGCGGGGGAAGCTGCCAGGCCCCACTCTGTGGGCCTCC
TATTCCCTGGAGTACGGGAAGGCTGAGCTGGAGATTCAGAAAGACGCCCTGGAGCCAGGA
CAGAGGGTGGTCGTCGTGGATGATCTGCTGGCCACTGGTGGAACCATGAACGCTGCCTGT
GAGCTGCTGGGCCGCCTGCAGGCTGAGGTCCTGGAGTGCGTGAGCCTGGTGGAGCTGACC
TCGCTTAAGGGCAGGGAGAAGCTGGCACCTGTACCCTTCTTCTCTCTCCTGCAGTATGAG
TGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00156</identifier>
            <name>Pribosyltran</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>adenine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>adenine phosphoribosyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>AMP binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>adenine salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>AMP salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to insulin stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>grooming behavior</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lactation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleobase-containing small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>purine nucleobase metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>purine-containing compound salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001181</id>
      <name>Angiogenin</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P03950" source="Swiss-Prot">
        <name>Angiogenin</name>
        <general-function>Rrna binding</general-function>
        <specific-function>Binds to actin on the surface of endothelial cells; once bound, angiogenin is endocytosed and translocated to the nucleus. Stimulates ribosomal RNA synthesis including that containing the initiation site sequences of 45S rRNA. Cleaves tRNA within anticodon loops to produce tRNA-derived stress-induced fragments (tiRNAs) which inhibit protein synthesis and triggers the assembly of stress granules (SGs). Angiogenin induces vascularization of normal and malignant tissues. Angiogenic activity is regulated by interaction with RNH1 in vivo.</specific-function>
        <gene-name>ANG</gene-name>
        <locus>14q11.1-q11.2</locus>
        <cellular-location>Cytoplasmic vesicle</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-24</signal-regions>
        <theoretical-pi>10.09</theoretical-pi>
        <molecular-weight>16549.95</molecular-weight>
        <chromosome-location>14</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:483</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ANG</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M11567</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>178250</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P03950</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ANGI_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.27.-</synonym>
          <synonym>Ribonuclease 5</synonym>
          <synonym>RNase 5</synonym>
          <synonym>RNASE5</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002349|Angiogenin
MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLT
SPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRA
TAGFRNVVVACENGLPVHLDQSIFRRP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010823|Angiogenin (ANG)
ATGGTGATGGGCCTGGGCGTTTTGTTGTTGGTCTTCGTGCTGGGTCTGGGTCTGACCCCA
CCGACCCTGGCTCAGGATAACTCCAGGTACACACACTTCCTGACCCAGCACTATGATGCC
AAACCACAGGGCCGGGATGACAGATACTGTGAAAGCATCATGAGGAGACGGGGCCTGACC
TCACCCTGCAAAGACATCAACACATTTATTCATGGCAACAAGCGCAGCATCAAGGCCATC
TGTGAAAACAAGAATGGAAACCCTCACAGAGAAAACCTAAGAATAAGCAAGTCTTCTTTC
CAGGTCACCACTTGCAAGCTACATGGAGGTTCCCCCTGGCCTCCATGCCAGTACCGAGCC
ACAGCGGGGTTCAGAAACGTTGTTGTTGCTTGTGAAAATGGCTTACCTGTCCACTTGGAT
CAGTCAATTTTCCGTCGTCCGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00074</identifier>
            <name>RnaseA</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>angiogenin-PRI complex</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>basal lamina</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>growth cone</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>neuronal cell body</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleolus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>actin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>copper ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>endonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>heparin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>peptide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein homodimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ribonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>rRNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>actin filament polymerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>activation of phospholipase A2 activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>activation of phospholipase C activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>activation of protein kinase B activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>adherens junction organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>angiogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>antibacterial humoral response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>antifungal humoral response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell communication</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell junction assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell-cell junction organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>defense response to Gram-positive bacterium</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>diacylglycerol biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>homeostatic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of smooth muscle cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of translation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleic acid phosphodiester bond hydrolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oocyte maturation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ovarian follicle development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>placenta development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of endothelial cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of protein secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to hormone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to hypoxia</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to yeast</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA phosphodiester bond hydrolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>rRNA transcription</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002493</id>
      <name>Glucose-1-phosphate thymidylyltransferase</name>
      <organism>Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9HU22" source="TrEMBL">
        <name>Glucose-1-phosphate thymidylyltransferase</name>
        <general-function>Nucleotide binding</general-function>
        <specific-function>Catalyzes the formation of dTDP-glucose, from dTTP and glucose 1-phosphate, as well as its pyrophosphorolysis.</specific-function>
        <gene-name>rmlA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.02</theoretical-pi>
        <molecular-weight>32456.65</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="208964">Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE004091</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9HU22</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q9HU22_PSEAE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.7.24</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0022427|Glucose-1-phosphate thymidylyltransferase
MKRKGIILAGGSGTRLHPATLAISKQLLPVYDKPMIYYPLSTLMLAGIREILIISTPQDT
PRFQQLLGDGSNWGLDLQYAVQPSPDGLAQAFLIGESFIGNDLSALVLGDNLYYGHDFHE
LLGSASQRQTGASVFAYHVLDPERYGVVEFDQGGKAISLEEKPLEPKSNYAVTGLYFYDQ
QVVDIARDLKPSPRGELEITDVNRAYLERGQLSVEIMGRGYAWLDTGTHDSLLEAGQFIA
TLENRQGLKVACPEEIAYRQKWIDAAQLEKLAAPLAKNGYGQYLKRLLTETVY</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0022428|Glucose-1-phosphate thymidylyltransferase (rmlA)
ATGAAACGCAAGGGCATCATCCTCGCCGGAGGCTCGGGCACCCGCCTGCACCCGGCAACG
CTGGCCATCTCCAAGCAGTTGCTGCCGGTGTACGACAAGCCGATGATCTACTACCCGCTC
AGTACCCTGATGCTGGCGGGCATCCGCGAGATACTGATCATCTCGACCCCACAGGACACC
CCACGCTTCCAGCAGTTGCTGGGCGACGGTTCGAACTGGGGCCTGGACCTGCAATATGCC
GTGCAACCGTCGCCGGACGGCCTGGCCCAGGCCTTCCTGATCGGCGAGTCGTTCATCGGC
AACGACCTCAGCGCGCTGGTCCTGGGCGACAACCTCTATTACGGCCACGACTTCCACGAG
TTGCTCGGCAGCGCTTCGCAGCGCCAGACCGGCGCCAGTGTCTTCGCCTACCACGTGCTG
GACCCGGAGCGCTACGGCGTGGTCGAGTTCGACCAGGGCGGCAAGGCCATCAGCCTGGAA
GAGAAGCCACTGGAGCCGAAGTCGAACTACGCGGTCACCGGCCTGTATTTCTACGACCAG
CAGGTGGTGGACATCGCCAGGGACCTGAAGCCTTCGCCGCGCGGCGAGCTGGAGATCACC
GACGTCAACCGCGCCTATCTGGAGCGCGGCCAGCTCAGCGTGGAGATCATGGGCCGCGGC
TACGCCTGGCTGGATACCGGCACCCACGATTCGCTGCTCGAGGCCGGCCAGTTCATCGCC
ACCCTGGAGAACCGCCAGGGTCTCAAGGTGGCCTGCCCGGAAGAGATCGCCTACCGGCAG
AAGTGGATCGACGCCGCGCAACTGGAAAAACTCGCCGCGCCGCTGGCCAAGAACGGCTAC
GGCCAATACCTCAAGCGCCTGCTGACCGAGACCGTGTACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00483</identifier>
            <name>NTP_transferase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>glucose-1-phosphate thymidylyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleotide binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>extracellular polysaccharide biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001426</id>
      <name>Beta-lactamase 2</name>
      <organism>Bacillus cereus</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P04190" source="Swiss-Prot">
        <name>Beta-lactamase 2</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Can hydrolyze carbapenem compounds.</specific-function>
        <gene-name>blm</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-30</signal-regions>
        <theoretical-pi>9.29</theoretical-pi>
        <molecular-weight>28092.24</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1396">Bacillus cereus</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M11189</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>142604</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P04190</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>BLA2_BACCE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.5.2.6</synonym>
          <synonym>Beta-lactamase II</synonym>
          <synonym>Cephalosporinase</synonym>
          <synonym>Penicillinase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011000|Beta-lactamase 2
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINAVVPGH
GEVGDKGLLLHTLDLLK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0002830|774 bp
ATGAAAAAGAATACGTTGTTAAAAGTAGGATTATGTGTAGGTTTACTAGGAACAATTCAA
TTTGTTAGCACAATTTCTTCTGTACAAGCATCACAAAAGGTAGAGAAAACAGTAATAAAA
AATGAGACGGGAACCATTTCAATATCTCAGTTAAACAAGAATGTATGGGTTCATACGGAG
TTAGGTTCTTTTAATGGAGAAGCAGTTCCTTCGAACGGTCTAGTTCTTAATACTTCTAAA
GGGTTAGTACTTGTGGATTCTTCTTGGGATGACAAATTAACGAAGGAACTAATAGAAATG
GTAGAAAAGAAATTTCAGAAGCGCGTAACGGATGTCATTATTACACATGCGCACGCTGAT
CGAATTGGCGGAATAAAAACGTTGAAAGAAAGAGGCATTAAAGCGCATAGTACAGCATTA
ACTGCAGAACTAGCAAAGAAAAATGGATATGAAGAACCGCTTGGAGATTTACAAACCGTT
ACAAATTTGAAGTTTGGAAATATGAAAGTAGAAACATTTTATCCAGGGAAAGGGCATACA
GAAGATAATATTGTCGTATGGTTACCGCAATACAATATTTTAGTTGGAGGCTGTTTAGTG
AAATCTACGTCCGCGAAAGATTTAGGAAACGTTGCGGATGCTTATGTAAATGAATGGTCT
ACATCGATTGAGAATGTGCTGAAGCGATATAGAAATATAAATGCAGTAGTGCCTGGTCAT
GGGGAAGTAGGGGACAAAGGATTACTTTTACATACATTGGATTTATTAAAATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00753</identifier>
            <name>Lactamase_B</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>beta-lactamase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>antibiotic catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to antibiotic</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002653</id>
      <name>Glyoxalase family protein</name>
      <organism>Bacillus cereus (strain ATCC 14579 / DSM 31)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q81F54" source="TrEMBL">
        <name>Glyoxalase family protein</name>
        <general-function/>
        <specific-function/>
        <gene-name/>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.59</theoretical-pi>
        <molecular-weight>16581.885</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="226900">Bacillus cereus (strain ATCC 14579 / DSM 31 / JCM 2152 / NBRC 15305 / NCIMB 9373 / NRRL B-3711)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE016877</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q81F54</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q81F54_BACCR</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0022016|Glyoxalase family protein
MAKNKLLRMDNVSIVVESLDNAISFFEEIGLNLEGRANVEGEWAGRVTGLGSQCVEIAMM
VTPDGHSRIELSRFLTPPTIADHRTAPVNALGYLRVMFTVEDIDEMVSRLTKHGAELVGE
VVQYENSYRLCYIRGVEGILIGLAEELGNK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0022017|Glyoxalase family protein
ATGGCAAAAAACAAATTACTACGAATGGACAATGTCAGCATCGTTGTAGAATCCCTTGAT
AACGCAATCTCTTTCTTTGAGGAGATTGGCTTGAATCTCGAAGGTCGAGCAAATGTCGAA
GGTGAATGGGCTGGTCGCGTAACTGGACTCGGTTCTCAGTGCGTAGAGATTGCTATGATG
GTCACTCCAGATGGCCACAGCCGAATTGAACTTTCGCGATTTCTCACCCCTCCTACTATA
GCAGATCACCGAACAGCTCCTGTAAACGCCCTCGGTTATCTACGCGTCATGTTCACTGTC
GAGGATATTGACGAAATGGTATCGAGACTCACTAAGCATGGTGCAGAGCTCGTTGGCGAA
GTAGTTCAGTACGAGAACTCGTATCGTCTCTGCTACATTCGTGGAGTCGAAGGAATTTTA
ATCGGTTTAGCAGAAGAACTCGGTAATAAATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF12681</identifier>
            <name>Glyoxalase_2</name>
          </pfam>
        </pfams>
        <go-classifiers/>
      </polypeptide>
    </target>
    <target>
      <id>BE0001480</id>
      <name>Uridine-cytidine kinase 2</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BZX2" source="Swiss-Prot">
        <name>Uridine-cytidine kinase 2</name>
        <general-function>Uridine kinase activity</general-function>
        <specific-function>Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate. Does not phosphorylate deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP as a phosphate donor. Can also phosphorylate cytidine and uridine nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4-thiouridine, 5-bromouridine, N(4)-acetylcytidine, N(4)-benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5-methylcytidine, and N(4)-anisoylcytidine.</specific-function>
        <gene-name>UCK2</gene-name>
        <locus>1q23</locus>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.68</theoretical-pi>
        <molecular-weight>29298.92</molecular-weight>
        <chromosome-location>1</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:12562</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>UCK2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D78335</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>1655420</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9BZX2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>UCK2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.1.48</synonym>
          <synonym>Cytidine monophosphokinase 2</synonym>
          <synonym>Testis-specific protein TSA903</synonym>
          <synonym>UCK 2</synonym>
          <synonym>UMPK</synonym>
          <synonym>Uridine monophosphokinase 2</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002938|Uridine-cytidine kinase 2
MAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILS
QDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRK
EETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQ
ILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNG
CLNGYTPSRKRQASESSSRPH</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019126|Uridine-cytidine kinase 2 (UCK2)
ATGGCCGGGGACAGCGAGCAGACCCTGCAGAACCACCAGCAGCCCAACGGCGGCGAGCCC
TTCCTTATAGGCGTCAGCGGGGGAACAGCTAGCGGCAAGTCTTCCGTGTGTGCTAAGATC
GTGCAGCTCCTGGGGCAGAATGAGGTGGACTATCGCCAGAAGCAGGTGGTCATCCTGAGC
CAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCAGAAGGCCAAAGCCCTGAAGGGCCAG
TTCAACTTTGACCACCCGGATGCCTTTGACAATGAACTCATTCTCAAAACACTCAAAGAA
ATCACTGAAGGGAAAACAGTCCAGATCCCCGTGTATGACTTTGTCTCCCATTCCCGGAAG
GAGGAGACAGTTACTGTCTATCCCGCAGACGTGGTGCTCTTTGAAGGGATCCTGGCCTTC
TACTCCCAGGAGGTACGAGACCTGTTCCAGATGAAGCTTTTTGTGGATACAGATGCGGAC
ACCCGGCTCTCACGCAGAGTATTAAGGGACATCAGCGAGAGAGGCAGGGATCTTGAGCAG
ATTTTATCTCAGTACATTACGTTCGTCAAGCCTGCCTTTGAGGAATTCTGCTTGCCAACA
AAGAAGTATGCTGATGTGATCATCCCTAGAGGTGCAGATAATCTGGTGGCCATCAACCTC
ATCGTGCAGCACATCCAGGACATCCTGAATGGAGGGCCCTCCAAACGGCAGACCAATGGC
TGTCTCAACGGCTACACCCCTTCACGCAAGAGGCAGGCATCGGAGTCCAGCAGCAGGCCG
CATTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00485</identifier>
            <name>PRK</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleoside kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>uridine kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>CMP salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>CTP salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleobase-containing small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyrimidine nucleobase metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pyrimidine nucleoside salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>UMP salvage</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000999</id>
      <name>Tumor necrosis factor ligand superfamily member 13B</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y275" source="Swiss-Prot">
        <name>Tumor necrosis factor ligand superfamily member 13B</name>
        <general-function>Receptor binding</general-function>
        <specific-function>Cytokine that binds to TNFRSF13B/TACI and TNFRSF17/BCMA. TNFSF13/APRIL binds to the same 2 receptors. Together, they form a 2 ligands -2 receptors pathway involved in the stimulation of B- and T-cell function and the regulation of humoral immunity. A third B-cell specific BAFF-receptor (BAFFR/BR3) promotes the survival of mature B-cells and the B-cell response.Isoform 2 seems to inhibit isoform 1 secretion and bioactivity.Isoform 3: Acts as a transcription factor for its own parent gene, in association with NF-kappa-B p50 subunit, at least in autoimmune and proliferative B-cell diseases. The presence of Delta4BAFF is essential for soluble BAFF release by IFNG/IFN-gamma-stimulated monocytes and for B-cell survival. It can directly or indirectly regulate the differential expression of a large number of genes involved in the innate immune response and the regulation of apoptosis.</specific-function>
        <gene-name>TNFSF13B</gene-name>
        <locus>13q32-34</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>47-67</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>6.15</theoretical-pi>
        <molecular-weight>31222.48</molecular-weight>
        <chromosome-location>13</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11929</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>TNFSF13B</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF136293</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>4761612</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9Y275</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>TN13B_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>B lymphocyte stimulator</synonym>
          <synonym>B-cell-activating factor</synonym>
          <synonym>BAFF</synonym>
          <synonym>BLYS</synonym>
          <synonym>Dendritic cell-derived TNF-like molecule</synonym>
          <synonym>TALL-1</synonym>
          <synonym>TALL1</synonym>
          <synonym>TNF- and APOL-related leukocyte expressed ligand 1</synonym>
          <synonym>TNFSF20</synonym>
          <synonym>ZTNF4</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001989|Tumor necrosis factor ligand superfamily member 13B
MDDSTEREQSRLTSCLKKREEMKLKECVSILPRKESPSVRSSKDGKLLAATLLLALLSCC
LTVVSFYQVAALQGDLASLRAELQGHHAEKLPAGAGAPKAGLEEAPAVTAGLKIFEPPAP
GEGNSSQNSRNKRAVQGPEETVTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEE
KENKILVKETGYFFIYGQVLYTDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETL
PNNSCYSAGIAKLEEGDELQLAIPRENAQISLDGDVTFFGALKLL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010699|Tumor necrosis factor ligand superfamily member 13B (TNFSF13B)
ATGGATGACTCCACAGAAAGGGAGCAGTCACGCCTTACTTCTTGCCTTAAGAAAAGAGAA
GAAATGAAACTGAAGGAGTGTGTTTCCATCCTCCCACGGAAGGAAAGCCCCTCTGTCCGA
TCCTCCAAAGACGGAAAGCTGCTGGCTGCAACCTTGCTGCTGGCACTGCTGTCTTGCTGC
CTCACGGTGGTGTCTTTCTACCAGGTGGCCGCCCTGCAAGGGGACCTGGCCAGCCTCCGG
GCAGAGCTGCAGGGCCACCACGCGGAGAAGCTGCCAGCAGGAGCAGGAGCCCCCAAGGCC
GGCCTGGAGGAAGCTCCAGCTGTCACCGCGGGACTGAAAATCTTTGAACCACCAGCTCCA
GGAGAAGGCAACTCCAGTCAGAACAGCAGAAATAAGCGTGCCGTTCAGGGTCCAGAAGAA
ACAGGATCTTACACATTTGTTCCATGGCTTCTCAGCTTTAAAAGGGGAAGTGCCCTAGAA
GAAAAAGAGAATAAAATATTGGTCAAAGAAACTGGTTACTTTTTTATATATGGTCAGGTT
TTATATACTGATAAGACCTACGCCATGGGACATCTAATTCAGAGGAAGAAGGTCCATGTC
TTTGGGGATGAATTGAGTCTGGTGACTTTGTTTCGATGTATTCAAAATATGCCTGAAACA
CTACCCAATAATTCCTGCTATTCAGCTGGCATTGCAAAACTGGAAGAAGGAGATGAACTC
CAACTTGCAATACCAAGAGAAAATGCACAAATATCACTGGATGGAGATGTCACATTTTTT
GGTGCATTGAAACTGCTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00229</identifier>
            <name>TNF</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>perinuclear region of cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>B cell costimulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>B cell homeostasis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>immunoglobulin secretion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of B cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of germinal center formation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of T cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>T cell costimulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tumor necrosis factor-mediated signaling pathway</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002757</id>
      <name>Laccase domain protein YfiH</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P33644" source="Swiss-Prot">
        <name>Laccase domain protein YfiH</name>
        <general-function>Copper ion binding</general-function>
        <specific-function/>
        <gene-name>yfiH</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.65</theoretical-pi>
        <molecular-weight>26338.69</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U50134</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P33644</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>YFIH_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011941|Laccase domain protein YfiH
MSKLIVPQWPQPKGVAACSSTRIGGVSLPPYDSLNLGAHCGDNPDHVEENRKRLFAAGNL
PSKPVWLEQVHGKDVLKLTGEPYASKRADASYSNTPGTVCAVMTADCLPVLFCNRAGTEV
AAAHAGWRGLCAGVLEETVSCFADNPENILAWLGPAIGPRAFEVGGEVREAFMAVDAKAS
AAFIQHGDKYLADIYQLARQRLANVGVEQIFGGDRCTYTENETFFSYRRDKTTGRMASFI
WLI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011942|Laccase domain protein YfiH (yfiH)
ATGAGTAAGCTGATTGTCCCGCAGTGGCCGCAGCCAAAAGGTGTTGCGGCCTGTAGCTCC
ACTCGTATCGGCGGCGTGAGCTTGCCCCCGTATGACTCACTCAACCTCGGTGCCCATTGT
GGCGATAACCCGGATCACGTTGAGGAGAATCGCAAGCGACTTTTTGCTGCGGGCAATTTG
CCTTCTAAACCGGTCTGGCTTGAGCAGGTACACGGCAAAGATGTGCTTAAGCTCACTGGC
GAACCTTATGCCTCAAAACGGGCGGATGCCTCTTATAGCAATACGCCCGGCACGGTTTGC
GCAGTGATGACTGCCGACTGCCTCCCTGTGCTGTTTTGCAATCGAGCGGGAACGGAAGTC
GCCGCCGCTCATGCTGGCTGGCGTGGACTGTGCGCAGGCGTGCTGGAAGAGACGGTTTCC
TGTTTTGCTGATAATCCGGAAAATATTCTCGCCTGGTTAGGGCCGGCAATTGGTCCACGC
GCGTTCGAAGTGGGGGGGGAGGTTCGCGAGGCGTTTATGGCAGTAGACGCTAAAGCAAGT
GCAGCTTTCATTCAGCATGGTGATAAGTATCTGGCGGATATTTATCAGCTTGCCCGGCAG
CGTCTGGCGAACGTGGGTGTTGAGCAAATTTTCGGCGGCGACCGTTGTACATATACGGAA
AATGAGACTTTCTTCTCTTATCGTCGCGACAAGACCACCGGTCGTATGGCAAGTTTCATT
TGGCTGATATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02578</identifier>
            <name>Cu-oxidase_4</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>copper ion binding</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000845</id>
      <name>Betaine--homocysteine S-methyltransferase 1</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q93088" source="Swiss-Prot">
        <name>Betaine--homocysteine S-methyltransferase 1</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline.</specific-function>
        <gene-name>BHMT</gene-name>
        <locus>5q13.1-q15</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.85</theoretical-pi>
        <molecular-weight>44998.205</molecular-weight>
        <chromosome-location>5</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:1047</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>BHMT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U50929</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>1522683</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q93088</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>BHMT1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.1.5</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016225|Betaine--homocysteine S-methyltransferase 1
MPPVGGKKAKKGILERLNAGEIVIGDGGFVFALEKRGYVKAGPWTPEAAVEHPEAVRQLH
REFLRAGSNVMQTFTFYASEDKLENRGNYVLEKISGQEVNEAACDIARQVADEGDALVAG
GVSQTPSYLSCKSETEVKKVFLQQLEVFMKKNVDFLIAEYFEHVEEAVWAVETLIASGKP
VAATMCIGPEGDLHGVPPGECAVRLVKAGASIIGVNCHFDPTISLKTVKLMKEGLEAARL
KAHLMSQPLAYHTPDCNKQGFIDLPEFPFGLEPRVATRWDIQKYAREAYNLGVRYIGGCC
GFEPYHIRAIAEELAPERGFLPPASEKHGSWGSGLDMHTKPWVRARARKEYWENLRIASG
RPYNPSMSKPDGWGVTKGTAELMQQKEATTEQQLKELFEKQKFKSQ</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016226|Betaine--homocysteine S-methyltransferase 1 (BHMT)
ATGCCACCCGTTGGGGGCAAAAAGGCCAAGAAGGGCATCCTAGAACGTTTAAATGCTGGA
GAGATTGTGATTGGAGATGGAGGGTTTGTCTTTGCACTGGAGAAGAGGGGCTACGTAAAG
GCAGGACCCTGGACTCCTGAAGCTGCTGTGGAGCACCCAGAAGCAGTTCGCCAGCTTCAT
CGAGAGTTCCTCAGAGCTGGCTCAAACGTCATGCAGACCTTCACCTTCTATGCGAGTGAA
GACAAGCTGGAGAACAGGGGCAACTATGTCTTAGAGAAGATATCTGGGCAGGAAGTCAAT
GAAGCTGCTTGCGACATCGCCCGACAAGTGGCTGATGAAGGAGATGCTTTGGTAGCAGGA
GGAGTGAGTCAGACACCTTCATACCTTAGCTGCAAGAGTGAAACTGAAGTCAAAAAAGTA
TTTCTGCAACAGTTAGAGGTCTTTATGAAGAAGAACGTGGACTTCTTGATTGCAGAGTAT
TTTGAACACGTTGAAGAAGCTGTGTGGGCAGTTGAAACCTTGATAGCATCCGGTAAACCT
GTGGCAGCAACCATGTGCATTGGCCCAGAAGGAGATTTGCATGGCGTGCCCCCCGGCGAG
TGTGCAGTGCGCCTGGTGAAAGCAGGAGCATCCATCATTGGTGTGAACTGCCACTTTGAC
CCCACCATTAGTTTAAAAACAGTGAAGCTCATGAAGGAGGGCTTGGAGGCTGCCCGACTG
AAAGCTCACCTGATGAGCCAGCCCTTGGCTTACCACACTCCTGACTGCAACAAGCAGGGA
TTCATCGATCTCCCAGAATTCCCATTTGGACTGGAACCCAGAGTTGCCACCAGATGGGAT
ATTCAAAAATACGCCAGAGAGGCCTACAACCTGGGGGTCAGGTACATTGGCGGGTGCTGT
GGATTTGAGCCCTACCACATCAGGGCAATTGCAGAGGAGCTGGCCCCAGAAAGGGGCTTT
TTGCCACCAGCTTCAGAAAAACATGGCAGCTGGGGAAGTGGTTTGGACATGCACACCAAA
CCCTGGGTTAGAGCAAGGGCCAGGAAGGAATACTGGGAGAATCTTCGGATAGCCTCAGGC
CGGCCATACAACCCTTCAATGTCAAAGCCAGATGGCTGGGGAGTGACCAAAGGAACAGCC
GAGCTGATGCAGCAGAAAGAAGCCACAACTGAGCAGCAGCTGAAAGAGCTCTTTGAAAAA
CAAAAATTCAAATCACAGTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02574</identifier>
            <name>S-methyl_trans</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>betaine-homocysteine S-methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>S-adenosylmethionine-homocysteine S-methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>amino-acid betaine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>amino-acid betaine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>L-methionine salvage</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein methylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of homocysteine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>S-methylmethionine cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sulfur amino acid metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003268</id>
      <name>Ribose-5-phosphate isomerase A</name>
      <organism>Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P44725" source="Swiss-Prot">
        <name>Ribose-5-phosphate isomerase A</name>
        <general-function>Ribose-5-phosphate isomerase activity</general-function>
        <specific-function>Catalyzes the reversible conversion of ribose-5-phosphate to ribulose 5-phosphate.</specific-function>
        <gene-name>rpiA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.78</theoretical-pi>
        <molecular-weight>23093.47</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="71421">Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L42023</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P44725</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>RPIA_HAEIN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>5.3.1.6</synonym>
          <synonym>Phosphoriboisomerase A</synonym>
          <synonym>PRI</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017045|Ribose-5-phosphate isomerase A
MNQLEMKKLAAQAALQYVKADTIVGVGSGSTVNCFIEALGTIKDKIQGAVAASKESEELL
RKQGIEVFNANDVSSLDIYVDGADEINPQKMMIKGGGAALTREKIVAALAKKFICIVDSS
KQVDVLGSTFPLPVEVIPMARSQVGRKLAALGGSPEYREGVVTDNGNVILDVHNFSILNP
VEIEKELNNVAGVVTNGIFALRGADVVIVGTPEGAKVID</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017046|Ribose-5-phosphate isomerase A (rpiA)
ATGAATCAATTAGAAATGAAAAAACTCGCCGCACAAGCTGCATTACAATATGTAAAAGCA
GATACGATTGTTGGGGTGGGAAGTGGCTCCACAGTGAACTGCTTTATTGAAGCTTTAGGT
ACAATCAAAGATAAAATTCAAGGTGCCGTTGCGGCTTCAAAAGAATCAGAAGAATTATTA
CGTAAGCAAGGTATCGAAGTATTTAATGCAAATGATGTCTCTAGCTTAGATATTTATGTG
GATGGTGCGGATGAAATCAATCCACAAAAAATGATGATTAAAGGCGGCGGCGCAGCACTC
ACTCGTGAAAAAATAGTCGCTGCATTAGCGAAAAAATTTATTTGTATTGTGGATTCAAGT
AAGCAAGTGGATGTGTTGGGTTCAACTTTCCCATTACCAGTTGAAGTGATTCCTATGGCA
CGCTCACAAGTAGGCAGAAAATTAGCCGCACTTGGTGGCTCACCTGAATATCGTGAAGGG
GTGGTGACTGACAACGGCAATGTGATTTTAGATGTACACAACTTCAGTATTTTAAATCCA
GTCGAAATTGAAAAAGAATTAAACAACGTTGCAGGTGTCGTCACTAATGGGATATTCGCG
TTACGTGGTGCAGATGTTGTGATCGTCGGGACGCCTGAGGGTGCCAAAGTTATTGACTAA
</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF06026</identifier>
            <name>Rib_5-P_isom_A</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>ribose-5-phosphate isomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pentose-phosphate shunt, non-oxidative branch</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001343</id>
      <name>Tryptophan--tRNA ligase</name>
      <organism>Geobacillus stearothermophilus</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00953" source="Swiss-Prot">
        <name>Tryptophan--tRNA ligase</name>
        <general-function>Tryptophan-trna ligase activity</general-function>
        <specific-function/>
        <gene-name>trpS</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.64</theoretical-pi>
        <molecular-weight>37192.385</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1422">Geobacillus stearothermophilus</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M14742</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>143784</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P00953</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SYW_GEOSE</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.1.1.2</synonym>
          <synonym>TrpRS</synonym>
          <synonym>Tryptophanyl-tRNA synthetase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010937|Tryptophan--tRNA ligase
MKTIFSGIQPSGVITIGNYIGALRQFVELQHEYNCYFCIVDQHAITVWQDPHELRQNIRR
LAAKYLAVGIDPTQATLFIQSEVPAHAQAAWMLQCIVYIGELERMTQFKEKSAGKEAVSA
GLLTYPPLMAADILLYNTDIVPVGEDQKQHIELTRDLAERFNKRYGELFTIPEARIPKVG
ARIMSLVDPTKKMSKSDPNPKAYITLLDDAKTIEKKIKSAVTDSEGTIRYDKEAKPGISN
LLNIYSTLSGQSIEELERQYEGKGYGVFKADLAQVVIETLRPIQERYHHWMESEELDRVL
DEGAEKANRVASEMVRKMEQAMGLGRRR</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0002666|987 bp
ATGAAAACCATTTTTTCCGGCATTCAGCCAAGCGGCGTCATCACCATTGGCAACTATATT
GGGGCGCTGCGGCAGTTTGTCGAGCTGCAGCATGAATACAACTGCTATTTTTGCATCGTT
GACCAACACGCCATTACCGTTTGGCAAGACCCACACGAACTGCGGCAAAACATCCGCCGC
CTCGCCGCAAAGTATTTGGCCGTCGGCATCGACCCGACGCAAGCGACGTTGTTCATCCAG
TCAGAAGTGCCGGCGCACGCTCAAGCCGCTTGGATGCTGCAGTGCATCGTTTATATCGGC
GAACTTGAGCGGATGACGCAATTTAAAGAAAAATCGGCCGGCAAAGAGGCGGTCAGCGCC
GGGCTGCTCACGTACCCGCCGCTGATGGCCGCTGACATTTTGCTTTATAACACCGACATC
GTCCCGGTCGGCGAAGACCAAAAGCAGCATATCGAATTGACGCGGGATCTGGCCGAGCGC
TTCAACAAACGGTATGGCGAGCTGTTTACGATCCCTGAGGCGCGCATTCCGAAAGTCGGC
GCCCGCATCATGTCGCTTGTCGACCCGACGAAAAAAATGAGCAAATCCGACCCCAACCCG
AAAGCGTACATCACACTGCTTGACGATGCGAAAACGATCGAGAAGAAGATCAAAAGCGCG
GTCACCGACTCGGAAGGAACGATTCGCTACGACAAAGAAGCGAAGCCAGGCATTTCGAAC
TTGCTCAATATTTATTCGACCCTATCCGGTCAATCGATCGAGGAGTTGGAGCGGCAATAC
GAAGGAAAAGGATACGGCGTCTTCAAAGCAGACCTCGCTCAAGTCGTCATCGAAACGCTT
CGACCGATTCAAGAGCGGTATCACCATTGGATGGAAAGCGAGGAGCTTGACCGCGTGTTG
GATGAAGGGGCGGAAAAAGCAAATCGGGTTGCATCGGAAATGGTGCGAAAAATGGAGCAA
GCCATGGGGCTCGGGCGGCGGCGGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00579</identifier>
            <name>tRNA-synt_1b</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>tryptophan-tRNA ligase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tryptophanyl-tRNA aminoacylation</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0002545</id>
      <name>GMP synthase [glutamine-hydrolyzing]</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P04079" source="Swiss-Prot">
        <name>GMP synthase [glutamine-hydrolyzing]</name>
        <general-function>Pyrophosphatase activity</general-function>
        <specific-function>Catalyzes the synthesis of GMP from XMP.</specific-function>
        <gene-name>guaA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.06</theoretical-pi>
        <molecular-weight>58678.78</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M10101</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P04079</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GUAA_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>6.3.5.2</synonym>
          <synonym>Glutamine amidotransferase</synonym>
          <synonym>GMP synthetase</synonym>
          <synonym>GMPS</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011815|GMP synthase [glutamine-hydrolyzing]
MTENIHKHRILILDFGSQYTQLVARRVRELGVYCELWAWDVTEAQIRDFNPSGIILSGGP
ESTTEENSPRAPQYVFEAGVPVFGVCYGMQTMAMQLGGHVEASNEREFGYAQVEVVNDSA
LVRGIEDALTADGKPLLDVWMSHGDKVTAIPSDFITVASTESCPFAIMANEEKRFYGVQF
HPEVTHTRQGMRMLERFVRDICQCEALWTPAKIIDDAVARIREQVGDDKVILGLSGGVDS
SVTAMLLHRAIGKNLTCVFVDNGLLRLNEAEQVLDMFGDHFGLNIVHVPAEDRFLSALAG
ENDPEAKRKIIGRVFVEVFDEEALKLEDVKWLAQGTIYPDVIESAASATGKAHVIKSHHN
VGGLPKEMKMGLVEPLKELFKDEVRKIGLELGLPYDMLYRHPFPGPGLGVRVLGEVKKEY
CDLLRRADAIFIEELRKADLYDKVSQAFTVFLPVRSVGVMGDGRKYDWVVSLRAVETIDF
MTAHWAHLPYDFLGRVSNRIINEVNGISRVVYDISGKPPATIEWE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011816|GMP synthase [glutamine-hydrolyzing] (guaA)
ATGACGGAAAACATTCATAAGCATCGCATCCTCATTCTGGACTTCGGTTCTCAGTACACT
CAACTGGTTGCGCGCCGCGTGCGTGAGCTGGGTGTTTACTGCGAACTGTGGGCGTGGGAT
GTGACAGAAGCACAAATTCGTGACTTCAATCCAAGCGGCATTATTCTTTCCGGCGGCCCG
GAAAGTACTACTGAAGAAAACAGTCCGCGTGCGCCGCAGTATGTCTTTGAAGCAGGCGTA
CCGGTATTCGGCGTTTGCTATGGCATGCAGACCATGGCAATGCAGTTGGGCGGTCACGTT
GAAGCCTCTAACGAACGTGAATTTGGCTACGCGCAGGTTGAAGTCGTAAACGACAGCGCA
CTGGTTCGCGGTATCGAAGATGCGCTGACCGCAGACGGTAAACCGCTGCTCGATGTCTGG
ATGAGCCACGGCGATAAAGTTACCGCTATTCCGTCCGACTTCATCACCGTAGCCAGCACC
GAAAGCTGCCCGTTTGCCATTATGGCTAACGAAGAAAAACGCTTCTATGGCGTACAGTTC
CACCCGGAAGTGACTCATACCCGCCAGGGTATGCGCATGCTGGAGCGTTTTGTGCGTGAT
ATCTGCCAGTGTGAAGCCCTGTGGACGCCAGCGAAAATTATCGACGATGCTGTAGCTCGC
ATCCGCGAGCAGGTAGGCGACGATAAAGTCATCCTCGGCCTCTCTGGTGGTGTGGATTCC
TCCGTAACCGCAATGCTGCTGCACCGCGCTATCGGTAAAAACCTGACTTGCGTATTCGTC
GACAACGGCCTGCTGCGCCTCAACGAAGCAGAGCAGGTTCTGGATATGTTTGGCGATCAC
TTTGGTCTTAACATTGTTCACGTACCGGCAGAAGATCGCTTCCTGTCAGCGCTGGCTGGC
GAAAACGATCCGGAAGCAAAACGTAAAATCATCGGTCGCGTTTTCGTTGAAGTATTCGAT
GAAGAAGCGCTGAAACTGGAAGACGTGAAGTGGCTGGCGCAGGGCACCATCTACCCTGAC
GTTATCGAATCTGCGGCGTCTGCAACCGGTAAAGCACACGTCATCAAATCTCACCACAAC
GTGGGCGGCCTGCCGAAAGAGATGAAGATGGGCCTGGTTGAACCGCTGAAAGAGCTGTTC
AAAGACGAAGTGCGTAAGATTGGTCTGGAGCTGGGCCTGCCGTACGACATGCTGTACCGT
CACCCGTTCCCGGGACCAGGCCTTGGCGTTCGTGTTCTGGGTGAAGTGAAGAAAGAGTAC
TGTGACCTGCTGCGCCGTGCTGACGCCATCTTCATTGAAGAACTGCGTAAAGCGGACCTG
TACGACAAAGTCAGCCAGGCGTTCACTGTGTTCCTGCCGGTACGTTCCGTTGGCGTAATG
GGCGATGGTCGTAAGTATGACTGGGTTGTCTCTCTGCGTGCTGTCGAAACCATCGACTTT
ATGACCGCACACTGGGCGCATCTGCCGTACGATTTCCTCGGTCGCGTTTCCAACCGCATT
ATCAATGAAGTGAACGGTATTTCCCGCGTGGTGTATGACATCAGCGGCAAGCCGCCAGCT
ACCATTGAGTGGGAATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00117</identifier>
            <name>GATase</name>
          </pfam>
          <pfam>
            <identifier>PF00958</identifier>
            <name>GMP_synt_C</name>
          </pfam>
          <pfam>
            <identifier>PF02540</identifier>
            <name>NAD_synthase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GMP synthase (glutamine-hydrolyzing) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>GMP synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyrophosphatase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glutamine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>GMP biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000747</id>
      <name>Aldose reductase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15121" source="Swiss-Prot">
        <name>Aldose reductase</name>
        <general-function>Glyceraldehyde oxidoreductase activity</general-function>
        <specific-function>Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.</specific-function>
        <gene-name>AKR1B1</gene-name>
        <locus>7q35</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.99</theoretical-pi>
        <molecular-weight>35853.125</molecular-weight>
        <chromosome-location>7</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:381</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>AKR1B1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>J04795</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>178487</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>2768</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P15121</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ALDR_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.1.1.21</synonym>
          <synonym>Aldehyde reductase</synonym>
          <synonym>Aldo-keto reductase family 1 member B1</synonym>
          <synonym>ALDR1</synonym>
          <synonym>AR</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016194|Aldose reductase
MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQ
EKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGK
EFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKP
AVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAK
HNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCA
LLSCTSHKDYPFHEEF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016195|Aldose reductase (AKR1B1)
ATGGCAAGCCGTCTCCTGCTCAACAACGGCGCCAAGATGCCCATCCTGGGGTTGGGTACC
TGGAAGTCCCCTCCAGGGCAGGTGACTGAGGCCGTGAAGGTGGCCATTGACGTCGGGTAC
CGCCACATCGACTGTGCCCATGTGTACCAGAATGAGAATGAGGTGGGGGTGGCCATTCAG
GAGAAGCTCAGGGAGCAGGTGGTGAAGCGTGAGGAGCTCTTCATCGTCAGCAAGCTGTGG
TGCACGTACCATGAGAAGGGCCTGGTGAAAGGAGCCTGCCAGAAGACACTCAGCGACCTG
AAGCTGGACTACCTGGACCTCTACCTTATTCACTGGCCGACTGGCTTTAAGCCTGGGAAG
GAATTTTTCCCATTGGATGAGTCGGGCAATGTGGTTCCCAGTGACACCAACATTCTGGAC
ACGTGGGCGGCCATGGAAGAGCTGGTGGATGAAGGGCTGGTGAAAGCTATTGGCATCTCC
AACTTCAACCATCTCCAGGTGGAGATGATCTTAAACAAACCTGGCTTGAAGTATAAGCCT
GCAGTTAACCAGATTGAGTGCCACCCATATCTCACTCAGGAGAAGTTAATCCAGTACTGC
CAGTCCAAAGGCATCGTGGTGACCGCCTACAGCCCCCTCGGCTCTCCTGACAGGCCCTGG
GCCAAGCCCGAGGACCCTTCTCTCCTGGAGGATCCCAGGATCAAGGCGATCGCAGCCAAG
CACAATAAAACTACAGCCCAGGTCCTGATCCGGTTCCCCATGCAGAGGAACTTGGTGGTG
ATCCCCAAGTCTGTGACACCAGAACGCATTGCTGAGAACTTTAAGGTCTTTGACTTTGAA
CTGAGCAGCCAGGATATGACCACCTTACTCAGCTACAACAGGAACTGGAGGGTCTGTGCC
TTGTTGAGCTGTACCTCCCACAAGGATTACCCCTTCCATGAAGAGTTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00248</identifier>
            <name>Aldo_ket_red</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cell projection cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mast cell granule</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>paranodal junction</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>perinuclear region of cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Schmidt-Lanterman incisure</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Schwann cell microvillus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>alditol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>aldo-keto reductase (NADP) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>electron carrier activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glyceraldehyde oxidoreductase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>C21-steroid hormone biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to hydrogen peroxide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to methylglyoxal</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to peptide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>daunorubicin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>doxorubicin metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fructose biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fructose metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>inner medullary collecting duct development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>maternal process involved in female pregnancy</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>naphthalene metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>norepinephrine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of JAK-STAT cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of smooth muscle cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to thyroid hormone</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to water deprivation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sorbitol biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>steroid metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>stress-activated protein kinase signaling cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tissue homeostasis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004443</id>
      <name>Inosine triphosphate pyrophosphatase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BY32" source="Swiss-Prot">
        <name>Inosine triphosphate pyrophosphatase</name>
        <general-function>Xtp diphosphatase activity</general-function>
        <specific-function>Pyrophosphatase that hydrolyzes the non-canonical purine nucleotides inosine triphosphate (ITP), deoxyinosine triphosphate (dITP) as well as 2'-deoxy-N-6-hydroxylaminopurine triposphate (dHAPTP) and xanthosine 5'-triphosphate (XTP) to their respective monophosphate derivatives. The enzyme does not distinguish between the deoxy- and ribose forms. Probably excludes non-canonical purines from RNA and DNA precursor pools, thus preventing their incorporation into RNA and DNA and avoiding chromosomal lesions.</specific-function>
        <gene-name>ITPA</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>21445.495</molecular-weight>
        <chromosome-location>20</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:6176</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9BY32</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ITPA_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.6.1.19</synonym>
          <synonym>C20orf37</synonym>
          <synonym>ITPase</synonym>
          <synonym>Non-canonical purine NTP pyrophosphatase</synonym>
          <synonym>Non-standard purine NTP pyrophosphatase</synonym>
          <synonym>NTPase</synonym>
          <synonym>Nucleoside-triphosphate diphosphatase</synonym>
          <synonym>Nucleoside-triphosphate pyrophosphatase</synonym>
          <synonym>Putative oncogene protein hlc14-06-p</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009364|Inosine triphosphate pyrophosphatase
MAASLVGKKIVFVTGNAKKLEEVVQILGDKFPCTLVAQKIDLPEYQGEPDEISIQKCQEA
VRQVQGPVLVEDTCLCFNALGGLPGPYIKWFLEKLKPEGLHQLLAGFEDKSAYALCTFAL
STGDPSQPVRLFRGRTSGRIVAPRGCQDFGWDPCFQPDGYEQTYAEMPKAEKNAVSHRFR
ALLELQEYFGSLAA</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0013113|Inosine triphosphate pyrophosphatase (ITPA)
ATGGCGGCCTCATTGGTGGGGAAGAAGATCGTGTTTGTAACGGGGAACGCCAAGAAGCTG
GAGGAGGTACAGGGGCCCGTGCTGGTTGAGGACACTTGTCTGTGCTTCAATGCCCTTGGA
GGGCTCCCCGGCCCCTACATAAAGTGGTTTCTGGAGAAGTTAAAGCCTGAAGGTCTCCAC
CAGCTCCTGGCCGGGTTCGAGGACAAGTCAGCCTATGCGCTCTGCACGTTTGCACTCAGC
ACCGGGGACCCAAGCCAGCCCGTGCGCCTGTTCAGGGGCCGGACCTCGGGCCGGATCGTG
GCACCCAGAGGCTGCCAGGACTTTGGCTGGGACCCCTGCTTTCAGCCTGATGGATATGAG
CAGACGTACGCAGAGATGCCTAAGGCGGAGAAGAACGCTGTCTCCCATCGCTTCCGGGCC
CTGCTGGAGCTGCAGGAGTACTTTGGCAGTTTGGCAGCTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01725</identifier>
            <name>Ham1p_like</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>dITP diphosphatase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ITP diphosphatase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleotide binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>XTP diphosphatase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chromosome organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>deoxyribonucleoside triphosphate catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ITP catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleobase-containing small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0004459</id>
      <name>Citrate synthase, mitochondrial</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75390" source="Swiss-Prot">
        <name>Citrate synthase, mitochondrial</name>
        <general-function>Poly(a) rna binding</general-function>
        <specific-function/>
        <gene-name>CS</gene-name>
        <locus/>
        <cellular-location>Mitochondrion matrix</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi/>
        <molecular-weight>51712.025</molecular-weight>
        <chromosome-location>12</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:2422</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O75390</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CISY_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.3.3.1</synonym>
          <synonym>Citrate (Si)-synthase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009380|Citrate synthase, mitochondrial
MALLTAAARLLGTKNASCLVLAARHASASSTNLKDILADLIPKEQARIKTFRQQHGKTVV
GQITVDMMYGGMRGMKGLVYETSVLDPDEGIRFRGFSIPECQKLLPKAKGGEEPLPEGLF
WLLVTGHIPTEEQVSWLSKEWAKRAALPSHVVTMLDNFPTNLHPMSQLSAAVTALNSESN
FARAYAQGISRTKYWELIYEDSMDLIAKLPCVAAKIYRNLYREGSGIGAIDSNLDWSHNF
TNMLGYTDHQFTELTRLYLTIHSDHEGGNVSAHTSHLVGSALSDPYLSFAAAMNGLAGPL
HGLANQEVLVWLTQLQKEVGKDVSDEKLRDYIWNTLNSGRVVPGYGHAVLRKTDPRYTCQ
REFALKHLPNDPMFKLVAQLYKIVPNVLLEQGKAKNPWPNVDAHSGVLLQYYGMTEMNYY
TVLFGVSRALGVLAQLIWSRALGFPLERPKSMSTEGLMKFVDSKSG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0013122|Citrate synthase, mitochondrial (CS)
ATGGCTTTACTTACTGCGGCCGCCCGGCTCTTGGGAACCAAGAATGCATCTTGTCTTGTT
CTTGCAGCCCGGCATGCCAGTGCTTCCTCCACGAATTTGAAAGACATATTGGCTGACCTG
ATACCTAAGGAGCAGGCCAGAATTAAGACTTTCAGGCAGCAACATGGCAAGACGGTGGTG
GGCCAAATCACTGTGGACATGATGTATGGTGGCATGAGAGGCATGAAGGGATTGGTCTAT
GAAACATCAGTTCTTGATCCTGATGAGGGCATCCGTTTCCGAGGCTTTAGTATCCCTGAA
TGCCAGAAACTGCTACCCAAGGCTAAGGGTGGGGAAGAACCCCTGCCTGAGGGCTTATTT
TGGCTGCTGGTAACTGGACATATCCCAACAGAGGAACAGGTATCTTGGCTCTCAAAAGAG
TGGGCAAAGAGGGCAGCTCTGCCTTCCCATGTGGTCACCATGCTGGACAACTTTCCCACC
AATCTACACCCCATGTCTCAGCTCAGTGCAGCTGTTACAGCCCTCAACAGTGAAAGTAAC
TTTGCCCGAGCATATGCACAGGGTATCAGCCGAACCAAGTACTGGGAGTTGATTTATGAA
GACTCTATGGATCTAATCGCAAAGCTACCTTGTGTTGCAGCAAAGATCTACCGAAATCTC
TACAGAGAAGGCAGCGGTATTGGGGCCATTGACTCTAACCTGGACTGGTCTCACAATTTC
ACCAACATGTTAGGCTATACTGATCATCAGTTCACTGAGCTCACGCGCCTGTACCTCACC
ATCCACAGTGACCATGAGGGTGGCAATGTAAGTGCCCATACCAGCCATTTGGTGGGCAGT
GCCCTTTCCGACCCTTACCTGTCCTTTGCAGCAGCCATGAACGGGCTGGCAGGGCCTCTC
CATGGACTGGCAAATCAGGAAGTGCTTGTCTGGCTAACACAGCTGCAGAAGGAAGTTGGC
AAAGATGTGTCAGATGAGAAGTTACGAGACTACATCTGGAACACACTCAACTCAGGACGG
GTTGTTCCAGGCTATGGCCATGCAGTACTAAGGAAGACTGATCCGCGATATACCTGTCAG
CGAGAGTTTGCTCTGAAACACCTGCCTAATGACCCCATGTTTAAGTTGGTTGCTCAGCTG
TACAAGATTGTGCCCAATGTCCTCTTAGAGCAGGGTAAAGCCAAGAATCCTTGGCCCAAT
GTAGATGCTCACAGTGGGGTGCTGCTCCAGTATTATGGCATGACGGAGATGAATTACTAC
ACGGTCCTGTTTGGGGTGTCACGAGCATTGGGTGTACTGGCACAGCTCATCTGGAGCCGA
GCCTTAGGCTTCCCTCTAGAAAGGCCCAAGTCCATGAGCACAGAGGGTCTGATGAAGTTT
GTGGACTCTAAGTCAGGGTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00285</identifier>
            <name>Citrate_synt</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial matrix</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>citrate (Si)-synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>poly(A) RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003269</id>
      <name>Lysozyme</name>
      <organism>Enterobacteria phage P1</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q37875" source="Swiss-Prot">
        <name>Lysozyme</name>
        <general-function>Lysozyme activity</general-function>
        <specific-function>Essential for lysis of bacterial cell wall, by showing cell wall hydrolyzing activity.</specific-function>
        <gene-name>17</gene-name>
        <locus/>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>9.15</theoretical-pi>
        <molecular-weight>20256.17</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="10678">Enterobacteria phage P1</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X87673</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q37875</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>LYS_BPP1</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.2.1.17</synonym>
          <synonym>Endolysin</synonym>
          <synonym>lysa</synonym>
          <synonym>Lysis protein</synonym>
          <synonym>lyz</synonym>
          <synonym>Muramidase</synonym>
          <synonym>Protein gp17</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012280|Lysozyme
MKGKTAAGGGAICAIAVMITIVMGNGNVRTNQAGLELIGNAEGCRRDPYMCPAGVWTDGI
GNTHGVTPGVRKTDQQIAADWEKNILIAERCINQHFRGKDMPDNAFSAMTSAAFNMGCNS
LRTYYSKARGMRVETSIHKWAQKGEWVNMCNHLPDFVNSNGVPLRGLKIRREKERQLCLT
GLVNE</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012281|Lysozyme (17)
ATGAAGGGAAAAACAGCCGCAGGAGGCGGTGCAATTTGCGCTATCGCGGTGATGATTACC
ATCGTAATGGGTAATGGCAATGTGCGAACCAACCAGGCGGGGCTTGAGCTGATTGGTAAC
GCTGAAGGTTGCCGACGTGATCCATACATGTGCCCGGCGGGGGTATGGACTGACGGGATC
GGTAATACACACGGGGTAACGCCGGGTGTGCGAAAAACCGACCAGCAAATCGCCGCTGAT
TGGGAAAAGAATATCCTGATCGCTGAACGCTGTATTAATCAGCACTTCCGGGGCAAAGAC
ATGCCCGATAATGCCTTCAGCGCAATGACAAGCGCGGCATTCAATATGGGATGCAATAGC
TTACGGACCTACTACAGCAAAGCGCGAGGCATGCGAGTCGAAACGTCCATCCACAAGTGG
GCGCAGAAAGGGGAATGGGTGAATATGTGTAACCATCTCCCTGATTTCGTGAACAGTAAC
GGCGTGCCCCTGCGAGGTTTAAAGATTCGCCGTGAAAAAGAACGCCAGCTTTGCCTGACG
GGACTGGTCAATGAATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00959</identifier>
            <name>Phage_lysozyme</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>lysozyme activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell wall macromolecule catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cytolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>defense response to bacterium</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>peptidoglycan catabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001541</id>
      <name>Heparan sulfate glucosamine 3-O-sulfotransferase 3A1</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y663" source="Swiss-Prot">
        <name>Heparan sulfate glucosamine 3-O-sulfotransferase 3A1</name>
        <general-function>Sulfotransferase activity</general-function>
        <specific-function>Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) to catalyze the transfer of a sulfo group to an N-unsubstituted glucosamine linked to a 2-O-sulfo iduronic acid unit on heparan sulfate. Catalyzes the O-sulfation of glucosamine in IdoUA2S-GlcNS and also in IdoUA2S-GlcNH2. The substrate-specific O-sulfation generates an enzyme-modified heparan sulfate which acts as a binding receptor to Herpes simplex virus-1 (HSV-1) and permits its entry. Unlike 3-OST-1, does not convert non-anticoagulant heparan sulfate to anticoagulant heparan sulfate.</specific-function>
        <gene-name>HS3ST3A1</gene-name>
        <locus>17p12-p11.2</locus>
        <cellular-location>Golgi apparatus membrane</cellular-location>
        <transmembrane-regions>25-43</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>9.98</theoretical-pi>
        <molecular-weight>44899.155</molecular-weight>
        <chromosome-location>17</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:5196</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>HS3ST3A1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF105376</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>4835723</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9Y663</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>HS3SA_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.8.2.30</synonym>
          <synonym>3-OST-3A</synonym>
          <synonym>3OST3A1</synonym>
          <synonym>h3-OST-3A</synonym>
          <synonym>Heparan sulfate 3-O-sulfotransferase 3A1</synonym>
          <synonym>Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1</synonym>
          <synonym>HS3ST3A</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011092|Heparan sulfate glucosamine 3-O-sulfotransferase 3A1
MAPPGPASALSTSAEPLSRSIFRKFLLMLCSLLTSLYVFYCLAERCQTLSGPVVGLSGGG
EEAGAPGGGVLAGGPRELAVWPAAAQRKRLLQLPQWRRRRPPAPRDDGEEAAWEEESPGL
SGGPGGSGAGSTVAEAPPGTLALLLDEGSKQLPQAIIIGVKKGGTRALLEFLRVHPDVRA
VGAEPHFFDRSYDKGLAWYRDLMPRTLDGQITMEKTPSYFVTREAPARISAMSKDTKLIV
VVRDPVTRAISDYTQTLSKRPDIPTFESLTFKNRTAGLIDTSWSAIQIGIYAKHLEHWLR
HFPIRQMLFVSGERLISDPAGELGRVQDFLGLKRIITDKHFYFNKTKGFPCLKKAEGSSR
PHCLGKTKGRTHPEIDREVVRRLREFYRPFNLKFYQMTGHDFGWDG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011093|Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (HS3ST3A1)
ATGGCCCCTCCGGGCCCGGCCAGTGCCCTCTCCACCTCGGCCGAGCCGCTGTCCCGCAGC
ATCTTCCGGAAGTTCTTGCTGATGCTCTGCTCCCTGCTCACGTCCCTTTACGTCTTCTAC
TGCCTGGCCGAGCGCTGCCAGACCCTGTCCGGCCCCGTCGTGGGGCTGTCCGGCGGCGGC
GAGGAGGCGGGGGCCCCTGGTGGCGGCGTCCTGGCCGGAGGCCCGAGGGAGCTGGCGGTG
TGGCCGGCGGCGGCACAGAGAAAGCGCCTCCTGCAACTGCCGCAGTGGCGGAGGCGCCGG
CCGCCCGCGCCCCGCGACGACGGCGAGGAGGCGGCCTGGGAAGAAGAGTCCCCTGGCCTG
TCAGGGGGTCCGGGCGGCTCCGGGGCCGGAAGCACCGTGGCCGAGGCCCCGCCGGGGACC
CTGGCGCTGCTCCTGGACGAAGGCAGCAAGCAGCTGCCGCAGGCCATCATCATCGGAGTG
AAGAAGGGCGGCACGCGGGCGCTGCTGGAGTTCCTGCGCGTGCACCCCGACGTGCGCGCC
GTGGGCGCCGAGCCCCACTTCTTCGACCGCAGCTACGACAAGGGCCTCGCCTGGTACCGG
GACCTGATGCCCAGAACCCTGGACGGGCAGATCACCATGGAGAAGACGCCCAGTTACTTC
GTCACGCGGGAGGCCCCCGCGCGCATCTCGGCCATGTCCAAGGACACCAAGCTCATCGTG
GTGGTGCGGGACCCGGTGACCAGGGCCATCTCGGACTACACGCAGACGCTGTCCAAGCGG
CCCGACATCCCCACCTTCGAGAGCTTGACGTTCAAAAACAGGACAGCGGGCCTCATCGAC
ACGTCGTGGAGCGCCATCCAGATCGGCATCTACGCCAAGCACCTGGAGCACTGGCTGCGC
CACTTCCCCATCCGCCAGATGCTCTTCGTGAGCGGCGAGCGGCTCATCAGCGACCCGGCC
GGGGAGCTGGGCCGCGTGCAAGACTTCCTGGGCCTCAAGAGGATCATCACGGACAAGCAC
TTCTACTTCAACAAGACCAAGGGCTTCCCCTGCCTGAAGAAGGCGGAGGGCAGCAGCCGG
CCCCATTGCCTGGGCAAGACCAAGGGCAGGACCCATCCTGAGATCGACCGCGAGGTGGTG
CGCAGGCTGCGCGAGTTCTACCGGCCTTTCAACCTCAAGTTCTACCAGATGACCGGGCAC
GACTTTGGCTGGGATGGATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00685</identifier>
            <name>Sulfotransfer_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>Golgi membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>sulfotransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>carbohydrate metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycosaminoglycan biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycosaminoglycan metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003270</id>
      <name>Glycerol uptake operon antiterminator regulatory protein</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9X1F0" source="TrEMBL">
        <name>Glycerol uptake operon antiterminator regulatory protein</name>
        <general-function/>
        <specific-function/>
        <gene-name/>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.94</theoretical-pi>
        <molecular-weight>19296.645</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9X1F0</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q9X1F0_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Glycerol uptake operon antiterminator-related protein</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012282|Glycerol uptake operon antiterminator regulatory protein
MFKGIIAALWDMDSIGEIEPDVVFLLKSDILNLKFHLKILKDRGKTVFVDMDFVNGLGEG
EEAILFVKKAGADGIITIKPKNYVVAKKNGIPAVLRFFALDSKAVERGIEQIETLGVDVV
EVLPGAVAPKVARKIPGRTVIAAGLVETEEEAREILKHVSAISTSSRILWKMKFLP</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012283|Glycerol uptake operon antiterminator regulatory protein
ATGTTCAAGGGGATAATAGCTGCGCTGTGGGATATGGATTCCATAGGAGAAATAGAACCC
GATGTGGTCTTCCTTTTGAAGAGCGACATTTTGAATCTGAAGTTTCATCTGAAGATTCTC
AAAGACAGGGGAAAAACCGTTTTTGTTGATATGGATTTTGTGAACGGACTAGGAGAGGGA
GAAGAAGCGATTCTTTTTGTGAAAAAGGCCGGTGCCGATGGTATCATCACGATAAAGCCA
AAAAATTACGTCGTTGCAAAGAAGAACGGAATTCCCGCTGTCCTCAGATTCTTTGCTCTC
GACTCGAAAGCGGTCGAAAGAGGTATCGAACAGATAGAAACGCTCGGGGTAGATGTGGTG
GAAGTCCTTCCAGGTGCGGTGGCTCCGAAAGTGGCCAGAAAAATACCCGGCAGGACAGTG
ATCGCCGCCGGGCTCGTTGAAACAGAGGAAGAAGCTCGCGAAATCCTCAAACACGTTTCA
GCGATCTCTACAAGTTCAAGAATCCTCTGGAAGATGAAGTTTCTACCATGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF04309</identifier>
            <name>G3P_antiterm</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to biotic stimulus</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000182</id>
      <name>cGMP-specific 3',5'-cyclic phosphodiesterase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O76074" source="Swiss-Prot">
        <name>cGMP-specific 3',5'-cyclic phosphodiesterase</name>
        <general-function>Metal ion binding</general-function>
        <specific-function>Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:9714779, PubMed:15489334). Specifically regulates nitric-oxide-generated cGMP (PubMed:15489334).</specific-function>
        <gene-name>PDE5A</gene-name>
        <locus>4q25-q27</locus>
        <cellular-location>Cytoplasmic</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.0</theoretical-pi>
        <molecular-weight>99984.14</molecular-weight>
        <chromosome-location>4</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:8784</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PDE5A</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF043731</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>3420185</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>1304</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O76074</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PDE5A_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.4.35</synonym>
          <synonym>CGB-PDE</synonym>
          <synonym>cGMP-binding cGMP-specific phosphodiesterase</synonym>
          <synonym>PDE5</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036966|cGMP-specific 3',5'-cyclic phosphodiesterase
MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAE
RVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEG
TVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLI
SADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPL
NIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDE
KDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIIS
FMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTME
PLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGK
VKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETREL
QSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWIL
SVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGV
NNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAI
LATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAE
LVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCF
PLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0009989|cGMP-specific 3',5'-cyclic phosphodiesterase (PDE5A)
ATGGAGCGGGCCGGCCCCAGCTTCGGGCAGCAGCGACAGCAGCAGCAGCCCCAGCAGCAG
AAGCAGCAGCAGAGGGATCAGGACTCGGTCGAAGCATGGCTGGACGATCACTGGGACTTT
ACCTTCTCATACTTTGTTAGAAAAGCCACCAGAGAAATGGTCAATGCATGGTTTGCTGAG
AGAGTTCACACCATCCCTGTGTGCAAGGAAGGTATCAGAGGCCACACCGAATCTTGCTCT
TGTCCCTTGCAGCAGAGTCCTCGTGCAGATAACAGTGCCCCTGGAACACCAACCAGGAAA
ATCTCTGCCTCTGAATTTGACCGGCCTCTTAGACCCATTGTTGTCAAGGATTCTGAGGGA
ACTGTGAGCTTCCTCTCTGACTCAGAAAAGAAGGAACAGATGCCTCTAACCCCTCCAAGG
TTTGATCATGATGAAGGGGACCAGTGCTCAAGACTCTTGGAATTAGTGAAGGATATTTCT
AGTCATTTGGATGTCACAGCCTTATGTCACAAAATTTTCTTGCATATCCATGGACTGATA
TCTGCTGACCGCTATTCCCTGTTCCTTGTCTGTGAAGACAGCTCCAATGACAAGTTTCTT
ATCAGCCGCCTCTTTGATGTTGCTGAAGGTTCAACACTGGAAGAAGTTTCAAATAACTGT
ATCCGCTTAGAATGGAACAAAGGCATTGTGGGACATGTGGCAGCGCTTGGTGAGCCCTTG
AACATCAAAGATGCATATGAGGATCCTCGGTTCAATGCAGAAGTTGACCAAATTACAGGC
TACAAGACACAAAGCATTCTTTGTATGCCAATTAAGAATCATAGGGAAGAGGTTGTTGGT
GTAGCCCAGGCCATCAACAAGAAATCAGGAAACGGTGGGACATTTACTGAAAAAGATGAA
AAGGACTTTGCTGCTTATTTGGCATTTTGTGGTATTGTTCTTCATAATGCTCAGCTCTAT
GAGACTTCACTGCTGGAGAACAAGAGAAATCAGGTGCTGCTTGACCTTGCTAGTTTAATT
TTTGAAGAACAACAATCATTAGAAGTAATTTTGAAGAAAATAGCTGCCACTATTATCTCT
TTCATGCAAGTGCAGAAATGCACCATTTTCATAGTGGATGAAGATTGCTCCGATTCTTTT
TCTAGTGTGTTTCACATGGAGTGTGAGGAATTAGAAAAATCATCTGATACATTAACAAGG
GAACATGATGCAAACAAAATCAATTACATGTATGCTCAGTATGTCAAAAATACTATGGAA
CCACTTAATATCCCAGATGTCAGTAAGGATAAAAGATTTCCCTGGACAACTGAAAATACA
GGAAATGTAAACCAGCAGTGCATTAGAAGTTTGCTTTGTACACCTATAAAAAATGGAAAG
AAGAATAAAGTTATAGGGGTTTGCCAACTTGTTAATAAGATGGAGGAGAATACTGGCAAG
GTTAAGCCTTTCAACCGAAATGACGAACAGTTTCTGGAAGCTTTTGTCATCTTTTGTGGC
TTGGGGATCCAGAACACGCAGATGTATGAAGCAGTGGAGAGAGCCATGGCCAAGCAAATG
GTCACATTGGAGGTTCTGTCGTATCATGCTTCAGCAGCAGAGGAAGAAACAAGAGAGCTA
CAGTCGTTAGCGGCTGCTGTGGTGCCATCTGCCCAGACCCTTAAAATTACTGACTTTAGC
TTCAGTGACTTTGAGCTGTCTGATCTGGAAACAGCACTGTGTACAATTCGGATGTTTACT
GACCTCAACCTTGTGCAGAACTTCCAGATGAAACATGAGGTTCTTTGCAGATGGATTTTA
AGTGTTAAGAAGAATTATCGGAAGAATGTTGCCTATCATAATTGGAGACATGCCTTTAAT
ACAGCTCAGTGCATGTTTGCTGCTCTAAAAGCAGGCAAAATTCAGAACAAGCTGACTGAC
CTGGAGATACTTGCATTGCTGATTGCTGCACTAAGCCACGATTTGGATCACCGTGGTGTG
AATAACTCTTACATACAGCGAAGTGAACATCCACTTGCCCAGCTTTACTGCCATTCAATC
ATGGAACACCATCATTTTGACCAGTGCCTGATGATTCTTAATAGTCCAGGCAATCAGATT
CTCAGTGGCCTCTCCATTGAAGAATATAAGACCACGTTGAAAATAATCAAGCAAGCTATT
TTAGCTACAGACCTAGCACTGTACATTAAGAGGCGAGGAGAATTTTTTGAACTTATAAGA
AAAAATCAATTCAATTTGGAAGATCCTCATCAAAAGGAGTTGTTTTTGGCAATGCTGATG
ACAGCTTGTGATCTTTCTGCAATTACAAAACCCTGGCCTATTCAACAACGGATAGCAGAA
CTTGTAGCAACTGAATTTTTTGATCAAGGAGACAGAGAGAGAAAAGAACTCAACATAGAA
CCCACTGATCTAATGAACAGGGAGAAGAAAAACAAAATCCCAAGTATGCAAGTTGGGTTC
ATAGATGCCATCTGCTTGCAACTGTATGAGGCCCTGACCCACGTGTCAGAGGACTGTTTC
CCTTTGCTAGATGGCTGCAGAAAGAACAGGCAGAAATGGCAGGCCCTTGCAGAACAGCAG
GAGAAGATGCTGATTAATGGGGAAAGCGGCCAGGCCAAGCGGAACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01590</identifier>
            <name>GAF</name>
          </pfam>
          <pfam>
            <identifier>PF00233</identifier>
            <name>PDEase_I</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>3',5'-cyclic-GMP phosphodiesterase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>3',5'-cyclic-nucleotide phosphodiesterase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cGMP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>metal ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cGMP catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cardiac muscle contraction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of T cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cardiac muscle hypertrophy</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of MAP kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of oocyte development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of cGMP metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>relaxation of cardiac muscle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003271</id>
      <name>3-carboxy-cis,cis-muconate cycloisomerase</name>
      <organism>Pseudomonas putida</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P32427" source="Swiss-Prot">
        <name>3-carboxy-cis,cis-muconate cycloisomerase</name>
        <general-function>3-carboxy-cis,cis-muconate cycloisomerase activity</general-function>
        <specific-function>Catalyzes an anti cycloisomerization.</specific-function>
        <gene-name>pcaB</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.93</theoretical-pi>
        <molecular-weight>44675.755</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="303">Pseudomonas putida</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>L17082</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P32427</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PCAB_PSEPU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3-carboxymuconate lactonizing enzyme</synonym>
          <synonym>5.5.1.2</synonym>
          <synonym>CMLE</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006379|3-carboxy-cis,cis-muconate cycloisomerase
MTNQLFDAYFTAPAMREIFSDRGRLQGMLDFEAALARAEAAAGLVPHSAVAAIEAACKAE
RYDVGALANAIATAGNSAIPLVKALGKVIASGVPEAERYVHLGATSQDAMDTGLVLQLRD
ALDLIEADLGKLADTLSQQALKHADTPMVGRTWLQHATPVTLGMKLAGVLGALTRHRQRL
QELGPPCWCCSSGGASGSLAALGSKAMPVAEALAEQLKLSLPEQPWHTQRDRLVEFASVL
GLVAGSLGKFGRDVSLLMQTEAGEVFEPSAPGKGGSSTMPHKRNPVGAAVLIGAATRVPG
LVSTLFAAMPQEHERSLGLWHAEWETLPDICCLVSGALRQAQVIAEGIEVDAARMRRNLD
LTQGLVLAEAVSIVLARTLGRDRAHHLLEQCCQRAVAEQRHLRAVLGDDPQVSAELSAEE
LD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0006378|1224 bp
ATGACCAACCAACTGTTCGACGCCTACTTCACCGCGCCGGCCATGCGCGAGATTTTCTCC
GACCGTGGCCGCTTGCAGGGCATGCTCGATTTCGAAGCCGCGCTGGCCCGTGCCGAAGCT
GCTGCGGGGCTGGTCCCGCACAGCGCCGTGGCCGCCATCGAGGCGGCATGCAAGGCCGAG
CGCTATGACGTGGGGGCGCTGGCCAATGCCATCGCAACCGCTGGCAACTCGGCAATCCCG
CTGGTGAAGGCGTTGGGCAAGGTGATTGCCAGTGGCGTGCCCGAGGCCGAGCGCTATGTG
CACTTGGGCGCCACCAGCCAGGACGCGATGGACACCGGTCTGGTGTTGCAGTTGCGCGAT
GCCCTCGACCTGATCGAAGCGGACCTGGGCAAACTGGCCGATACCCTGTCGCAGCAGGCA
TTGAAGCACGCCGATACGCCAATGGTGGGCCGCACCTGGCTGCAACACGCTACCCCGGTG
ACCCTGGGCATGAAACTGGCTGGCGTGCTGGGGGCATTGACCCGCCACCGTCAGCGCCTG
CAAGAGCTCGGCCCGCCCTGTTGGTGCTGCAGTTCCGGCGGCGCCTCGGGCAGCCTGGCC
GCTCTGGGCAGCAAGGCGATGCCGGTGGCCGAGGCCCTGGCCGAGCAACTGAAGCTGAGC
CTGCCCGAGCAACCCTGGCACACCCAGCGTGATCGCCTGGTGGAGTTTGCCTCGGTGCTG
GGCCTTGTGGCCGGCAGCCTGGGCAAGTTCGGCCGCGATGTCAGCCTGCTGATGCAAACC
GAGGCGGGGGAGGTGTTCGAGCCTTCTGCACCAGGCAAGGGCGGCTCCTCGACCATGCCA
CACAAGCGCAACCCGGTGGGCGCTGCGGTGCTGATCGGTGCCGCGACTCGCGTGCCGGGG
CTGGTATCGACGCTGTTCGCCGCCATGCCCCAGGAGCACGAGCGCAGCCTGGGCCTGTGG
CATGCCGAATGGGAAACCCTCCCGGACATCTGCTGCCTGGTCTCCGGCGCGCTGCGCCAG
GCCCAGGTCATTGCCGAGGGCATTGAAGTAGACGCAGCGCGCATGCGCCGTAACCTCGAC
CTGACCCAAGGGCTGGTGCTGGCAGAAGCGGTGAGTATCGTCCTGGCCCGAACGCCTGGG
CCGCGACCGTGCCCACCACTTGCTGGAGCAATGCTGCCAGCGAGCCGTGGCCGAACAGCG
GCACCTGCGTGCGGTGCTGGGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00206</identifier>
            <name>Lyase_1</name>
          </pfam>
          <pfam>
            <identifier>PF10397</identifier>
            <name>ADSL_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>3-carboxy-cis,cis-muconate cycloisomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>3,4-dihydroxybenzoate catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>beta-ketoadipate pathway</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000838</id>
      <name>Proto-oncogene tyrosine-protein kinase Src</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P12931" source="Swiss-Prot">
        <name>Proto-oncogene tyrosine-protein kinase Src</name>
        <general-function>Sh3/sh2 adaptor activity</general-function>
        <specific-function>Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1. Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation. Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of ADRBK1, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376'. Phosphorylates BCAR1 at 'Tyr-128'. Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity. Required for podosome formation (By similarity).</specific-function>
        <gene-name>SRC</gene-name>
        <locus>20q12-q13</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.47</theoretical-pi>
        <molecular-weight>59834.295</molecular-weight>
        <chromosome-location>20</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:11283</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SRC</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AL133293</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>10635153</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>2206</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P12931</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SRC_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.10.2</synonym>
          <synonym>p60-Src</synonym>
          <synonym>pp60c-src</synonym>
          <synonym>Proto-oncogene c-Src</synonym>
          <synonym>SRC1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037090|Proto-oncogene tyrosine-protein kinase Src
MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAE
PKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGD
WWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRES
ETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGL
CHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL
KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY
LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT
ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER
GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021959|Proto-oncogene tyrosine-protein kinase Src (SRC)
ATGGGTAGCAACAAGAGCAAGCCCAAGGATGCCAGCCAGCGGCGCCGCAGCCTGGAGCCC
GCCGAGAACGTGCACGGCGCTGGCGGGGGCGCTTTCCCCGCCTCGCAGACCCCCAGCAAG
CCAGCCTCGGCCGACGGCCACCGCGGCCCCAGCGCGGCCTTCGCCCCCGCGGCCGCCGAG
CCCAAGCTGTTCGGAGGCTTCAACTCCTCGGACACCGTCACCTCCCCGCAGAGGGCGGGC
CCGCTGGCCGGTGGAGTGACCACCTTTGTGGCCCTCTATGACTATGAGTCTAGGACGGAG
ACAGACCTGTCCTTCAAGAAAGGCGAGCGGCTCCAGATTGTCAACAACACAGAGGGAGAC
TGGTGGCTGGCCCACTCGCTCAGCACAGGACAGACAGGCTACATCCCCAGCAACTACGTG
GCGCCCTCCGACTCCATCCAGGCTGAGGAGTGGTATTTTGGCAAGATCACCAGACGGGAG
TCAGAGCGGTTACTGCTCAATGCAGAGAACCCGAGAGGGACCTTCCTCGTGCGAGAAAGT
GAGACCACGAAAGGTGCCTACTGCCTCTCAGTGTCTGACTTCGACAACGCCAAGGGCCTC
AACGTGAAGCACTACAAGATCCGCAAGCTGGACAGCGGCGGCTTCTACATCACCTCCCGC
ACCCAGTTCAACAGCCTGCAGCAGCTGGTGGCCTACTACTCCAAACACGCCGATGGCCTG
TGCCACCGCCTCACCACCGTGTGCCCCACGTCCAAGCCGCAGACTCAGGGCCTGGCCAAG
GATGCCTGGGAGATCCCTCGGGAGTCGCTGCGGCTGGAGGTCAAGCTGGGCCAGGGCTGC
TTTGGCGAGGTGTGGATGGGGACCTGGAACGGTACCACCAGGGTGGCCATCAAAACCCTG
AAGCCTGGCACGATGTCTCCAGAGGCCTTCCTGCAGGAGGCCCAGGTCATGAAGAAGCTG
AGGCATGAGAAGCTGGTGCAGTTGTATGCTGTGGTTTCAGAGGAGCCCATTTACATCGTC
ACGGAGTACATGAGCAAGGGGAGTTTGCTGGACTTTCTCAAGGGGGAGACAGGCAAGTAC
CTGCGGCTGCCTCAGCTGGTGGACATGGCTGCTCAGATCGCCTCAGGCATGGCGTACGTG
GAGCGGATGAACTACGTCCACCGGGACCTTCGTGCAGCCAACATCCTGGTGGGAGAGAAC
CTGGTGTGCAAAGTGGCCGACTTTGGGCTGGCTCGGCTCATTGAAGACAATGAGTACACG
GCGCGGCAAGGTGCCAAATTCCCCATCAAGTGGACGGCTCCAGAAGCTGCCCTCTATGGC
CGCTTCACCATCAAGTCGGACGTGTGGTCCTTCGGGATCCTGCTGACTGAGCTCACCACA
AAGGGACGGGTGCCCTACCCTGGGATGGTGAACCGCGAGGTGCTGGACCAGGTGGAGCGG
GGCTACCGGATGCCCTGCCCGCCGGAGTGTCCCGAGTCCCTGCACGACCTCATGTGCCAG
TGCTGGCGGAAGGAGCCTGAGGAGCGGCCCACCTTCGAGTACCTGCAGGCCTTCCTGGAG
GACTACTTCACGTCCACCGAGCCCCAGTACCAGCCCGGGGAGAACCTCTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF07714</identifier>
            <name>Pkinase_Tyr</name>
          </pfam>
          <pfam>
            <identifier>PF00017</identifier>
            <name>SH2</name>
          </pfam>
          <pfam>
            <identifier>PF00018</identifier>
            <name>SH3_1</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>actin filament</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>caveola</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extrinsic component of cytoplasmic side of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>late endosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>lysosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial inner membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>perinuclear region of cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>ruffle membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ephrin receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>growth factor receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>heme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>hormone receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>integrin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ion channel binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>kinase binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>non-membrane spanning protein tyrosine kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>phosphoprotein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein tyrosine kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>scaffold protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>SH2 domain binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>SH3/SH2 adaptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>angiotensin-activated signaling pathway involved in heart process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>axon guidance</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>blood coagulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bone resorption</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>branching involved in mammary gland duct morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell adhesion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to fluid shear stress</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to peptide hormone stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to platelet-derived growth factor stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to progesterone stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to reactive oxygen species</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ephrin receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epidermal growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Fc-gamma receptor signaling pathway involved in phagocytosis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>fibroblast growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>forebrain development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>integrin-mediated signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intracellular signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>leukocyte migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>membrane organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of anoikis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cysteine-type endopeptidase activity involved in apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of extrinsic apoptotic signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of focal adhesion assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of intrinsic apoptotic signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of mitochondrial depolarization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of protein homooligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of telomerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of telomere maintenance via telomerase</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>neurotrophin TRK receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>oogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>osteoclast development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>peptidyl-tyrosine autophosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>peptidyl-tyrosine phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>platelet activation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of canonical Wnt signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of epithelial cell migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of ERK1 and ERK2 cascade</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of integrin activation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of lamellipodium morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of peptidyl-tyrosine phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of podosome assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of protein kinase B signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of protein serine/threonine kinase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>progesterone receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein autophosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein destabilization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>Ras protein signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of bone resorption</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of caveolin-mediated endocytosis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of cell cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of cell projection assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of cell-cell adhesion</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of early endosome to late endosome transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of epithelial cell migration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of intracellular estrogen receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of podosome assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of vascular permeability</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to interleukin-1</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal complex assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small GTPase mediated signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>stimulatory C-type lectin receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>stress fiber assembly</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>substrate adhesion-dependent cell spreading</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>T cell costimulation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transforming growth factor beta receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>uterus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vascular endothelial growth factor receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003272</id>
      <name>Pyruvate decarboxylase</name>
      <organism>Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P06672" source="Swiss-Prot">
        <name>Pyruvate decarboxylase</name>
        <general-function>Thiamine pyrophosphate binding</general-function>
        <specific-function/>
        <gene-name>pdc</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.96</theoretical-pi>
        <molecular-weight>60925.005</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="264203">Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M15368</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P06672</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PDC_ZYMMO</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>4.1.1.1</synonym>
          <synonym>PDC</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017043|Pyruvate decarboxylase
MSYTVGTYLAERLVQIGLKHHFAVAGDYNLVLLDNLLLNKNMEQVYCCNELNCGFSAEGY
ARAKGAAAAVVTYSVGALSAFDAIGGAYAENLPVILISGAPNNNDHAAGHVLHHALGKTD
YHYQLEMAKNITAAAEAIYTPEEAPAKIDHVIKTALREKKPVYLEIACNIASMPCAAPGP
ASALFNDEASDEASLNAAVEETLKFIANRDKVAVLVGSKLRAAGAEEAAVKFADALGGAV
ATMAAAKSFFPEENPHYIGTSWGEVSYPGVEKTMKEADAVIALAPVFNDYSTTGWTDIPD
PKKLVLAEPRSVVVNGIRFPSVHLKDYLTRLAQKVSKKTGALDFFKSLNAGELKKAAPAD
PSAPLVNAEIARQVEALLTPNTTVIAETGDSWFNAQRMKLPNGARVEYEMQWGHIGWSVP
AAFGYAVGAPERRNILMVGDGSFQLTAQEVAQMVRLKLPVIIFLINNYGYTIEVMIHDGP
YNNIKNWDYAGLMEVFNGNGGYDSGAGKGLKAKTGGELAEAIKVALANTDGPTLIECFIG
REDCTEELVKWGKRVAAANSRKPVNKLL</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0017044|Pyruvate decarboxylase (pdc)
ATGAGTTATACTGTCGGTACCTATTTAGCGGAGCGGCTTGTCCAGATTGGTCTCAAGCAT
CACTTCGCAGTCGCGGGCGACTACAACCTCGTCCTTCTTGACAACCTGCTTTTGAACAAA
AACATGGAGCAGGTTTATTGCTGTAACGAACTGAACTGCGGTTTCAGTGCAGAAGGTTAT
GCTCGTGCCAAAGGCGCAGCAGCAGCCGTCGTTACCTACAGCGTCGGTGCGCTTTCCGCA
TTTGATGCTATCGGTGGCGCCTATGCAGAAAACCTTCCGGTTATCCTGATCTCCGGTGCT
CCGAACAACAATGATCACGCTGCTGGTCACGTGTTGCATCACGCTCTTGGCAAAACCGAC
TATCACTATCAGTTGGAAATGGCCAAGAACATCACGGCCGCCGCTGAAGCGATTTACACC
CCGGAAGAAGCTCCGGCTAAAATCGATCACGTGATTAAAACTGCTCTTCGTGAGAAGAAG
CCGGTTTATCTCGAAATCGCTTGCAACATTGCTTCCATGCCCTGCGCCGCTCCTGGACCG
GCAAGCGCATTGTTCAATGACGAAGCCAGCGACGAAGCTTCTTTGAATGCAGCGGTTGAA
GAAACCCTGAAATTCATCGCCAACCGCGACAAAGTTGCCGTCCTCGTCGGCAGCAAGCTG
CGCGCAGCTGGTGCTGAAGAAGCTGCTGTCAAATTTGCTGATGCTCTCGGTGGCGCAGTT
GCTACCATGGCTGCTGCAAAAAGCTTCTTCCCAGAAGAAAACCCGCATTACATCGGCACC
TCATGGGGTGAAGTCAGCTATCCGGGCGTTGAAAAGACGATGAAAGAAGCCGATGCGGTT
ATCGCTCTGGCTCCTGTCTTCAACGACTACTCCACCACTGGTTGGACGGATATTCCTGAT
CCTAAGAAACTGGTTCTCGCTGAACCGCGTTCTGTCGTCGTTAACGGCATTCGCTTCCCC
AGCGTCCATCTGAAAGACTATCTGACCCGTTTGGCTCAGAAAGTTTCCAAGAAAACCGGT
GCATTGGACTTCTTCAAATCCCTCAATGCAGGTGAACTGAAGAAAGCCGCTCCGGCTGAT
CCGAGTGCTCCGTTGGTCAACGCAGAAATCGCCCGTCAGGTCGAAGCTCTTCTGACCCCG
AACACGACGGTTATTGCTGAAACCGGTGACTCTTGGTTCAATGCTCAGCGCATGAAGCTC
CCGAACGGTGCTCGCGTTGAATATGAAATGCAGTGGGGTCACATTGGTTGGTCCGTTCCT
GCCGCCTTCGGTTATGCCGTCGGTGCTCCGGAACGTCGCAACATCCTCATGGTTGGTGAT
GGTTCCTTCCAGCTGACGGCTCAGGAAGTCGCTCAGATGGTTCGCCTGAAACTGCCGGTT
ATCATCTTCTTGATCAATAACTATGGTTACACCATCGAAGTTATGATCCATGATGGTCCG
TACAACAACATCAAGAACTGGGATTATGCCGGTCTGATGGAAGTGTTCAACGGTAACGGT
GGTTATGACAGCGGTGCTGGTAAAGGCCTGAAGGCTAAAACCGGTGGCGAACTGGCAGAA
GCTATCAAGGTTGCTCTGGCAAACACCGACGGCCCAACCCTGATCGAATGCTTCATCGGT
CGTGAAGACTGCACTGAAGAATTGGTCAAATGGGGTAAGCGCGTTGCTGCCGCCAACAGC
CGTAAGCCTGTTAACAAGCTCCTCTAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02775</identifier>
            <name>TPP_enzyme_C</name>
          </pfam>
          <pfam>
            <identifier>PF00205</identifier>
            <name>TPP_enzyme_M</name>
          </pfam>
          <pfam>
            <identifier>PF02776</identifier>
            <name>TPP_enzyme_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyruvate decarboxylase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>thiamine pyrophosphate binding</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0003317</id>
      <name>Ribonuclease pancreatic</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07998" source="Swiss-Prot">
        <name>Ribonuclease pancreatic</name>
        <general-function>Ribonuclease a activity</general-function>
        <specific-function>Endonuclease that catalyzes the cleavage of RNA on the 3' side of pyrimidine nucleotides. Acts on single-stranded and double-stranded RNA.</specific-function>
        <gene-name>RNASE1</gene-name>
        <locus>14q11.2</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-28</signal-regions>
        <theoretical-pi>8.94</theoretical-pi>
        <molecular-weight>17644.125</molecular-weight>
        <chromosome-location>14</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10044</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>RNASE1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>D26129</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P07998</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>RNAS1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.27.5</synonym>
          <synonym>HP-RNase</synonym>
          <synonym>RIB-1</synonym>
          <synonym>RIB1</synonym>
          <synonym>Ribonuclease 1</synonym>
          <synonym>Ribonuclease A</synonym>
          <synonym>RNase 1</synonym>
          <synonym>RNase A</synonym>
          <synonym>RNase UpI-1</synonym>
          <synonym>RNS1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012319|Ribonuclease pancreatic
MALEKSLVRLLLLVLILLVLGWVQPSLGKESRAKKFQRQHMDSDSSPSSSSTYCNQMMRR
RNMTQGRCKPVNTFVHEPLVDVQNVCFQEKVTCKNGQGNCYKSNSSMHITDCRLTNGSRY
PNCAYRTSPKERHIIVACEGSPYVPVHFDASVEDST</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0012320|Ribonuclease pancreatic (RNASE1)
ATGGCTCTGGAGAAGTCTCTTGTCCGGCTCCTTCTGCTTGTCCTGATACTGCTGGTGCTG
GGCTGGGTCCAGCCTTCCCTGGGCAAGGAATCCCGGGCCAAGAAATTCCAGCGGCAGCAT
ATGGACTCAGACAGTTCCCCCAGCAGCAGCTCCACCTACTGTAACCAAATGATGAGGCGC
CGGAATATGACACAGGGGCGGTGCAAACCAGTGAACACCTTTGTGCACGAGCCCCTGGTA
GATGTCCAGAATGTCTGTTTCCAGGAAAAGGTCACCTGCAAGAACGGGCAGGGCAACTGC
TACAAGAGCAACTCCAGCATGCACATCACAGACTGCCGCCTGACAAACGGCTCCAGGTAC
CCCAACTGTGCATACCGGACCAGCCCGAAGGAGAGACACATCATTGTGGCCTGTGAAGGG
AGCCCATATGTGCCAGTCCACTTTGATGCTTCTGTGGAGGACTCTACCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00074</identifier>
            <name>RnaseA</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleic acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ribonuclease A activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA phosphodiester bond hydrolysis, endonucleolytic</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001524</id>
      <name>Isocitrate dehydrogenase [NADP]</name>
      <organism>Bacillus subtilis (strain 168)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P39126" source="Swiss-Prot">
        <name>Isocitrate dehydrogenase [NADP]</name>
        <general-function>Nad binding</general-function>
        <specific-function/>
        <gene-name>icd</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>4.74</theoretical-pi>
        <molecular-weight>46417.39</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="224308">Bacillus subtilis (strain 168)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U05257</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>487434</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P39126</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>IDH_BACSU</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.1.1.42</synonym>
          <synonym>citC</synonym>
          <synonym>IDH</synonym>
          <synonym>IDP</synonym>
          <synonym>NADP(+)-specific ICDH</synonym>
          <synonym>Oxalosuccinate decarboxylase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011078|Isocitrate dehydrogenase [NADP]
MAQGEKITVSNGVLNVPNNPIIPFIEGDGTGPDIWNAASKVLEAAVEKAYKGEKKITWKE
VYAGEKAYNKTGEWLPAETLDVIREYFIAIKGPLTTPVGGGIRSLNVALRQELDLFVCLR
PVRYFTGVPSPVKRPEDTDMVIFRENTEDIYAGIEYAKGSEEVQKLISFLQNELNVNKIR
FPETSGIGIKPVSEEGTSRLVRAAIDYAIEHGRKSVTLVHKGNIMKFTEGAFKNWGYELA
EKEYGDKVFTWAQYDRIAEEQGKDAANKAQSEAEAAGKIIIKDSIADIFLQQILTRPNEF
DVVATMNLNGDYISDALAAQVGGIGIAPGANINYETGHAIFEATHGTAPKYAGLDKVNPS
SVILSGVLLLEHLGWNEAADLVIKSMEKTIASKVVTYDFARLMDGATEVKCSEFGEELIK
NMD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011079|Isocitrate dehydrogenase [NADP] (icd)
GTGGCACAAGGTGAAAAAATTACAGTCTCTAACGGAGTATTAAACGTACCAAACAACCCG
ATTATCCCATTTATCGAAGGAGACGGAACCGGTCCTGATATTTGGAACGCGGCTTCGAAG
GTTTTGGAAGCAGCAGTAGAAAAAGCATACAAAGGCGAAAAGAAAATTACATGGAAAGAA
GTTTACGCCGGAGAAAAGGCTTATAATAAAACAGGTGAGTGGCTCCCTGCTGAAACATTA
GATGTGATCCGCGAATATTTCATCGCGATTAAAGGCCCGTTAACGACACCTGTCGGCGGC
GGTATCCGTTCTTTGAACGTAGCGCTCAGACAAGAGCTTGACCTATTCGTCTGCTTAAGA
CCTGTAAGATACTTTACTGGAGTGCCGTCACCGGTAAAACGCCCTGAAGATACTGATATG
GTCATCTTCCGTGAAAATACAGAAGATATTTACGCAGGCATCGAGTATGCAAAAGGCTCT
GAAGAAGTGCAAAAGCTTATCAGCTTCCTTCAAAATGAGTTAAACGTCAATAAAATCCGT
TTCCCTGAGACATCAGGTATCGGCATTAAGCCTGTTTCAGAAGAAGGAACAAGCCGCTTG
GTCAGAGCTGCCATTGATTATGCGATCGAGCATGGCCGCAAATCTGTAACACTTGTTCAC
AAAGGAAACATCATGAAGTTCACAGAAGGCGCCTTCAAAAACTGGGGCTATGAACTTGCT
GAAAAAGAATACGGAGATAAAGTCTTCACATGGGCTCAATATGACCGCATTGCTGAAGAA
CAAGGAAAAGACGCTGCCAACAAAGCGCAAAGCGAAGCGGAAGCAGCAGGAAAAATCATT
ATCAAAGACAGCATTGCTGACATTTTCCTTCAGCAGATCTTAACGCGTCCAAACGAGTTT
GATGTCGTTGCGACAATGAACTTGAACGGAGATTACATTTCTGATGCTCTTGCTGCGCAA
GTCGGCGGAATCGGCATTGCTCCTGGAGCGAACATCAACTACGAAACAGGACATGCGATT
TTCGAGGCGACGCACGGAACGGCTCCTAAATATGCAGGCCTTGATAAAGTAAACCCATCT
TCAGTTATTCTTTCAGGCGTTCTGCTTCTTGAGCATTTAGGATGGAACGAAGCGGCTGAT
TTGGTTATCAAATCTATGGAAAAAACAATCGCTTCTAAAGTCGTAACTTACGATTTTGCC
AGATTAATGGACGGGGCGACTGAAGTGAAATGTTCAGAGTTCGGAGAAGAACTGATCAAA
AACATGGACTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00180</identifier>
            <name>Iso_dh</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>isocitrate dehydrogenase (NADP+) activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>magnesium ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NAD binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glyoxylate cycle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tricarboxylic acid cycle</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000372</id>
      <name>Glycine N-methyltransferase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14749" source="Swiss-Prot">
        <name>Glycine N-methyltransferase</name>
        <general-function>Glycine n-methyltransferase activity</general-function>
        <specific-function>Catalyzes the methylation of glycine by using S-adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine.</specific-function>
        <gene-name>GNMT</gene-name>
        <locus>6p12</locus>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.03</theoretical-pi>
        <molecular-weight>32742.0</molecular-weight>
        <chromosome-location>6</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:4415</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>GNMT</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF101477</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>8671584</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q14749</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GNMT_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.1.20</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010119|Glycine N-methyltransferase
MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQR
VLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMT
LDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNY
DHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSK
FRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010120|Glycine N-methyltransferase (GNMT)
ATGGTGGACAGCGTGTACCGGACCCGCTCCCTGGGGGTGGCGGCCGAAGGGCTCCCGGAC
CAGTACGCGGACGGGGAGGCGGCGCGCGTGTGGCAGCTGTATATCGGAGACACCCGCAGC
CGCACCGCCGAGTACAAGGCATGGCTGCTTGGGCTGCTGCGCCAGCACGGCTGCCAGCGG
GTGCTCGACGTAGCCTGTGGCACTGGGGTGGACTCCATTATGCTGGTGGAAGAGGGCTTC
AGTGTGACGAGTGTGGATGCCAGTGACAAGATGCTGAAGTATGCACTTAAGGAGCGCTGG
AACCGGCGGCACGAGCCCGCCTTCGACAAGTGGGTCATCGAAGAAGCCAACTGGATGACT
CTGGACAAAGATGTGCCCCAGTCAGCAGAGGGTGGCTTTGATGCTGTCATCTGCCTTGGA
AACAGTTTCGCTCACTTGCCAGACTGCAAAGGGGACCAGAGTGAGCACCGGCTGGCGCTG
AAAAACATTGCGAGCATGGTGCGGGCAGGGGGCCTACTGGTCATTGATCATCGCAACTAC
GACCACATCCTCAGTACAGGCTGTGCACCCCCAGGGAAGAACATCTACTATAAGAGTGAC
TTGACCAAGGACGTCACAACATCAGTGCTGATAGTGAACAACAAGGCCCACATGGTGACC
CTGGACTATACGGTGCAGGTGCCGGGGGCTGGCCAGGATGGCTCTCCTGGCTTGAGTAAG
TTCCGGCTCTCCTACTACCCACACTGTCTGGCATCCTTCACGGAGCTGCTCCAAGCAGCC
TTCGGAGGTAAGTGCCAGCACAGCGTCCTGGGCGACTTCAAGCCTTACAAGCCAGGCCAA
ACCTACATTCCCTGCTACTTCATCCACGTGCTCAAGAGGACAGACTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF08242</identifier>
            <name>Methyltransf_12</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>folic acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine N-methyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular protein modification process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycogen metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>methionine metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>one-carbon metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein homotetramerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of gluconeogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>S-adenosylmethionine metabolic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000908</id>
      <name>Eosinophil cationic protein</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P12724" source="Swiss-Prot">
        <name>Eosinophil cationic protein</name>
        <general-function>Ribonuclease activity</general-function>
        <specific-function>Cytotoxin and helminthotoxin with low-efficiency ribonuclease activity. Possesses a wide variety of biological activities. Exhibits antibacterial activity, including cytoplasmic membrane depolarization of preferentially Gram-negative, but also Gram-positive strains. Promotes E.coli outer membrane detachment, alteration of the overall cell shape and partial loss of cell content.</specific-function>
        <gene-name>RNASE3</gene-name>
        <locus>14q24-q31</locus>
        <cellular-location>Secreted</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-27</signal-regions>
        <theoretical-pi>10.33</theoretical-pi>
        <molecular-weight>18385.145</molecular-weight>
        <chromosome-location>14</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10046</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>RNASE3</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X15161</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31077</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P12724</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ECP_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.1.27.-</synonym>
          <synonym>ECP</synonym>
          <synonym>Ribonuclease 3</synonym>
          <synonym>RNase 3</synonym>
          <synonym>RNS3</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010638|Eosinophil cationic protein
MVPKLFTSQICLLLLLGLMGVEGSLHARPPQFTRAQWFAIQHISLNPPRCTIAMRAINNY
RWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNI
SNCTYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010639|Eosinophil cationic protein (RNASE3)
ATGGTTCCAAAACTGTTCACTTCCCAAATTTGTCTGCTTCTTCTGTTGGGGCTTATGGGT
GTGGAGGGCTCACTCCATGCCAGACCCCCACAGTTTACGAGGGCTCAGTGGTTTGCCATC
CAGCACATCAGTCTGAACCCCCCTCGATGCACCATTGCAATGCGGGCAATTAACAATTAT
CGATGGCGTTGCAAAAACCAAAATACTTTTCTTCGTACAACTTTTGCTAATGTAGTTAAT
GTTTGTGGTAACCAAAGTATACGCTGCCCTCATAACAGAACTCTCAACAATTGTCATCGG
AGTAGATTCCGGGTGCCTTTACTCCACTGTGACCTCATAAATCCAGGTGCACAGAATATT
TCAAACTGCACGTATGCAGACAGACCAGGAAGGAGGTTCTATGTAGTTGCATGTGACAAC
AGAGATCCACGGGATTCTCCACGGTATCCTGTGGTTCCAGTTCACCTGGATACCACCATC
TAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00074</identifier>
            <name>RnaseA</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular space</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>endonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleic acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ribonuclease activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>antibacterial humoral response</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>defense response to Gram-positive bacterium</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>innate immune response in mucosa</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>nucleic acid phosphodiester bond hydrolysis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA phosphodiester bond hydrolysis</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001482</id>
      <name>Beta-lactamase</name>
      <organism>Bacillus licheniformis</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00808" source="Swiss-Prot">
        <name>Beta-lactamase</name>
        <general-function>Beta-lactamase activity</general-function>
        <specific-function/>
        <gene-name>penP</gene-name>
        <locus/>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions/>
        <signal-regions>1-26</signal-regions>
        <theoretical-pi>5.61</theoretical-pi>
        <molecular-weight>33995.36</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1402">Bacillus licheniformis</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>V00093</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>39575</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P00808</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>BLAC_BACLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>3.5.2.6</synonym>
          <synonym>blaP</synonym>
          <synonym>Penicillinase</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011047|Beta-lactamase
MKLWFSTLKLKKAAAVLLFSCVALAGCANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVAYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNAAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PELNEVNPGETQDTSTARALVTSLRAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
DGWEVADKTGAASYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVMK
ALNMNGK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0002941|924 bp
ATGAAATTATGGTTCAGTACTTTAAAACTGAAAAAGGCTGCAGCAGTGTTGCTTTTCTCT
TGCGTCGCGCTTGCAGGATGCGCTAACAATCAAACGAATGCCTCGCAACCTGCCGAGAAG
AATGAAAAGACGGAGATGAAAGATGATTTTGCAAAACTTGAGGAACAATTTGATGCAAAA
CTCGGGATCTTTGCATTGGATACAGGTACAAACCGGACGGTAGCGTATCGGCCGGATGAG
CGTTTTGCTTTTGCTTCGACGATTAAGGCTTTAACTGTAGGCGTGCTTTTGCAACAGAAA
TCAATAGAAGATCTGAACCAGAGAATAACATATACACGTGATGATCTTGTAAACTACAAC
CCGATTACGGAAAAGCACGTTGATACGGGAATGACGCTCAAAGAGCTTGCGGATGCTTCG
CTTCGATATAGTGACAATGCGGCACAGAATCTCATTCTTAAACAAATTGGCGGACCTGAA
AGTTTGAAAAAGGAACTGAGGAAGATTGGTGATGAGGTTACAAATCCCGAACGATTCGAA
CCAGAGTTAAATGAAGTGAATCCGGGTGAAACTCAGGATACCAGTACAGCAAGAGCACTT
GTCACAAGCCTTCGAGCCTTTGCTCTTGAAGATAAACTTCCAAGTGAAAAACGCGAGCTT
TTAATCGATTGGATGAAACGAAATACCACTGGAGACGCCTTAATCCGTGCCGGTGTGCCG
GACGGTTGGGAAGTGGCTGATAAAACTGGAGCGGCATCATATGGAACCCGGAATGACATT
GCCATCATTTGGCCGCCAAAAGGAGATCCTGTCGTTCTTGCAGTATTATCCAGCAGGGAT
AAAAAGGACGCCAAGTATGATGATAAACTTATTGCAGAGGCAACAAAGGTGGTAATGAAA
GCCTTAAACATGAACGGCAAATAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00144</identifier>
            <name>Beta-lactamase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>beta-lactamase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>beta-lactam antibiotic catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to antibiotic</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0001042</id>
      <name>Solute carrier organic anion transporter family member 2B1</name>
      <organism>Humans</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A16113</ref-id>
            <pubmed-id>12724351</pubmed-id>
            <citation>Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8. Epub 2003 Apr 30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O94956" source="Swiss-Prot">
        <name>Solute carrier organic anion transporter family member 2B1</name>
        <general-function>Sodium-independent organic anion transmembrane transporter activity</general-function>
        <specific-function>Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost.</specific-function>
        <gene-name>SLCO2B1</gene-name>
        <locus>11q13</locus>
        <cellular-location>Cell membrane</cellular-location>
        <transmembrane-regions>50-69
89-109
116-140
186-215
235-255
274-298
367-388
409-432
437-460
565-587
597-622
656-673</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>8.39</theoretical-pi>
        <molecular-weight>76709.98</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:10962</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>SLCO2B1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB026256</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>5006263</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O94956</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>SO2B1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>KIAA0880</synonym>
          <synonym>OATP-B</synonym>
          <synonym>OATP-RP2</synonym>
          <synonym>OATP2B1</synonym>
          <synonym>OATPB</synonym>
          <synonym>OATPRP2</synonym>
          <synonym>Organic anion transporter B</synonym>
          <synonym>Organic anion transporter polypeptide-related protein 2</synonym>
          <synonym>SLC21A9</synonym>
          <synonym>Solute carrier family 21 member 9</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037115|Solute carrier organic anion transporter family member 2B1
MGPRIGPAGEVPQVPDKETKATMGTENTPGGKASPDPQDVRPSVFHNIKLFVLCHSLLQL
AQLMISGYLKSSISTVEKRFGLSSQTSGLLASFNEVGNTALIVFVSYFGSRVHRPRMIGY
GAILVALAGLLMTLPHFISEPYRYDNTSPEDMPQDFKASLCLPTTSAPASAPSNGNCSSY
TETQHLSVVGIMFVAQTLLGVGGVPIQPFGISYIDDFAHNSNSPLYLGILFAVTMMGPGL
AFGLGSLMLRLYVDINQMPEGGISLTIKDPRWVGAWWLGFLIAAGAVALAAIPYFFFPKE
MPKEKRELQFRRKVLAVTDSPARKGKDSPSKQSPGESTKKQDGLVQIAPNLTVIQFIKVF
PRVLLQTLRHPIFLLVVLSQVCLSSMAAGMAIFLPKFLERQFSITASYANLLIGCLSFPS
VIVGIVVGGVLVKRLHLGPVGCGALCLLGMLLCLFFSLPLFFIGCSSHQIAGITHQTSAH
PGLELSPSCMEACSCPLDGFNPVCDPSTRVEYITPCHAGCSSWVVQDALDNSQVFYTNCS
CVVEGNPVLAGSCDSTCSHLVVPFLLLVSLGSALACLTHTPSFMLILRGVKKEDKTLAVG
IQFMFLRILAWMPSPVIHGSAIDTTCVHWALSCGRRAVCRYYNNDLLRNRFIGLQFFFKT
GSVICFALVLAVLRQQDKEARTKESRSSPAVEQQLLVSGPGKKPEDSRV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010728|Solute carrier organic anion transporter family member 2B1 (SLCO2B1)
ATGGGCACAGAAAACACACCTGGAGGCAAAGCCAGCCCAGACCCTCAGGACGTGCGGCCA
AGTGTGTTCCATAACATCAAGCTGTTCGTTCTGTGCCACAGCCTGCTGCAGCTGGCGCAG
CTCATGATCTCCGGCTACCTAAAGAGCTCCATCTCCACAGTGGAGAAGCGCTTCGGCCTC
TCCAGCCAGACGTCGGGGCTGCTGGCCTCCTTCAACGAGGTGGGGAACACAGCCTTGATT
GTGTTTGTGAGCTATTTTGGCAGCCGGGTGCACCGACCCCGAATGATTGGCTATGGGGCT
ATCCTTGTGGCCCTGGCGGGCCTGCTCATGACTCTCCCGCACTTCATCTCGGAGCCATAC
CGCTACGACAACACCAGCCCTGAGGATATGCCACAGGACTTCAAGGCTTCCCTGTGCCTG
CCCACAACCTCGGCCCCAGCCTCGGCCCCCTCCAATGGCAACTGCTCAAGCTACACAGAA
ACCCAGCATCTGAGTGTGGTGGGGATCATGTTCGTGGCACAGACCCTGCTGGGCGTGGGC
GGGGTGCCCATTCAGCCCTTTGGCATCTCCTACATCGATGACTTTGCCCACAACAGCAAC
TCGCCCCTCTACCTCGGGATCCTGTTTGCAGTGACCATGATGGGGCCAGGCCTGGCCTTT
GGGCTGGGCAGCCTCATGCTGCGCCTTTATGTGGACATTAACCAGATGCCAGAAGGTGGT
ATCAGCCTGACCATAAAGGACCCCCGATGGGTGGGTGCCTGGTGGCTGGGTTTCCTCATC
GCTGCCGGTGCAGTGGCCCTGGCTGCCATCCCCTACTTCTTCTTCCCCAAGGAAATGCCC
AAGGAAAAACGTGAGCTTCAGTTTCGGCGAAAGGTCTTAGCAGTCACAGACTCACCTGCC
AGGAAGGGCAAGGACTCTCCCTCTAAGCAGAGCCCTGGGGAGTCCACGAAGAAGCAGGAT
GGCCTAGTCCAGATTGCACCAAACCTGACTGTGATCCAGTTCATTAAAGTCTTCCCCAGG
GTGCTGCTGCAGACCCTACGCCACCCCATCTTCCTGCTGGTGGTCCTGTCCCAGGTATGC
TTGTCATCCATGGCTGCGGGCATGGCCACCTTCCTGCCCAAGTTCCTGGAGCGCCAGTTT
TCCATCACAGCCTCCTACGCCAACCTGCTCATCGGCTGCCTCTCCTTCCCTTCGGTCATC
GTGGGCATCGTGGTGGGTGGCGTCCTGGTCAAGCGGCTCCACCTGGGCCCTGTGGGATGC
GGTGCCCTTTGCCTGCTGGGGATGCTGCTGTGCCTCTTCTTCAGCCTGCCGCTCTTCTTT
ATCGGCTGCTCCAGCCACCAGATTGCGGGCATCACACACCAGACCAGTGCCCACCCTGGG
CTGGAGCTGTCTCCAAGCTGCATGGAGGCCTGCTCCTGCCCATTGGACGGCTTTAACCCT
GTCTGCGACCCCAGCACTCGTGTGGAATACATCACACCCTGCCACGCAGGCTGCTCAAGC
TGGGTGGTCCAGGATGCTCTGGACAACAGCCAGGTTTTCTACACCAACTGCAGCTGCGTG
GTGGAGGGCAACCCCGTGCTGGCAGGATCCTGCGACTCAACGTGCAGCCATCTGGTGGTG
CCCTTCCTGCTCCTGGTCAGCCTGGGCTCGGCCCTGGCCTGTCTCACCCACACACCCTCC
TTCATGCTCATCCTAAGAGGAGTGAAGAAAGAAGACAAGACTTTGGCTGTGGGCATCCAG
TTCATGTTCCTGAGGATTTTGGCCTGGATGCCCAGCCCCGTGATCCACGGCAGCGCCATC
GACACCACCTGTGTGCACTGGGCCCTGAGCTGTGGGCGTCGAGCTGTCTGTCGCTACTAC
AATAATGACCTGCTCCGAAACCGGTTCATCGGCCTCCAGTTCTTCTTCAAAACAGGTTCT
GTGATCTGCTTCGCCTTAGTTTTGGCTGTCCTGAGGCAGCAGGACAAAGAGGCAAGGACC
AAAGAGAGCAGATCCAGCCCTGCCGTAGAGCAGCAATTGCTAGTGTCGGGGCCAGGGAAG
AAGCCAGAGGATTCCCGAGTGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF03137</identifier>
            <name>OATP</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>bile acid transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>organic anion transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>sodium-independent organic anion transmembrane transporter activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>anion transmembrane transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>bile acid and bile salt transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sodium-independent organic anion transport</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transmembrane transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </transporter>
  </transporters>
</drug>